Document:

EX-4.3

 Exhibit 4.3 
 $150,000,000 
 Acadia Healthcare Company, Inc. 

6.125% Senior Notes due 2021 
 REGISTRATION RIGHTS AGREEMENT 
 March 12, 2013 

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

 As Representative of the Initial Purchasers 
 One Bryant Park 
 New York, New York 10036 

Ladies and Gentlemen: 
 Acadia
Healthcare Company, Inc., a Delaware corporation (the “Company”), is issuing and selling to Merrill Lynch, Pierce, Fenner & Smith Incorporated and the other several initial purchasers (the “Initial
Purchasers”) named in Schedule I of the Purchase Agreement dated March 7, 2013 (the “Purchase Agreement”), by and among the Company, the guarantors named therein and Merrill Lynch, Pierce, Fenner & Smith
Incorporated, as representative (the “Representative”) of the several Initial Purchasers, upon the terms set forth in the Purchase Agreement, $150,000,000 aggregate principal amount of 6.125% Senior Notes due 2021 issued by the
Company (each, a “Note” and collectively, the “Notes”). As an inducement to the Initial Purchasers to enter into the Purchase Agreement, the Company and the Guarantors agree with the Initial Purchasers, for the
benefit of the Holders (as defined below) of the Notes (including, without limitation, the Initial Purchasers), as follows: 

Section 1. Definitions. 
 Capitalized terms that are used herein without definition and are defined in the Purchase Agreement shall have the respective meanings ascribed to them in the Purchase Agreement. As used in this
Agreement, the following terms shall have the following meanings: 
 “Additional Interest.” See
Section 4(a). 
 “Advice.” See Section 6(u). 

“Agreement.” This Registration Rights Agreement, dated as of the Closing Date, among the Company, the Guarantors and the
Initial Purchasers. 
 “Applicable Period.” See Section 2(e). 

 “Business Day.” A day that is not a Saturday, a Sunday or a day on which
banking institutions in the City of New York are authorized or required by law or executive order to be closed. 

“Closing Date.” March 12, 2013. 
 “Company.” See the introductory paragraph to this Agreement. 

“Day.” Unless otherwise expressly provided, a calendar day. 

“Effectiveness Date.” The 450th day after the Closing Date. 

“Effectiveness Period.” See Section 3(a). 
 “Exchange Act.” The Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder. 

“Exchange Notes.” 6.125% Senior Notes due 2021 of the Company, registered under the Securities Act, to be issued under
the Indenture, which Exchange Notes shall be identical in all material respects to the Notes, including the guarantees relating thereto, if any, except for provisions relating to series, restrictive legends and Additional Interest. 

“Exchange Offer.” See Section 2(a). 
 “Exchange Registration Statement.” See Section 2(a). 

“Filing Date.” The 360th day after the Closing Date. 

“FINRA.” Financial Industry Regulatory Authority, Inc. 

“Guarantor.” Each subsidiary of the Company that guarantees the obligations of the Company under the Notes and the
Indenture. 
 “Holder.” Any registered holder of Registrable Notes, unless the context requires beneficial
holder of Registrable Notes. 
 “Indemnified Party.” See Section 8(c). 

“Indemnifying Party.” See Section 8(c). 
 “Indenture.” The Indenture, dated as of the Closing Date, among the Company, the Guarantors and U.S. Bank National Association, as trustee, pursuant to which the Notes are being issued,
as amended or supplemented from time to time in accordance with the terms hereof. 
 “Initial Purchasers.” See
the introductory paragraph to this Agreement. 
 “Initial Shelf Registration.” See Section 3(a).

  
 2 

 “Inspectors.” See Section 6(o). 

“Losses.” See Section 8(a). 
 “Notes.” See the introductory paragraph to this Agreement. 

“Participating Broker-Dealer.” See Section 2(e). 

“Person.” An individual, trustee, corporation, partnership, limited liability company, joint stock company, trust,
unincorporated association, union, business association, firm, government or agency or political subdivision thereof, or other legal entity. 
 “Prospectus.” The prospectus included in any Registration Statement (including, without limitation, a prospectus that discloses information previously omitted from a prospectus filed as
part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement filed by the Company with the SEC, with respect to the terms of the offering of any
portion of the Registrable Notes covered by such Registration Statement, and all other amendments and supplements filed by the Company with the SEC to the Prospectus, including post-effective amendments, and all material incorporated by reference or
deemed to be incorporated by reference in such Prospectus. 
 “Purchase Agreement.” See the introductory
paragraph to this Agreement. 
 “Records.” See Section 6(o). 

“Registration Default.” See Section 4(a). 
 “Registrable Notes.” Notes; provided, however, that a Note shall cease to be a Registrable Note upon the earliest to occur of the following: (i) in the circumstances
contemplated by Section 2(a), the Note has been exchanged for an Exchange Note in an Exchange Offer as contemplated in Section 2(a); (ii) in the circumstances contemplated by Section 3, a Shelf Registration registering such Note
under the Securities Act has been declared or becomes effective and such Note has been sold or otherwise transferred by the holder thereof pursuant to and in a manner contemplated by such effective Shelf Registration; (iii) such Note is
actually sold by the holder thereof pursuant to Rule 144 under circumstances in which any legend borne by such Note relating to restrictions on transferability thereof, under the Securities Act or otherwise, is removed by the Company or pursuant to
the Indenture; or (iv) such Note shall cease to be outstanding. 
 “Registration Statement.” Any
registration statement of the Company and the Guarantors filed with the SEC under the Securities Act (including, but not limited to, the Exchange Registration Statement, the Initial Shelf Registration and any subsequent Shelf Registration) that
covers any of the Registrable Notes pursuant to the provisions of this Agreement, including the Prospectus, amendments and supplements to such registration statement, including post-effective amendments, all exhibits and all material incorporated by
reference or deemed to be incorporated by reference in such registration statement. 

  
 3 

 “Representative.” See the introductory paragraph to this Agreement.

 “Rule 144.” Rule 144 promulgated under the Securities Act, as such Rule may be amended from time to time, or
any similar rule (other than Rule 144A) or regulation hereafter adopted by the SEC providing for offers and sales of securities made in compliance therewith resulting in offers and sales by subsequent holders that are not affiliates of an issuer or
such securities being free of the registration and prospectus delivery requirements of the Securities Act. 
 “Rule
144A.” Rule 144A promulgated under the Securities Act, as such Rule may be amended from time to time, or any similar rule (other than Rule 144) or regulation hereafter adopted by the SEC. 

“Rule 415.” Rule 415 promulgated under the Securities Act, as such Rule may be amended from time to time, or any similar
rule or regulation hereafter adopted by the SEC. 
 “Rule 430A.” Rule 430A promulgated under the Securities
Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC. 

“SEC.” The United States Securities and Exchange Commission. 

“Securities.” The Notes and the Exchange Notes. 

“Securities Act.” The Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated
thereunder. 
 “Shelf Effectiveness Date.” The date that is the 90th day after the receipt of the relevant
Shelf Notice. 
 “Shelf Notice.” See Section 2(i). 

“Shelf Registration.” See Section 3(b). 
 “Shelf Suspension Period.” See Section 3(e). 

“Subsequent Shelf Registration.” See Section 3(b). 

“TIA.” The Trust Indenture Act of 1939, as amended. 

“Trustee.” The trustee under the Indenture and, if existent, the trustee under any indenture governing the Exchange
Notes. 
 “Underwritten Registration or Underwritten Offering.” A registration in which securities of
the Company are sold to an underwriter for reoffering to the public. 

  
 4 

 Section 2. Exchange Offer. 

(a) Unless the Exchange Offer would not be permitted by applicable laws or a policy of the SEC, the Company shall (and shall cause each
Guarantor to) (i) prepare and file with the SEC, in no event later than the Filing Date, a registration statement (the “Exchange Registration Statement”) on an appropriate form under the Securities Act with respect to an offer
(the “Exchange Offer”) to the Holders of Notes to issue and deliver to such Holders, in exchange for the Notes, a like principal amount of Exchange Notes, (ii) use its commercially reasonable efforts to cause the Exchange
Registration Statement to become effective as promptly as practicable after the filing thereof, but in no event later than the Effectiveness Date, (iii) use its commercially reasonable efforts to keep the Exchange Registration Statement
effective until the consummation of the Exchange Offer in accordance with its terms, and (iv) commence the Exchange Offer and use its commercially reasonable efforts to issue on or prior to 60 Business Days after the date on which the Exchange
Registration Statement is declared effective, Exchange Notes in exchange for all Notes tendered prior thereto in the Exchange Offer. The Exchange Offer shall not be subject to any conditions, other than that the Exchange Offer does not violate
applicable law or any applicable interpretation of the staff of the SEC. 
 (b) The Exchange Notes shall be issued under, and
entitled to the benefits of, the Indenture or a trust indenture that is substantially identical to the Indenture (other than such changes as are necessary to comply with any requirements of applicable law or the SEC to effect or maintain the
qualifications thereof under the TIA). 
 (c) Interest on the Exchange Notes will accrue from (i) the later of (x) the
last interest payment due date on which interest was paid on the Notes surrendered in exchange therefor or (y) if the Note is surrendered for exchange after the record date for an interest payment date to occur on or after the date of such
exchange and as to which interest will be paid, the date of such interest payment date or (ii), if no interest has been paid on the Notes, from the Closing Date. Each Exchange Note shall bear interest at the rate set forth thereon; provided,
that interest with respect to the period prior to the issuance thereof shall accrue at the rate or rates borne by the Notes from time to time during such period. 
 (d) The Company may require each Holder as a condition to participation in the Exchange Offer to represent (i) that any Exchange Notes received by such Holder will be acquired in the ordinary course
of its business, (ii) that at the time of the commencement and consummation of the Exchange Offer such Holder has not entered into any arrangement or understanding with any Person to participate in the distribution (within the meaning of the
Securities Act) of the Exchange Notes in violation of the provisions of the Securities Act, (iii) that if such Holder is an “affiliate” of the Company within the meaning of Rule 405 of the Securities Act, it will comply with the
registration and prospectus delivery requirements of the Securities Act to the extent applicable to it, (iv) if such Holder is not a broker-dealer, that it is not engaged in, and does not intend to engage in, the distribution of the Exchange
Notes and (v) if such Holder is a Participating Broker-Dealer (as defined below), that it will deliver a Prospectus in connection with any resale of the Exchange Notes. 

  
 5 

 (e) The Company shall (and shall cause each Guarantor to) include within the Prospectus
contained in the Exchange Registration Statement a section entitled “Plan of Distribution” reasonably acceptable to the Initial Purchasers, which shall contain all of the information that the SEC may require with respect to the potential
“underwriter” status of any broker-dealer that is the beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of Exchange Notes received by such broker-dealer in the Exchange Offer for its own account in exchange for Notes that
were acquired by it as a result of market-making or other trading activity and from whom the Company has received written notice that such broker-dealer will be a Participating Broker-Dealer in the applicable Exchange Offer (a “Participating
Broker-Dealer”). Such “Plan of Distribution” section shall also allow, to the extent permitted by applicable policies and regulations of the SEC, the use of the Prospectus by all Participating Broker-Dealers, and include a
statement describing the manner in which Participating Broker-Dealers may resell the Exchange Notes. The Company shall use its commercially reasonable efforts to keep the Exchange Registration Statement effective and to amend and supplement the
Prospectus contained therein, in order to permit such Prospectus to be lawfully delivered by Participating Broker-Dealers for such period of time as such Persons must comply with such requirements in order to resell the Exchange Notes; provided,
that such period shall not exceed the lesser of 180 days and the date on which all Participating Broker Dealers have sold all Exchange Notes held by them (the “Applicable Period”). 

(f) In connection with the Exchange Offer, the Company shall (and shall cause each Guarantor to): 

(i) mail or cause to be mailed to each Holder of record a copy of the Prospectus forming part of the Exchange Registration
Statement, together with an appropriate letter of transmittal (substantially in the form attached as an exhibit to the Exchange Offer Registration Statement) and any related documents; 

(ii) keep the Exchange Offer open for not less than 20 Business Days after the date notice thereof is mailed to the
Holders (or longer if required by applicable law) 
 (iii) utilize the services of a depository for the Exchange
Offer with an address in the Borough of Manhattan, the City of New York, which may be the Trustee or an affiliate thereof; 
 (iv) permit Holders to withdraw tendered Registrable Notes at any time prior to the close of business, New York City time, on the last Business Day on which the Exchange Offer shall remain open; and

 (v) otherwise comply in all material respects with all applicable laws. 

(g) As soon as practicable after the close of the Exchange Offer the Company shall (and shall cause each Guarantor to): 

(i) accept for exchange all Registrable Notes validly tendered pursuant to the Exchange Offer and not validly withdrawn;

  
 6 

 (ii) deliver or cause to be delivered to the Trustee for cancellation all
Registrable Notes so accepted for exchange; and 
 (iii) cause the Trustee to authenticate and deliver promptly
to each Holder validly tendering such Registrable Notes, Exchange Notes equal in principal amount to the Notes of such Holder so accepted for exchange. 
 (h) The Exchange Notes may be issued under (i) the Indenture or (ii) an indenture substantially identical to the Indenture (other than such changes as are necessary to comply with any
requirements of the SEC to effect or maintain the qualification thereof under the TIA), which in either event will provide that the Exchange Notes will not be subject to the transfer restrictions set forth in the Indenture, and that the Exchange
Notes and the Notes, if any, will be deemed one class of security (subject to the provisions of the Indenture). 
 (i) If:
(i) prior to the consummation of the Exchange Offer, the Holders of a majority in aggregate principal amount of Registrable Notes determines in its or their reasonable judgment that (A) upon the advice of counsel that the Exchange Notes
would not, upon receipt, be tradeable by the Holders thereof without restriction under the Securities Act and the Exchange Act and without material restrictions under applicable Blue Sky or state securities laws, or (B) the interests of the
Holders under this Agreement, taken as a whole, would be materially adversely affected by the consummation of the Exchange Offer, and in the case of (A) or (B), notifies the Company in writing of such determination; (ii) any change in law
or in applicable interpretations of the staff of the SEC would not permit the consummation of the Exchange Offer prior to the Effectiveness Date; (iii) subsequent to the consummation of the Exchange Offer, if any Initial Purchaser continues to
hold any Notes for its own account, and such Initial Purchaser so requests; (iv) the Exchange Registration Statement is not declared effective on or prior to the Effectiveness Date for any reason; or (v) in the case of (A) any Holder
not permitted by applicable law or SEC policy to participate in the Exchange Offer, (B) any Holder participating in the Exchange Offer that receives Exchange Notes that may not be sold without restriction under federal securities laws (other
than due solely to the status of such Holder as an affiliate of the Company within the meaning of Rule 405 of the Securities Act) or (C) any broker-dealer that holds Notes acquired by such broker-dealer directly from the Company or any of its
affiliates and, in each such case contemplated by clause (iii) or this clause (v), such Holder notifies the Company in writing within 20 Business Days of the consummation of the Exchange Offer, then the Company shall promptly (and in any event
within five Business Days of such notification) deliver to the Holders (or in the case of an occurrence of any event described in clause (v) of this Section 2(i), to any such Holder) and the Trustee notice thereof (the “Shelf
Notice”) and shall as promptly as practicable thereafter file an Initial Shelf Registration pursuant to Section 3. 

  
 7 

 Section 3. Shelf Registration. 

If a Shelf Notice is delivered pursuant to Section 2(i) prior to the commencement of the Exchange Offer, then this Section 3
shall apply to all Registrable Notes and the term “Shelf Notes” shall apply to all Registrable Notes. Otherwise, upon consummation of the Exchange Offer in accordance with Section 2, the provisions of Section 3 shall apply solely
with respect to (i) Notes held by any Holder thereof not permitted to participate in the Exchange Offer, (ii) Notes held by any broker-dealer that acquired such Notes directly from the Company or any of its affiliates and
(iii) Exchange Notes that are not freely tradeable, in each case as contemplated by Section 2(i)(v) hereof, provided that in each case that the relevant Holder has duly notified the Company within 20 Business Days of consummation of
the Exchange Offer as required by Section 2(i)(v), and the term “Shelf Notes” shall apply solely with respect to Registrable Notes held by such Holder. 
 (a) Initial Shelf Registration. The Company shall (and shall cause each Guarantor to), as promptly as practicable, file with the SEC a Registration Statement for an offering to be made on a
continuous basis pursuant to Rule 415 covering all of the Shelf Notes (the “Initial Shelf Registration”). The Company shall (and shall cause each Guarantor to) use its commercially reasonable efforts to cause the Initial Shelf
Registration to be declared effective as promptly as practicable thereafter (but in no event later than the Shelf Effectiveness Date). The Initial Shelf Registration shall be on Form S-3 or another appropriate form permitting registration of such
Shelf Notes for resale by Holders in the manner or manners reasonably designated by them (including, without limitation, one or more Underwritten Offerings). The Company and Guarantors shall not permit any securities other than the Shelf Notes to be
included in any Shelf Registration. The Company shall (and shall cause each Guarantor to) use its commercially reasonable efforts to keep the Initial Shelf Registration continuously effective under the Securities Act until the date which is one year
from the effectiveness date of the Initial Shelf Registration (subject to extension pursuant to Section 3(e) or Section 6) (the “Effectiveness Period”), or such shorter period ending when (i) all Shelf Notes covered
by the Initial Shelf Registration have been sold in the manner contemplated in the Initial Shelf Registration (ii) a Subsequent Shelf Registration covering all of the Registrable Notes covered by and not sold under the Initial Shelf
Registration or an earlier Subsequent Shelf Registration has been declared effective under the Securities Act, (iii) there cease to be any outstanding Shelf Notes registered thereunder or (iv) the date on which all Registrable Notes
covered by such Shelf Registration become eligible for resale without regard to volume, manner of sale or other restrictions contained in Rule 144. 
 (b) Subsequent Shelf Registrations. If the Initial Shelf Registration or any Subsequent Shelf Registration (as defined below) ceases to be effective for any reason at any time during the
Effectiveness Period (other than because of the sale of all of the securities registered thereunder), the Company shall (and shall cause each Guarantor to) use its commercially reasonable efforts to obtain the prompt withdrawal of any order
suspending the effectiveness thereof, and in any event shall use its commercially reasonable efforts to, within 30 days of such cessation of effectiveness amend such Shelf Registration in a manner to obtain the withdrawal of the order suspending the
effectiveness thereof, or file (and cause each Guarantor to file) a separate “shelf” Registration Statement pursuant to Rule 415 covering all of the Shelf Notes (a “Subsequent Shelf Registration”). If a Subsequent Shelf
Registration is filed, the Company shall (and shall cause each Guarantor to) use its commercially reasonable efforts to cause the Subsequent Shelf Registration to be declared effective as soon as

  
 8 

 
practicable after such filing and to keep such Subsequent Shelf Registration continuously effective for a period equal to the number of days in the Effectiveness Period less the aggregate number
of days during which the Initial Shelf Registration and any Subsequent Shelf Registration was previously continuously effective. As used herein the term “Shelf Registration” means the Initial Shelf Registration and any Subsequent
Shelf Registrations. 
 (c) Supplements and Amendments. The Company shall (and shall cause each Guarantor to) use its
reasonable best efforts to promptly supplement and amend any Shelf Registration if required by the rules, regulations or instructions applicable to the registration form used for such Shelf Registration, if required by the Securities Act, or if
reasonably requested in writing by the Holders of a majority in aggregate principal amount of the Shelf Notes covered by such Shelf Registration with respect to information relating to such Holders or by any underwriter of such Registrable Notes in
connection with an Underwritten Offering. 
 (d) Provision of Information. No Holder of Shelf Notes shall be entitled to
include any of its Shelf Notes in any Shelf Registration pursuant to this Agreement unless such Holder furnishes to the Company and the Trustee in writing, within 20 days after receipt of a written request therefor, such information as the Company
or the Trustee reasonably believe is required for inclusion in any Shelf Registration or Prospectus included therein and so requests, and no such Holder shall be entitled to Additional Interest pursuant to Section 4 hereof unless and until such
Holder shall have provided such information. 
 (e) Blackout Periods. Notwithstanding anything to the contrary in this
Agreement, at any time, the Company may delay the filing of any Initial Shelf Registration or Subsequent Shelf Registration or delay or suspend the effectiveness thereof, for a reasonable period of time, but not in excess of 90 days in the aggregate
during any 12-month period (a “Shelf Suspension Period”), if the Company determines reasonably and in good faith that the filing of any such Initial Shelf Registration or Subsequent Shelf Registration or the continuing effectiveness
thereof would require the disclosure of non-public material information that, in the reasonable judgment of the Company, would be detrimental to the Company if so disclosed or would otherwise materially adversely affect a financing, acquisition,
disposition, merger or other material transaction or such action is required by applicable law. 
 Section 4. Additional
Interest. 
 (a) The Company and each Guarantor acknowledges and agrees that the Holders of Registrable Notes will suffer
damages if the Company or any Guarantor fails to fulfill its material obligations under Section 2 or Section 3 hereof and that it would not be feasible to ascertain the extent of such damages with precision. Accordingly, the Company and
the Guarantors agree to pay additional cash interest on the Notes (“Additional Interest”) under the circumstances and to the extent set forth below (each event described in clauses (i) through (iii) below, a
“Registration Default” and each of which shall be given independent effect): 
 (i) if the
Exchange Registration Statement (or in lieu thereof, a Shelf Registration) has not been filed on or prior to the Filing Date, Additional Interest shall accrue on the Notes over and above any stated interest at a rate of 0.25% per annum of the
principal amount of such Notes for the first 90 days immediately following the Filing Date, such Additional Interest rate increasing by an additional 0.25% per annum at the beginning of each subsequent 90-day period; 

  
 9 

 (ii) if the Exchange Registration Statement (or in lieu thereof, a Shelf
Registration) is not declared effective on or prior to the Effectiveness Date, Additional Interest shall accrue on the Notes over and above any stated interest at a rate of 0.25% per annum of the principal amount of such Notes for the first 90
days immediately following the Effectiveness Date, such Additional Interest rate increasing by an additional 0.25% per annum at the beginning of each subsequent 90-day period; 

(iii) if (A) the Company (and any Guarantor) has not exchanged Exchange Notes for all Notes validly tendered in
accordance with the terms of the Exchange Offer on or prior to the 60th Business Day after the Effectiveness Date, (B) the Exchange Registration Statement ceases to be effective at any time prior to the time that the Exchange Offer is
consummated, (C) if applicable, a Shelf Registration has been declared effective and such Shelf Registration ceases to be effective at any time prior to the first anniversary of its effective date (other than such time as all Notes have been
disposed of thereunder) and is not declared effective again within 30 days, or (D) the Company issues a valid notice to suspend the use of the prospectus included in any Shelf Registration and such suspensions, when taken together with all
other suspensions, if any, during any 12-month period exceeds 120 days, then, in each such case, Additional Interest shall accrue on the Notes, over and above any stated interest, at a rate of 0.25% per annum of the principal amount of such
Notes commencing on (w) the 61st Business Day after the Effectiveness Date, in the case of (A) above, (x) the date the Exchange Registration Statement ceases to be effective without being declared effective again within 30 days, in
the case of clause (B) above, (y) the day such Shelf Registration ceases to be effective without being declared effective again within 30 days in case of (C) above, or (z) the day the Shelf Registration has ceased to be usable
for a period exceeding 120 days during any 12-month period in case of clause (D) above, such Additional Interest rate increasing by an additional 0.25% per annum at the beginning of each such subsequent 90-day period; 

provided, however, that the maximum Additional Interest rate on the Notes may not exceed at any one time in the aggregate 1.00% per annum;
and provided further, that (1) upon the filing of the Exchange Registration Statement (in the case of (i) above), (2) upon the effectiveness of the Exchange Registration Statement (in the case of (ii) above), (3) upon
the effectiveness of the Initial Shelf Registration or the Shelf Registration or, if Additional Interest shall be payable solely because an Initial Shelf Registration required pursuant to Section 2(i)(iv) has not been declared effective prior
to the Shelf Effectiveness Date, upon the effectiveness of the Exchange Registration Statement (in the 

  
 10 

 
case of (i) or (ii) above) or (4) upon the exchange of Exchange Notes for all Notes tendered (in the case of clause (iii)(A) above), or upon the effectiveness of the Exchange
Registration Statement that had ceased to remain effective (in the case of clause (iii)(B) above), or upon the effectiveness of a Shelf Registration which had ceased to remain effective (in the case of clause (iii)(C) above), or upon valid notice by
the Company that the suspended Shelf Registration has again become usable (in the case of clause (iii)(D) above), Additional Interest on the Notes or the Shelf Note, as applicable, as a result of such clause (or the relevant subclause thereof) shall
cease to accrue. Notwithstanding the foregoing, (x) the amount of Additional Interest payable shall not increase because more than one Registration Default has occurred and is pending, and (y) Additional Interest shall be payable for
Registration Defaults related to a failure of the Company to cause a Shelf Registration to be declared effective only to Holders of Shelf Notes. Additional Interest pursuant to this Section 4 shall be the sole and exclusive remedy available to
the Holders with respect to a Registration Default. 
 (b) The Company shall notify the Trustee within five Business Days after
each and every date on which a Registration Default occurs in respect of which Additional Interest is required to be paid. Any accrued amounts of Additional Interest due pursuant to clause (a)(i) or (a)(ii) of this Section 4 will be payable in
cash in arrears, on the dates and in the manner provided in the Indenture and whether or not any cash interest would then be payable on such date, commencing with the first such semi-annual date occurring after any such Additional Interest commences
to accrue. The amount of Additional Interest will be determined by multiplying the applicable Additional Interest rate by the applicable principal amount of the Notes or the Shelf Notes, as applicable, multiplied by a fraction, the numerator of
which is the number of days such Additional Interest rate was applicable during such period (determined on the basis of a 360-day year comprised of twelve 30-day months and, in the case of a partial month, the actual number of days elapsed), and the
denominator of which is 360. 
 Section 5. Hold-Back Agreements.  

The Company agrees that it will not effect any public or private sale or distribution (including a sale pursuant to Regulation D under
the Securities Act) of any securities the same as or substantially the same as those covered by a Registration Statement filed pursuant to Section 2 or 3 hereof (other than Additional Notes (as defined in the Indenture) issued under the
Indenture), or any securities convertible into or exchangeable or exercisable for such securities, during the 10 days prior to, and during the 90-day period beginning on, the effective date of any Registration Statement filed pursuant to Sections 2
and 3 hereof unless the Holders of a majority in the aggregate principal amount of the Registrable Notes to be included in such Registration Statement consent, if the managing underwriter thereof so requests in writing. 

Section 6. Registration Procedures.  
 In connection with the filing of any Registration Statement pursuant to Sections 2 or 3 hereof, the Company shall (and shall cause each Guarantor to) effect such registrations to permit the sale of such
securities covered thereby in accordance with the 

  
 11 

 
intended method or methods of disposition thereof, and pursuant thereto and in connection with any Registration Statement filed by the Company hereunder, the Company shall (and shall cause each
Guarantor to): 
 (a) Prepare and file with the SEC, on or prior to the Filing Date, the Exchange Registration Statement, or if
the Exchange Registration Statement is not filed because of the circumstances contemplated by Section 2(a)(i), a Shelf Registration as prescribed by Section 3, and use its commercially reasonable efforts to cause each such Registration
Statement to become effective and remain effective as provided herein; provided that, if (A) a Shelf Registration is filed pursuant to Section 3 or (B) a Prospectus contained in an Exchange Registration Statement filed pursuant
to Section 2 is required to be delivered under the Securities Act by any Participating Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period relating thereto from whom the Company has received prior written notice that it
will be a Participating Broker-Dealer in the Exchange Offer, before filing any Registration Statement or Prospectus or any amendments or supplements thereto the Company shall (and shall cause each Guarantor to), if requested, furnish to and afford,
in the case of clause (A) above, the Holders of the Registrable Notes to be registered pursuant to such Shelf Registration, in the case of clause (B) above, each Participating Broker-Dealer, the managing underwriters in an Underwritten
Offering, if any, and each of their respective counsel, a reasonable opportunity to review copies of all such documents (including copies of any documents to be incorporated by reference therein and all exhibits thereto) proposed to be filed (in
each case at least five Business Days prior to such filing). The Company and each Guarantor shall not file any such Registration Statement or Prospectus or any amendments or supplements thereto in respect of which the Holders must provide
information for the inclusion therein without the Holders being afforded an opportunity to review such documentation if the holders of a majority in aggregate principal amount of the Registrable Notes covered by such Registration Statement, or any
such Participating Broker-Dealer, as the case may be, the managing underwriters in an Underwritten Offering, if any, or any of their respective counsel shall reasonably object in writing within five Business Days after the receipt hereof. A Holder
shall be deemed to have reasonably objected to such filing if such Holder’s objection to such Registration Statement, amendment, Prospectus or supplement, as applicable, as proposed to be filed, relates to an untrue statement of a material fact
or an omission to state any material fact necessary to make the statements therein not misleading or a failure to comply with the applicable requirements of the Securities Act. 

(b) Provide an indenture trustee for the Registrable Notes or the Exchange Notes, as the case may be, and cause the Indenture (or other
indenture relating to the Registrable Notes) to be qualified under the TIA not later than the effective date of the first Registration Statement; and in connection therewith, to effect such changes to such indenture as may be required for such
indenture to be so qualified in accordance with the terms of the TIA; and execute, and use its commercially reasonable efforts to cause such trustee to execute, all documents as may be required to effect such changes, and all other forms and
documents required to be filed with the SEC to enable such indenture to be so qualified in a timely manner. 

  
 12 

 (c) Prepare and file with the SEC such pre-effective amendments and post-effective
amendments to each Shelf Registration or Exchange Registration Statement, as the case may be, as may be necessary to keep such Registration Statement continuously effective for the Effectiveness Period or the Applicable Period or until consummation
of the Exchange Offer, as the case may be, cause the related Prospectus to be supplemented by any Prospectus supplement required by applicable law, and as so supplemented to be filed pursuant to Rule 424 (or any similar provisions then in force)
promulgated under the Securities Act; and comply with the provisions of the Securities Act and the Exchange Act applicable to them with respect to the disposition of all securities covered by such Registration Statement as so amended or in such
Prospectus as so supplemented and with respect to the subsequent resale of any securities being sold by a Participating Broker-Dealer in the manner disclosed to the Company by such Participating Broker-Dealer covered by any such Prospectus. The
Company and each Guarantor shall not, during the Applicable Period, knowingly take any action that would result in selling Holders of the Registrable Notes covered by a Shelf Registration or Participating Broker-Dealers seeking to sell Exchange
Notes not being able to sell such Registrable Notes or such Exchange Notes during that period, unless such action is required by applicable law, rule or regulation or permitted by this Agreement. 

(d) Furnish to such selling Holders and Participating Broker-Dealers who so request in writing (i) upon the Company’s receipt,
a copy of the order of the SEC declaring such Registration Statement and any post-effective amendment thereto effective, (ii) such reasonable number of copies of such Registration Statement and of each amendment and supplement thereto (in each
case including any documents incorporated therein by reference and all exhibits unless such documents or exhibits are publicly available) and (iii) such reasonable number of copies of the Prospectus included in such Registration Statement
(including each preliminary Prospectus) and each amendment and supplement thereto, and such reasonable number of copies of the final Prospectus as filed by the Company and each Guarantor pursuant to Rule 424(b) under the Securities Act, in
conformity with the requirements of the Securities Act and each amendment and supplement thereto (including any amendments required to be filed pursuant to clause (c) of this Section). Subject to Section 3(c) hereof, the Company and the
Guarantors hereby consent to the use of the Prospectus by each of the selling Holders of Registrable Notes or each such Participating Broker-Dealer, as the case may be, and the underwriters or agents, if any, and dealers, if any, in connection with
the offering and sale of the Registrable Notes covered by, or the sale by Participating Broker-Dealers of the Exchange Notes pursuant to, such Prospectus and any amendment or supplement thereto. 

(e) If (i) a Shelf Registration is filed pursuant to Section 3, or (ii) a Prospectus contained in an Exchange Registration
Statement filed pursuant to Section 2 is required to be delivered under the Securities Act by any Participating Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period relating thereto from whom the Company has received
written notice that it will be a Participating Broker-Dealer in the Exchange Offer, the Company shall notify in writing the selling Holders of Registrable Notes, or each such Participating Broker-Dealer, as the case may be, the managing underwriters
in an Underwritten Offering, if any, and each of their respective counsel 

  
 13 

 
promptly (but in any event within two Business Days) (A) when a Prospectus or any Prospectus supplement or post-effective amendment has been filed, and, with respect to a Registration
Statement or any post-effective amendment, when the same has become effective (including in such notice a written statement that any Holder may, upon request, obtain, without charge, one conformed copy of such Registration Statement or
post-effective amendment including financial statements and schedules, documents incorporated or deemed to be incorporated by reference and exhibits), (B) of the issuance by the SEC of any stop order suspending the effectiveness of a
Registration Statement or of any order preventing or suspending the use of any Prospectus or the initiation of any proceedings for that purpose, (C) if at any time when a Prospectus is required by the Securities Act to be delivered in
connection with sales of the Registrable Notes the representations and warranties of the Company and any Guarantor contained in any agreement (including any underwriting agreement) contemplated by Section 6(n) hereof cease to be true and
correct, in all material respects, during the relevant offering period, (D) of the receipt by the Company or any Guarantor of any notification with respect to the suspension of the qualification or exemption from qualification of a Registration
Statement or any of the Registrable Notes or the Exchange Notes to be sold by any Participating Broker-Dealer for offer or sale in any jurisdiction, or the initiation or threatening of any proceeding for such purpose, (E) of the happening of
any event, the existence of any condition or any information becoming known to the Company that makes any statement made in such Registration Statement or related Prospectus or any document incorporated or deemed to be incorporated therein by
reference untrue in any material respect or that requires the making of any changes in, or amendments or supplements to, such Registration Statement, Prospectus or documents so that, in the case of the Registration Statement, it will not contain any
untrue statement of a material fact or omit to state any material fact required to be stated therein to make the statement not misleading, or in the case of a Prospectus or documents incorporated or deemed to be incorporated by reference, it will
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, (F) of
any reasonable determination by the Company or any Guarantor that a post-effective amendment to a Registration Statement would be appropriate and (G) of any request by the SEC for amendments to the Registration Statement or supplements to the
Prospectus or for additional information relating thereto. 
 (f) Use its commercially reasonable efforts to prevent the
issuance of any order suspending the effectiveness of a Registration Statement or of any order preventing or suspending the use of a Prospectus or suspending the qualification (or exemption from qualification) of any of the Registrable Notes or the
Exchange Notes to be sold by any Participating Broker-Dealer, for sale in any jurisdiction, and, if any such order is issued, to use its commercially reasonable efforts to obtain the withdrawal of any such order at the earliest possible date.

 (g) If (i) a Shelf Registration is filed pursuant to Section 3, (ii) a Prospectus contained in an Exchange
Registration Statement filed pursuant to Section 2 is required to be delivered under the Securities Act by any Participating Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period or (iii) reasonably requested in
writing 

  
 14 

 
by the managing underwriters, if any, or the Holders of a majority in aggregate principal amount of the Registrable Notes being sold in connection with an Underwritten Offering, other than during
a Shelf Suspension Period (A) promptly incorporate in a Prospectus supplement or post-effective amendment such information or revisions to information therein relating to such underwriters or selling Holders as the managing underwriters, if
any, or such Holders or any of their respective counsel reasonably request in writing to be included or made therein and (B) make all required filings of such Prospectus supplement or such post-effective amendment as soon as practicable after
the Company has received notification of the matters to be incorporated in such Prospectus supplements or post-effective amendment; provided, however, that the Company shall not be required to take any action hereunder that would, in
the written opinion of counsel to the Company, violate applicable laws. 
 (h) Prior to any public offering of Registrable Notes
or any delivery of a Prospectus contained in the Exchange Registration Statement by any Participating Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, use its commercially reasonable efforts to register or qualify, and to
cooperate with the selling Holders of Registrable Notes or each such Participating Broker-Dealer, as the case may be, the underwriters, if any, and their respective counsel in connection with the registration or qualification (or exemption from such
registration or qualification) of such Registrable Notes or Exchange Notes, as the case may be, for offer and sale under the securities or Blue Sky laws of such jurisdictions within the United States as any selling Holder, Participating
Broker-Dealer or any managing underwriter or underwriters, if any, in an Underwritten Offering reasonably request in writing; provided, that where Exchange Notes held by Participating Broker-Dealers or Registrable Notes are offered other than
through an Underwritten Offering, the Company and each Guarantor shall use its commercially reasonable efforts to cause its counsel to perform Blue Sky investigations and shall use its commercially reasonable efforts to file any registrations and
qualifications required to be filed pursuant to this Section 6(h), use its commercially reasonable efforts to keep each such registration or qualification (or exemption therefrom) effective during the period such Registration Statement is
required to be kept effective and use its commercially reasonable efforts to do any and all other acts or things reasonably necessary or advisable to enable the disposition in such jurisdictions of the Exchange Notes held by Participating
Broker-Dealers or the Registrable Notes covered by the applicable Registration Statement; provided that neither the Company nor any Guarantor shall be required to (i) qualify generally to do business in any jurisdiction where it is not
then so qualified, (ii) take any action that would subject it to general service of process in any such jurisdiction where it is not then so subject or (iii) subject itself to taxation in any such jurisdiction where it is not then so
subject. 
 (i) If (i) a Shelf Registration is filed pursuant to Section 3 or (ii) a Prospectus contained in an
Exchange Registration Statement filed pursuant to Section 2 is requested to be delivered under the Securities Act by any Participating Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, cooperate with the selling
Holders of Registrable Notes and the managing underwriter or underwriters, if any, in an Underwritten Offering to facilitate the timely preparation and delivery of certificates representing Registrable Notes to be sold, which certificates shall not
bear any restrictive 

  
 15 

 
legends and shall be in a form eligible for deposit with The Depository Trust Company, and enable such Registrable Notes to be in such denominations permitted by the Indenture and registered in
such names as the managing underwriter or underwriters, if any, in an Underwritten Offering or Holders may reasonably request. 

(j) Use its commercially reasonable efforts to cause the Registrable Notes covered by any Registration Statement to be registered with or
approved by such U.S. governmental agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter, if any, to consummate the disposition of such Registrable Notes, except as may be required solely as a
consequence of the nature of such selling Holder’s business, in which case the Company shall (and shall cause each Guarantor to) cooperate in all reasonable respects with the filing of such Registration Statement and the granting of such
approvals; provided that neither the Company nor any Guarantor shall be required to (i) qualify generally to do business in any jurisdiction where it is not then so qualified, (ii) take any action that would subject it to general
service of process in any jurisdiction where it is not then so subject or (iii) subject itself to taxation in any such jurisdiction where it is not then so subject. 
 (k) If (i) a Shelf Registration is filed pursuant to Section 3, or (ii) a Prospectus contained in an Exchange Registration Statement filed pursuant to Section 2 is required to be
delivered under the Securities Act by any Participating Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, upon the occurrence of any event contemplated by paragraph 6(e)(v) (other than during a Shelf Suspension Period), as
promptly as practicable, prepare and file with the SEC, at the expense of the Company and the Guarantors, a supplement or post-effective amendment to the Registration Statement or a supplement to the related Prospectus or any document incorporated
or deemed to be incorporated therein by reference, or file any other required document so that, as thereafter delivered to the purchasers of the Registrable Notes being sold thereunder or to the purchasers of the Exchange Notes to whom such
Prospectus will be delivered by a Participating Broker-Dealer, such Registration Statement will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein to make the statements not misleading
or such Prospectus or documents incorporated by reference or deemed to be incorporated by reference will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading, and, if SEC review is required, use its commercially reasonable efforts to cause such post-effective amendment to be declared effective as soon as
possible. 
 (l) Use its commercially reasonable efforts to cause the Registrable Notes covered by a Registration Statement to
be rated with such appropriate rating agencies, if so requested in writing by the Holders of a majority in aggregate principal amount of the Registrable Notes covered by such Registration Statement or the managing underwriter or underwriters, if
any. 
 (m) Prior to the initial issuance of the Exchange Notes, (i) provide the Trustee with one or more certificates for
the Exchange Notes in a form eligible for deposit with The Depository Trust Company and (ii) provide a CUSIP number for the Exchange Notes. 

  
 16 

 (n) In connection with an Underwritten Offering of Registrable Securities pursuant to a
Shelf Registration filed pursuant to Section 3, enter into such agreements (including an underwriting agreement in form, scope and substance as is customary in underwritten offerings of debt securities similar to the Notes, as may be
appropriate in the circumstances) and take all such other actions in connection therewith (including those reasonably requested in writing by the managing underwriters, if any, or the Holders of a majority in aggregate principal amount of the
Registrable Notes being sold) in order to expedite or facilitate the registration or the disposition of such Registrable Notes, and in such connection: (i) make such representations and warranties to the Holders and the underwriters, if any,
with respect to the business of the Company and its subsidiaries as then conducted, and the Registration Statement, Prospectus and documents, if any, incorporated or deemed to be incorporated by reference therein, in each case, in form, substance
and scope as are customarily made by issuers to underwriters in underwritten offerings of debt securities similar to the Notes, as may be appropriate in the circumstances, and confirm the same if and when reasonably required; (ii) use its
commercially reasonable efforts to obtain an opinion of counsel to the Company and the Guarantors and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the managing underwriters, if any,
and the Holders of a majority in aggregate principal amount of the Registrable Notes being sold), addressed to each selling Holder and addressed to each of the underwriters, if any, covering the matters customarily covered in opinions of counsel to
the Company and the Guarantors requested in underwritten offerings of debt securities similar to the Notes, as may be appropriate in the circumstances; (iii) use its commercially reasonable efforts to obtain “cold comfort” letters and
updates thereof (which letters and updates (in form, scope and substance) shall be reasonably satisfactory to the managing underwriters) from the independent certified public accountants of the Company and the Guarantors (and, if necessary, any
other independent certified public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement),
addressed to each of the underwriters, such letters to be in customary form and covering matters of the type customarily covered in “cold comfort” letters in connection with underwritten offerings of debt securities similar to the Notes,
as may be appropriate in the circumstances, and such other matters as reasonably requested in writing by the underwriters; and (iv) deliver such documents and certificates as may be reasonably requested in writing by the Holders of a majority
in aggregate principal amount of the Registrable Notes being sold and the managing underwriters, if any, to evidence the continued validity of the representations and warranties of the Company and its subsidiaries made pursuant to clause
(i) above and to evidence compliance with any conditions contained in the underwriting agreement or other similar agreement entered into by the Company or any Guarantor. 
 (o) If (i) a Shelf Registration is filed pursuant to Section 3, or (ii) a Prospectus contained in an Exchange Registration Statement filed pursuant to Section 2 is required to be
delivered under the Securities Act by any Participating Broker-Dealer who seeks to 

  
 17 

 
sell Exchange Notes during the Applicable Period, make available for inspection by any selling Holder of such Registrable Notes being sold, or each such Participating Broker-Dealer, as the case
may be, any underwriter participating in any such disposition of Registrable Notes, if any, and any attorney, accountant or other agent retained by any such selling Holder or each such Participating Broker-Dealer, as the case may be, or underwriter
(collectively, the “Inspectors”), at the offices where normally kept, during reasonable business hours and in a reasonable manner, all pertinent financial and other records and pertinent corporate documents of the Company and its
subsidiaries (collectively, the “Records”) as shall be reasonably requested by them and necessary to enable them to exercise any applicable due diligence responsibilities, and cause the officers, directors and employees of the
Company and its subsidiaries to supply all information reasonably requested in writing by any such Inspector in connection with such Registration Statement; provided that the foregoing inspection and information gathering on behalf of the
Holders shall be coordinated by one counsel designated by and on behalf of the Holders. Each Inspector shall agree in writing that it will keep the Records confidential and it will not disclose, any of the Records unless (A) the disclosure of
such Records is necessary to avoid or correct a misstatement or omission in such Registration Statement, (B) the release of such Records is ordered pursuant to a subpoena or other order from a court of competent jurisdiction, (C) the
information in such Records is public or has been made generally available to the public other than as a result of a disclosure or failure to safeguard by such Inspector or (D) disclosure of such information is, in the reasonable written
opinion of counsel for any Inspector, necessary or advisable in connection with any action, claim, suit or proceeding, directly or indirectly, involving or potentially involving such Inspector and arising out of, based upon, related to, or involving
this Agreement, or any transaction contemplated hereby or arising hereunder. Each selling Holder of such Registrable Notes and each such Participating Broker-Dealer will be required to agree that information obtained by it as a result of such
inspections shall be deemed confidential and shall not be used by it as the basis for any market transactions in the securities of the Company unless and until such information is made generally available to the public. Each Inspector, each selling
Holder of such Registrable Notes and each such Participating Broker-Dealer will be required to further agree that it will, upon learning that disclosure of such Records is sought in a court of competent jurisdiction, give notice to the Company and,
to the extent practicable, use its commercially reasonable efforts to allow the Company, at its expense, to undertake appropriate action to prevent disclosure of the Records deemed confidential at its expense. 

(p) Use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC and make generally available to
the security holders of the Company with regard to any Applicable Registration Statement earning statements satisfying the provisions of section 11(a) of the Securities Act and Rule 158 thereunder (or any similar rule promulgated under the
Securities Act) no later than 45 days after the end of any 12-month period (or 90 days after the end of any 12-month period if such period is a fiscal year) (i) commencing at the end of any fiscal quarter in which Registrable Notes are sold to
underwriters in a firm commitment or best efforts Underwritten Offering and (ii) if not sold to underwriters in such an offering, commencing on the first day of the first fiscal quarter of the Company after the effective date of a Registration
Statement, which statements shall cover said 12-month periods. 

  
 18 

 (q) If the Exchange Offer is to be consummated, upon delivery of the Registrable Notes by
the Holders to the Company and the Guarantors (or to such other Person as directed by the Company and the Guarantors) in exchange for the Exchange Notes, the Company and the Guarantors shall mark, or caused to be marked, on such Registrable Notes
that the Exchange Notes are being issued as substitute evidence of the indebtedness originally evidenced by the Registrable Notes; provided that in no event shall such Registrable Notes be marked as paid or otherwise satisfied. 

(r) Cooperate with each seller of Registrable Notes covered by any Registration Statement and each underwriter, if any, participating in
the disposition of such Registrable Notes and their respective counsel in connection with any filings required to be made with FINRA. 
 (s) Use its commercially reasonable efforts to take all other steps reasonably necessary to effect the registration of the Registrable Notes covered by a Registration Statement contemplated hereby.

 (t) Each seller of Registrable Notes or Participating Broker-Dealer as to which any registration is being effected shall
furnish to the Company such information regarding such seller or Participating Broker-Dealer and the distribution of such Registrable Notes as the Company may, from time to time, reasonably request in writing. The Company may exclude from such
registration the Registrable Notes of any seller who fails to furnish such information within a reasonable time (which time in no event shall exceed 20 days, subject to Section 3(d) hereof) after receiving such request. Each seller of
Registrable Notes or Participating Broker-Dealer as to which any registration is being effected agrees to furnish promptly to the Company all information required to be disclosed in order to make the information previously furnished by such seller
not materially misleading. 
 (u) Each Holder of Registrable Notes and each Participating Broker-Dealer agrees by acquisition of
such Registrable Notes or Exchange Notes to be sold by such Participating Broker-Dealer, as the case may be, that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 6(e)(ii)(B),
6(e)(ii)(D) and 6(e)(ii)(E) or the commencement of a Shelf Suspension Period, such Holder will forthwith discontinue disposition of such Registrable Notes covered by a Registration Statement and such Participating Broker-Dealer will forthwith
discontinue disposition of such Exchange Notes pursuant to any Prospectus and, in each case, forthwith discontinue dissemination of such Prospectus until such Holder’s or Participating Broker-Dealer’s receipt of the copies of the
supplemented or amended Prospectus contemplated by Section 6(k), or until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed, and has received copies of any
amendments or supplements thereto and, if so directed by the Company, such Holder or Participating Broker-Dealer, as the case may be, will deliver to the Company all copies, other than permanent file copies, then in such Holder’s or

  
 19 

 
Participating Broker-Dealer’s possession, of the Prospectus covering such Registrable Notes current at the time of the receipt of such notice. In the event the Company and the Guarantors
shall give any such notice, the Applicable Period shall be extended by the number of days during such periods from and including the date of the giving of such notice to and including the date when each Participating Broker-Dealer shall have
received (x) the copies of the supplemented or amended Prospectus contemplated by Section 6(k) or (y) the Advice. 
 Section 7. Registration Expenses. 
 (a) All fees and expenses incident
to the performance of or compliance with this Agreement by the Company and the Guarantors shall be borne by the Company and the Guarantors, whether or not the Exchange Offer or a Shelf Registration is filed or becomes effective, including, without
limitation: (i) all registration and filing fees, including, without limitation, (A) fees with respect to filings required to be made with FINRA in connection with any underwritten offering and (B) fees and expenses of compliance with
state securities or Blue Sky laws as provided in Section 6(h) hereof (including, without limitation, reasonable fees and disbursements of counsel in connection with Blue Sky qualifications of the Registrable Notes or Exchange Notes and
determination of the eligibility of the Registrable Notes or Exchange Notes for investment under the laws of such jurisdictions (x) where the Holders are located, in the case of the Exchange Notes, or (y) as provided in Section 6(h),
in the case of Registrable Notes or Exchange Notes to be sold by a Participating Broker-Dealer during the Applicable Period), (ii) printing expenses, including, without limitation, expenses of printing Prospectuses if the printing of
Prospectuses is requested by the managing underwriter or underwriters, if any, in an Underwritten Offering or by the Holders of a majority in aggregate principal amount of the Registrable Notes included in any Shelf Registration or by any
Participating Broker-Dealer during the Applicable Period, as the case may be, (iii) messenger, telephone and delivery expenses incurred in connection with the performance of their obligations hereunder, (iv) fees and disbursements of
counsel for the Company, the Guarantors and, to the extent provided in Section 7(b), the Holders, (v) fees and disbursements of all independent certified public accountants referred to in Section 6 (including, without limitation, the
expenses of any special audit and “cold comfort” letters required by or incident to such performance), (vi) rating agency fees, if any, and the fees and expenses incurred in connection with making Exchange Notes eligible for trading
through the Depository Trust Company, (vii) Securities Act liability insurance, if the Company and the Guarantors desire such insurance, (viii) fees and expenses of all other Persons retained by the Company and the Guarantors,
(ix) fees and expenses of any “qualified independent underwriter” or other independent appraiser participating in an offering pursuant to Section 3 of Schedule E to the By-laws of FINRA, but only where the need for such a
“qualified independent underwriter” arises due to a relationship with the Company and the Guarantors, (x) internal expenses of the Company and the Guarantors (including, without limitation, all salaries and expenses of officers and
employees of the Company or the Guarantors performing legal or accounting duties), (xi) the expense of any annual audit, (xii) the fees and expenses of the Trustee and the Exchange Agent and (xiii) the expenses relating to printing,
word processing and distributing all Registration Statements, underwriting 

  
 20 

 
agreements and indentures relating to the Notes or the Exchange Notes and any other documents necessary in order to comply with this Agreement. Notwithstanding anything to the contrary, each
Holder shall pay all underwriting discounts and commissions of any underwriters with respect to any Registrable Notes sold by or on behalf of it. 
 (b) The Company and the Guarantors shall reimburse the Holders for the reasonable fees and disbursements of not more than one counsel chosen by the Holders of a majority in aggregate principal amount of
the Registrable Notes to be included in any Shelf Registration. The Company and the Guarantors shall pay all documentary, stamp, transfer or other transactional taxes attributable to the issuance or delivery of the Exchange Notes in exchange for the
Notes; provided that the Company shall not be required to pay taxes payable in respect of any transfer involved in the issuance or delivery of any Exchange Note in a name other than that of the Holder of the Note in respect of which such
Exchange Note is being issued. The Company and the Guarantors shall reimburse the Holders for fees and expenses (including reasonable fees and expenses of counsel to the Holders) relating to any enforcement of any rights of the Holders under this
Agreement. 
 Section 8. Indemnification. 
 (a) Indemnification by the Company and the Guarantors. The Company and the Guarantors jointly and severally agree to indemnify and hold harmless each Holder of Registrable Notes and each
Participating Broker-Dealer selling Exchange Notes during the Applicable Period, each Person, if any, who controls each such Holder (within the meaning of Section 15 of the Securities Act or Section 20(a) of the Exchange Act) and the
officers, directors, agents, employees and partners of each such Holder, Participating Broker-Dealer and controlling person, to the fullest extent lawful, from and against any and all losses, claims, damages, liabilities, costs (including, without
limitation, reasonable costs of preparation and reasonable attorneys” fees as provided in this Section 8) and reasonable expenses (including, without limitation, reasonable costs and expenses incurred in connection with investigating,
preparing, pursuing or defending against any of the foregoing) (collectively, “Losses”), as incurred, directly or indirectly caused by, related to, based upon, or arising out of or in connection with, in the case of the Registration
Statement or in any amendments thereto, any untrue statement or alleged untrue statement of a material fact contained in any Registration Statement or Prospectus or any omission or alleged omission to state therein a material fact required to be
stated therein to make the statements not misleading, or in the case of any Prospectus or form of prospectus, or in any amendment or supplement thereto, or in any preliminary prospectus, any untrue or alleged untrue statement of a material fact
contained therein or any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, except
insofar as such Losses are solely based upon information relating to such Holder or Participating Broker-Dealer and furnished in writing to the Company and the Guarantors by such Holder or Participating Broker-Dealer or their counsel expressly for
use therein. 

  
 21 

 (b) Indemnification by Holder. In connection with any Registration Statement,
Prospectus or form of prospectus, any amendment or supplement thereto, or any preliminary prospectus in which a Holder is participating, such Holder shall furnish to the Company and the Guarantors in writing such information as the Company and the
Guarantors reasonably request for use in connection with any Registration Statement, Prospectus or form of prospectus, any amendment or supplement thereto, or any preliminary prospectus and shall indemnify and hold harmless the Company, the
Guarantors, their respective directors, officers, agents, employees and each Person, if any, who controls the Company and the Guarantors (within the meaning of Section 15 of the Securities Act and Section 20(a) of the Exchange Act), and
the directors, officers, employees and partners of such controlling persons, to the fullest extent lawful, from and against all Losses arising out of or based upon, in the case of the Registration Statement or in any amendments thereto, untrue or
alleged untrue statement of a material fact contained therein or any omission or alleged omission to state therein a material fact required to be stated therein to make the statements not misleading, or in the case of any Prospectus or form of
prospectus, or in any amendment or supplement thereto, or in any preliminary prospectus, any untrue or alleged untrue statement of a material fact contained therein or any omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading to the extent, but only to the extent, that such losses are finally judicially determined by a court of
competent jurisdiction in a final, unappealable order to have resulted solely from an untrue statement or alleged untrue statement of a material fact or omission or alleged omission of a material fact contained in or omitted from any information so
furnished in writing by such Holder to the Company and the Guarantors expressly for use therein. Notwithstanding the foregoing, in no event shall the liability of any selling Holder be greater in amount than such Holder’s Maximum Contribution
Amount (as defined below). 
 (c) Conduct of Indemnification Proceedings. If any proceeding shall be brought or asserted
against any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the party or parties from which such indemnity is sought (the “Indemnifying Party” or
“Indemnifying Parties”, as applicable) in writing; but the failure to so notify the Indemnifying Party (i) will not relieve such Indemnifying Party from any liability under paragraph (a) or (b) above unless and only
to the extent it is materially prejudiced as a result thereof and (ii) will not, in any event, relieve the Indemnifying Party from any obligations to any Indemnified Party other than the indemnification obligation provided in paragraphs
(a) and (b) above. 
 The Indemnifying Party shall have the right, exercisable by giving written notice to an
Indemnified Party, within 20 Business Days after receipt of written notice from such Indemnified Party of such proceeding, to assume, at its expense, the defense of any such proceeding; provided, that an Indemnified Party shall have the right
to employ separate counsel in any such proceeding and to participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or parties unless: (1) the Indemnifying Party has agreed to
pay such fees and expenses; or (2) the Indemnifying Party shall have failed promptly to assume the defense of such 

  
 22 

 
proceeding or shall have failed to employ counsel reasonably satisfactory to such Indemnified Party; or (3) the named parties to any such proceeding (including any impleaded parties) include
both such Indemnified Party and the Indemnifying Party or any of its affiliates or controlling persons, and such Indemnified Party shall have been advised by counsel that there may be one or more defenses available to such Indemnified Party that are
in addition to, or in conflict with, those defenses available to the Indemnifying Party or such affiliate or controlling person (in which case, if such Indemnified Party notifies the Indemnifying Parties in writing that it elects to employ separate
counsel at the expense of the Indemnifying Parties, the Indemnifying Parties shall not have the right to assume the defense and the reasonable fees and expenses of such counsel shall be at the expense of the Indemnifying Party; it being understood,
however, that, the Indemnifying Party shall not, in connection with any one such proceeding or separate but substantially similar or related proceedings in the same jurisdiction, arising out of the same general allegations or circumstances, be
liable for the fees and expenses of more than one separate firm of attorneys (together with appropriate local counsel) at any time for such Indemnified Party). 
 No Indemnifying Party shall be liable for any settlement of any such proceeding effected without its written consent, which shall not be unreasonably withheld, but if settled with its written consent, or
if there be a final judgment for the plaintiff in any such proceeding, each Indemnifying Party jointly and severally agrees, subject to the exceptions and limitations set forth above, to indemnify and hold harmless each Indemnified Party from and
against any and all Losses by reason of such settlement or judgment. The Indemnifying Party shall not consent to the entry of any judgment or enter into any settlement without the consent of an Indemnified Party, which shall not be unreasonably
withheld, unless such judgment or settlement (i) includes as an unconditional term thereof the giving by the claimant or plaintiff to each Indemnified Party of a release, in form and substance reasonably satisfactory to the Indemnified Party,
from all liability in respect of such proceeding for which such Indemnified Party would be entitled to indemnification hereunder (whether or not any Indemnified Party is a party thereto) and (ii) does not include a statement assigning, or an
admission of fault, culpability or a failure to act by or on behalf of any Indemnified Party. 
 (d) Contribution. If the
indemnification provided for in this Section 8 is unavailable to an Indemnified Party or is insufficient to hold such Indemnified Party harmless for any Losses in respect of which this Section 8 would otherwise apply by its terms (other
than by reason of exceptions provided in this Section 8), then each applicable Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall have a joint and several obligation to contribute to the amount paid or payable by such
Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party, on the one hand, and such Indemnified Party, on the other hand, in connection with the actions, statements or
omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party, on the one hand, and Indemnified Party, on the other hand, shall be determined by reference to, among other
things, whether any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by such Indemnifying Party or Indemnified

  
 23 

 
Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent any such statement or omission. The amount paid or payable by an Indemnified
Party as a result of any Losses shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with any proceeding, to the extent such party would have been indemnified for such fees or expenses if the
indemnification provided for in Section 8(a) or 8(b) was available to such party. 
 The parties hereto agree that it would
not be just and equitable if contribution pursuant to this Section 8(d) were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately
preceding paragraph. Notwithstanding the provisions of this Section 8(d), a selling Holder shall not be required to contribute, in the aggregate, any amount in excess of such Holder’s Maximum Contribution Amount. A selling Holder’s
“Maximum Contribution Amount” shall equal the excess of (i) the aggregate net proceeds received by such Holder pursuant to the sale of such Registrable Notes or Exchange Notes over (ii) the aggregate amount of damages that
such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. The Holders’ obligations to contribute pursuant to this Section 8(d) are several in proportion to the respective principal amount of
the Registrable Notes held by each Holder hereunder and not joint. The Company’s and the Guarantors’ obligations to contribute pursuant to this Section 8(d) are joint and several. 

The indemnity and contribution agreements contained in this Section 8 are in addition to any liability that the Indemnifying Parties
may have to the Indemnified Parties. 
 Section 9. Rules 144 and 144A. 

(a) The Company covenants that, so long as the Registrable Notes remain outstanding, it shall (i) file the reports required to be
filed by it (if so required) under the Securities Act and the Exchange Act in a timely manner and, if at any time the Company is not required to file such reports, it will, upon the written request of any Holder of Registrable Notes, make publicly
available other information necessary to permit sales pursuant to Rule 144 and Rule 144A and (ii) take such further action as any Holder may reasonably request in writing, all to the extent required from time to time to enable such Holder to
sell Registrable Notes without registration under the Securities Act pursuant to the exemptions provided by Rule 144 and Rule 144A. 
 (b) Availability of Rule 144 Not Excuse for Obligations under Section 2. The fact that Holders of Registrable Notes may become eligible to sell such Registrable Notes pursuant to Rule 144
shall not (1) cause such Notes to cease to be Registrable Notes or (2) excuse the Company’s and the Guarantors’ obligations set forth in Section 2 of this Agreement, including without limitation the obligations in respect of
an Exchange Offer, Shelf Registration and Additional Interest. 

  
 24 

 Section 10. Underwritten Registrations of Registrable Notes. 

If any of the Registrable Notes covered by any Shelf Registration are to be sold in an Underwritten Offering, the investment banker or
investment bankers and manager or managers that will manage the offering will be selected by the Holders of a majority in aggregate principal amount of such Registrable Notes included in such offering; provided, however, that such investment banker
or investment bankers and manager or managers must be reasonably acceptable to the Company. The Company shall be required to effect an Underwritten Offering only if the Company is required to file a Shelf Registration and in no event shall the
Company be required to effect more than three Underwritten Offerings pursuant to this Agreement. 
 No Holder of Registrable
Notes may participate in any Underwritten Registration hereunder unless such Holder (a) agrees to sell such Holder’s Registrable Notes on the basis provided in any underwriting arrangements approved by the Persons entitled hereunder to
approve such arrangements and (b) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents required under the terms of such underwriting arrangements. 

Section 11. Miscellaneous. 
 (a) No Inconsistent Agreements. The Company and each of the Guarantors have not entered, as of the date hereof, and the Company and each of the Guarantors shall not enter, after the date of this
Agreement, into any agreement with respect to any of its securities that is inconsistent with the rights granted to the Holders of Securities in this Agreement or otherwise conflicts with the provisions hereof. The Company and each of the Guarantors
have not entered and will not enter into any agreement with respect to any of its securities that will grant to any Person piggy-back rights with respect to a Registration Statement. 

(b) Adjustments Affecting Registrable Notes. The Company shall not, directly or indirectly, take any action with respect to the
Registrable Notes as a class that would adversely affect the ability of the Holders to include such Registrable Notes in a registration undertaken pursuant to this Agreement. 
 (c) Amendments and Waivers. The provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents to or departures from the provisions hereof may not be given,
other than with the prior written consent of the Holders of not less than a majority in aggregate principal amount of the then outstanding Registrable Notes in circumstances that would adversely affect any Holders of Registrable Notes;
provided, however, that Section 8 and this Section 11(c) may not be amended, modified or supplemented without the prior written consent of each Holder. Notwithstanding the foregoing, a waiver or consent to depart from the
provisions hereof with respect to a matter that relates exclusively to the rights of Holders of Registrable Notes whose securities are being tendered pursuant to the Exchange Offer or sold pursuant to a Shelf Registration and that does not directly
or indirectly affect, impair, limit or compromise the rights of other Holders of Registrable Notes may be given by Holders of at least a majority in aggregate principal amount of the Registrable Notes being tendered or being sold by such Holders
pursuant to such Shelf Registration. 

  
 25 

 (d) Notices. All notices and other communications provided for or permitted hereunder
shall be made in writing by hand delivery, registered first-class mail, next-day air courier or facsimile: 
 (i)
if to a Holder of Securities or to any Participating Broker-Dealer, at the most current address of such Holder or Participating Broker-Dealer, as the case may be, set forth on the records of the registrar of the Notes, with a copy in like manner to
the Initial Purchasers as follows: 
 Merrill Lynch, Pierce, Fenner & Smith Incorporated 

One Bryant Park 

New York, New York 10036 
 Facsimile: 212-901-7897 
 Attention: HY Legal Department 

with a copy to: 

Davis Polk & Wardwell LLP 
 450 Lexington Avenue 
 New York, New York 10017 

Facsimile: 212-701-5111 
 Attention: Michael Kaplan 
 (ii) if to the Initial Purchasers, at
the address specified in Section 11(d)(i); 
 (iii) if to the Company or any Guarantor, as follows:

 Acadia Healthcare Company, Inc. 
 830 Crescent Centre Drive, Suite 610 
 Franklin, Tennessee 37067 

Attention: Christopher L. Howard, Executive Vice President, General Counsel and Secretary 

with a copy to: 

Waller Lansden Dortch & Davis, LLP 
 James H. Nixon III 
 511 Union Street, Suite 2700 

Nashville, Tennessee 37219 
 All such notices and communications shall be deemed to have been duly given: when delivered by hand, if personally delivered; five Business Days after being deposited in the United States mail, postage
prepaid, if mailed; one Business Day after being timely delivered to a next-day air courier guaranteeing overnight delivery; and when receipt is acknowledged by the addressee, if sent by facsimile. 

  
 26 

 Copies of all such notices, demands or other communications shall be concurrently delivered
by the Person giving the same to the Trustee under the Indenture at the address specified in such Indenture. 
 (e)
Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties hereto, including, without limitation and without the need for an express assignment, subsequent
Holders of Securities. 
 (f) Counterparts. This Agreement may be executed in any number of counterparts and by the
parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 

(g) Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the
meaning hereof. 
 (h) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF
THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAW. THE COMPANY HEREBY IRREVOCABLY SUBMITS TO THE JURISDICTION OF ANY NEW YORK STATE COURT SITTING IN THE BOROUGH OF MANHATTAN IN THE CITY OF NEW YORK OR ANY FEDERAL COURT SITTING IN
THE BOROUGH OF MANHATTAN IN THE CITY OF NEW YORK IN RESPECT OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, AND IRREVOCABLY ACCEPTS FOR ITS AND IN RESPECT OF ITS PROPERTY, GENERALLY AND UNCONDITIONALLY, JURISDICTION
OF THE AFORESAID COURTS. THE COMPANY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO UNDER APPLICABLE LAW, TRIAL BY JURY AND ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH SUIT, ACTION OR
PROCEEDING BROUGHT IN ANY SUCH COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. THE COMPANY IRREVOCABLY CONSENTS, TO THE FULLEST EXTENT IT MAY EFFECTIVELY DO SO UNDER
APPLICABLE LAW, TO THE SERVICE OF PROCESS OF ANY OF THE AFOREMENTIONED COURTS IN ANY SUCH ACTION OR PROCEEDING BY THE MAILING OF COPIES THEREOF BY REGISTERED OR CERTIFIED MAIL, POSTAGE PREPAID, TO THE COMPANY AT ITS SAID ADDRESS, SUCH SERVICE TO
BECOME EFFECTIVE 30 DAYS AFTER SUCH MAILING. NOTHING HEREIN SHALL AFFECT THE RIGHT OF ANY HOLDER TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO COMMENCE LEGAL PROCEEDINGS OR OTHERWISE PROCEED AGAINST THE COMPANY IN ANY OTHER
JURISDICTION. 

  
 27 

 (i) Severability. If any term, provision, covenant or restriction of this Agreement
is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected,
impaired or invalidated, and the parties hereto shall use their reasonable best efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or
restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid,
illegal, void or unenforceable. 
 (j) Securities Held by the Company or Its Affiliates. Whenever the consent or approval
of Holders of a specified percentage of Securities is required hereunder, Securities held by the Company or its affiliates (as such term is defined in Rule 405 under the Securities Act) shall not be counted in determining whether such consent or
approval was given by the Holders of such required percentage. 
 (k) Third Party Beneficiaries. Holders and
Participating Broker-Dealers are intended third party beneficiaries of this Agreement and this Agreement may be enforced by such Persons. No other Person is intended to be, or shall be construed as, a third party beneficiary of this Agreement.

 (l) Entire Agreement. This Agreement, together with the Purchase Agreement and the Indenture, is intended by the
parties as a final and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein and therein and any and all prior oral or written agreements, representations, or warranties,
contracts, understanding, correspondence, conversations and memoranda between the Initial Purchasers on the one hand and the Company and the Guarantors on the other, or between or among any agents, representatives, parents, subsidiaries, affiliates,
predecessors in interest or successors in interest with respect to the subject matter hereof and thereof are merged herein and replaced hereby. 

  
 28 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written
above. 
  

					
	ACADIA HEALTHCARE COMPANY, INC.
		
	By:	 	 /s/ Brent Turner

		 	Name:	 	Brent Turner
		 	Title: 	 	President

 GUARANTORS: 

 

	
	 ABILENE BEHAVIORAL HEALTH, LLC

 
 ACADIA -YFCS HOLDINGS, INC.

 
 ACADIA MANAGEMENT COMPANY, LLC

 
 ACADIA MERGER SUB, LLC

 
 ACADIANA ADDICTION CENTER, LLC

 
 AMICARE BEHAVIORAL CENTERS, LLC

 
 AMICARE CONTRACT SERVICES, LLC

 
 ASCENT ACQUISITION CORPORATION

 
 ASCENT ACQUISITION CORPORATION -
CYPDC
  
 ASCENT ACQUISITION
CORPORATION - PSC
  
 BCA OF DETROIT,
LLC
  
 BCA REAL ESTATE HOLDINGS,
LLC
  
 BEHAVIORAL CENTERS OF
AMERICA, LLC
  
 BEHAVIORAL HEALTH
ONLINE, INC.
  
 CEDAR CREST
CLINIC
  
 CHILD & YOUTH
PEDIATRIC DAY CLINICS, INC.
  

CHILDREN’S BEHAVIORAL SOLUTIONS, LLC

 
 CHILDRENS MEDICAL TRANSPORTATION SERVICES,
LLC
  
 COMMODORE ACQUISTION SUB,
LLC
  
 DETROIT BEHAVIORAL INSTITUTE,
INC.
  
 FORT SMITH HEALTHCARE REAL
ESTATE, L.C.
  
 FSRE, LLC

 
 FVRE, LLC

 
 GENERATIONS BEHAVIORAL HEALTH - GENEVA,
LLC
  
 GREENLEAF CENTER,
LLC
  
 HABILITATION CENTER,
INC.
  
 HEALTHCARE MANAGEMENT AND
INVESTMENT OF OHIO, LLC
  
 HEP BCA
HOLDINGS CORP.
  
 HERMITAGE
BEHAVIORAL, LLC

 

	
	 HMIH CEDAR CREST, LLC

 
 KIDS BEHAVIORAL HEALTH OF MONTANA,
INC.
  
 LAKELAND HOSPITAL
ACQUISITION CORPORATION
  
 LAKEVIEW
BEHAVIORAL HEALTH SYSTEM LLC
  

LINDEN BCA BLOCKER CORP.
  

MED PROPERTIES, INC.
  

MEDUCARE TRANSPORT, L.L.C.
  

MEMORIAL HOSPITAL ACQUISITION CORPORATION

 
 MILLCREEK MANAGEMENT CORPORATION

 
 MILLCREEK SCHOOL OF ARKANSAS,
INC.
  
 MILLCREEK SCHOOLS
INC.
  
 NORTHEAST BEHAVIORAL HEALTH,
LLC
  
 OHIO HOSPITAL FOR PSYCHIATRY,
LLC
  
 OPTIONS COMMUNITY BASED
SERVICES, INC.
  
 OPTIONS TREATMENT
CENTER ACQUISITION CORPORATION
  

PEDIATRIC SPECIALTY CARE PROPERTIES, LLC

 
 PEDIATRIC SPECIALTY CARE, INC.

 
 PHC MEADOWWOOD, INC.

 
 PHC OF MICHIGAN, INC.

 
 PHC OF NEVADA, INC.

 
 PHC OF UTAH, INC.

 
 PHC OF VIRGINIA, INC.

 
 PINEWOOD ENTERPRISES, L.C.

 
 PINEWOOD HEALTHCARE REALTY, L.P.

 
 PINEWOOD SERVICES, INC.

 
 PINEY RIDGE TREATMENT CENTER, LLC

 
 PRC I, INC.

 
 PSYCHIATRIC RESOURCE PARTNERS,
INC.
  
 REBOUND BEHAVIORAL HEALTH,
LLC

 
 

	
	 RED RIVER HOSPITAL, LLC

 
 REHABILITATION CENTERS, INC.

 
 RENAISSANCE RECOVERY, INC.

 
 RESOLUTE ACQUISITION CORPORATION

 
 RESOURCE COMMUNITY BASED SERVICES,
INC.
  
 RIVERWOODS BEHAVIORAL
HEALTH, LLC
  
 ROLLING HILLS
HOSPITAL, INC.
  
 ROLLING HILLS
PROPERTIES, INC.
  
 RTC RESOURCE
ACQUISITION CORPORATION
  
 SBOF-BCA
HOLDINGS CORPORATION
  
 SEVEN HILLS
HOSPITAL, INC.
  
 SHAKER CLINIC,
LLC
  
 SONORA BEHAVIORAL HEALTH
HOSPITAL, LLC
  
 SOUTHWESTERN
CHILDREN’S HEALTH SERVICES, INC.
  
 SOUTHWOOD PSYCHIATRIC HOSPITAL, INC.
  
 STONE CREST CLINIC
  
 SUCCESS
ACQUISITION CORPORATION

 

	
	 SUNCOAST BEHAVIORAL, LLC

 
 SW BEHAVIORAL, LLC (HIGHLINE)

 
 TBA TEXARKANA, L.L.C.

 
 TEN LAKES CENTER, LLC

 
 TK BEHAVIORAL, LLC (TIMBERLINE
KNOLLS)
  
 VALLEY BEHAVIORAL HEALTH
SYSTEM, LLC
  
 VANTAGE POINT
BEHAVIORAL HEALTH, LLC
  
 VERMILION
HOSPITAL, LLC
  
 VILLAGE BEHAVIORAL
HEALTH, LLC
  
 VISTA BEHAVIORAL
HEALTH, LLC
  
 WELLPLACE,
INC.
  
 YFCS HOLDINGS - GEORGIA,
INC.
  
 YFCS MANAGEMENT,
INC.
  
 YOUTH AND FAMILY CENTERED
SERVICES OF FLORIDA, INC.
  
 YOUTH
AND FAMILY CENTERED SERVICES OF NEW MEXICO, INC.
  
 YOUTH AND FAMILY CENTERED
SERVICES, INC.

 
 

  

					
	By:	 	 /s/ Brent Turner

		 	Name:	 	Brent Turner
		 	Title: 	 	Vice President and Assistant Secretary

  
 31 

 ACCEPTED AND AGREED TO: 
  

					
	MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED
		
		 	 Acting on behalf of itself
 and as the Representative of
 the several Initial Purchasers

		
	By:	 	 /s/ James C. Brett

		 	Name:	 	James C. Brett
		 	Title:	 	DirectorEX-10.1

 Exhibit 10.1 
 $150,000,000 
 Acadia Healthcare Company, Inc. 

6.125% Senior Notes due 2021 
 PURCHASE AGREEMENT 
 March 7, 2013 

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

 As Representative of the Initial Purchasers 
 One Bryant Park 
 New York, New York 10036 

Ladies and Gentlemen: 
 Acadia
Healthcare Company, Inc., a Delaware corporation (the “Company”), and each of the Guarantors (as hereinafter defined) hereby agree with you as follows: 
 1. Issuance of Notes. Subject to the terms and conditions herein contained, the Company proposes to issue and sell to Merrill Lynch, Pierce, Fenner & Smith Incorporated
(“Merrill Lynch”) and the other several initial purchasers named in Schedule I hereto (the “Initial Purchasers”), $150,000,000 aggregate principal amount of the Company’s 6.125% Senior Notes due 2021
(each a “Note” and, collectively, the “Notes”) in connection with the offering and sale of the Notes as described herein (the “Offering”). The Notes will be issued pursuant to an indenture (the
“Indenture”), to be dated as of March 12, 2013, by and among the Company, the Guarantors (as hereinafter defined) party thereto and U.S. Bank National Association, as trustee (the “Trustee”). Merrill Lynch has
agreed to act as the representative of the several Initial Purchasers (the “Representative”) in connection with the Offering. 
 The Company will use the net proceeds from the offering of the Notes in the manner described under the caption “Use of Proceeds” in the Time of Sale Document (as defined below).

 The Notes will be offered and sold to the Initial Purchasers pursuant to exemptions from the registration requirements of the
Securities Act of 1933, as amended, and the rules and regulations of the Securities and Exchange Commission (the “SEC”) promulgated thereunder (collectively, the “Securities Act”). Upon original issuance thereof,
and until such time as the same is no longer required under the applicable requirements of the Securities Act, the Notes shall bear the legends substantially as set forth under the “Notice to Investors” section of the final offering
memorandum, dated the date hereof (the “Final Offering Memorandum”). The Company has prepared (i) a preliminary offering memorandum, dated March 4, 2013 (the “Preliminary Offering Memorandum”), (ii) a
pricing term sheet, dated the date hereof, attached hereto as Schedule II, which includes pricing terms and other information with respect to the Notes (the “Pricing Supplement”), and (iii) the Final Offering Memorandum, in
each case relating to the offer and sale of the Notes (the “Offering”). All references in this Agreement to the Preliminary Offering Memorandum, the Time of Sale Document or the Final Offering Memorandum include, unless expressly
stated otherwise, (i) all amendments or supplements 

 
thereto prepared by, or approved in writing by, the Company, (ii) all financial statements and schedules and other information contained therein (and references in this Agreement to such
information being “contained,” “included” or “stated” (and other references of like import) in the Preliminary Offering Memorandum, the Time of Sale Document or the Final Offering Memorandum shall be deemed to mean all
such information contained in, or incorporated by reference into, such documents), (iii) any electronic copy of the Time of Sale Document or Final Offering Memorandum and (iv) any offering memorandum “wrapper” to be used in
connection with offers to sell, solicitations of offers to buy or sales of the Notes in non-U.S. jurisdictions. The Preliminary Offering Memorandum and the Pricing Supplement are collectively referred to herein as the “Time of Sale
Document.” 
 2. Terms of Offering. The Initial Purchasers have advised the Company, and the Company
understands, that the Initial Purchasers will make offers to sell (the “Exempt Resales”) some or all of the Notes purchased by the Initial Purchasers hereunder on the terms set forth in the Final Offering Memorandum to persons (the
“Subsequent Purchasers”) whom the Initial Purchasers reasonably believe are (i) “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) (“QIBs”), and (ii) are
not “U.S. persons” (as defined in Regulation S under the Securities Act) and in compliance with the laws applicable to such persons in jurisdictions outside of the United States. 

The Notes will be guaranteed on a senior unsecured basis by each of the Company’s U.S. subsidiaries signatory hereto (the
“Guarantors”). The corresponding guarantees of such Guarantors are referred to herein as the “Guarantees” and, together with the Notes, the “Securities.” 

Holders of the Notes (including Subsequent Purchasers) will have the registration rights set forth in a registration rights agreement
applicable to the Notes (the “Registration Rights Agreement”) to be executed on and dated as of the Closing Date (as hereinafter defined). Pursuant to the Registration Rights Agreement, the Company will agree, among other things, to
file with the SEC (a) a registration statement under the Securities Act (the “Exchange Offer Registration Statement”) relating to notes to be offered in exchange for the Notes (the “Exchange Notes”) which shall
be identical to the Notes, except that the Exchange Notes shall have been registered pursuant to the Exchange Offer Registration Statement and will not be subject to restrictions on transfer or contain additional interest provisions, (such offer to
exchange being referred to as the “Exchange Offer”), and/or (b) under certain circumstances, a shelf registration statement pursuant to Rule 415 under the Securities Act (the “Shelf Registration Statement”)
relating to the resale by certain holders of the Notes. If required under the Registration Rights Agreement, the Company will issue Exchange Notes to the Initial Purchasers (the “Private Exchange Notes”). If the Company fails to
satisfy its obligations under the Registration Rights Agreement, it will be required to pay additional interest to the holders of the Notes under certain circumstances to be set forth in the Registration Rights Agreement. 

This Agreement, the Indenture, the Registration Rights Agreement, the Notes, the Guarantees and the Exchange Notes are collectively
referred to herein as the “Transaction Documents”, and the transactions contemplated hereby and thereby are collectively referred to herein as the “Transactions.” 

  
 Page 2

 3. Purchase, Sale and Delivery. On the basis of the representations,
warranties, agreements and covenants herein contained and subject to the terms and conditions herein set forth, the Company agrees to issue and sell to the Initial Purchasers, severally and not jointly, and the Initial Purchasers agree, severally
and not jointly, to purchase from the Company, the Securities at a purchase price of 98% of the aggregate principal amount thereof. Delivery to the Initial Purchasers of and payment for the Securities shall be made at a closing (the
“Closing”) to be held at 10:00 a.m., New York City time, on March 12, 2013 (the “Closing Date”) at the offices of Davis Polk & Wardwell LLP, 450 Lexington Avenue, New York, New York 10017 (or such
other place as shall be reasonably acceptable to the Initial Purchasers); provided, however, that if the Closing has not taken place on the Closing Date because of a failure to satisfy one or more of the conditions specified in
Section 7 hereof and this Agreement has not otherwise been terminated by the Initial Purchasers in accordance with its terms, “Closing Date” shall mean 10:00 a.m. New York time on the first business day following the
satisfaction (or waiver) of all such conditions after notification by the Company to the Representative of the satisfaction (or waiver) of such conditions. 
 The Company shall deliver to the Representative one or more certificates representing the Securities in definitive form, registered in such names and denominations as the Initial Purchasers may request,
against payment by the Initial Purchasers of the purchase price therefor by immediately available federal funds bank wire transfer to such bank account or accounts as the Company shall designate to the Representative at least two business days prior
to the Closing. The certificates representing the Securities in definitive form shall be made available to the Initial Purchasers for inspection at the offices of Davis Polk & Wardwell LLP, 450 Lexington Avenue, New York, New York 10017 (or
such other place as shall be reasonably acceptable to the Representative) not later than 10:00 a.m., New York City time, one business day immediately preceding the Closing Date. Securities to be represented by one or more definitive global
securities in book-entry form will be deposited on the Closing Date, by or on behalf of the Company, with The Depository Trust Company (“DTC”) or its designated custodian, and registered in the name of Cede & Co.

 4. Representations and Warranties of the Company and the Guarantors. As of the date hereof and as of the
Closing Date, the Company and the Guarantors, jointly and severally, represent and warrant to, and agree with each Initial Purchaser, that: 
  

	(a)	Offering Materials Furnished to Initial Purchasers. The Company has delivered to the Initial Purchasers the Time of Sale Document, the Final Offering Memorandum
and each Company Additional Written Communication (as hereinafter defined) in such quantities and at such places as the Initial Purchasers have reasonably requested. 

 

	(b)	 Limitation on Offering Materials. The Company has not prepared, made, used, authorized, approved or distributed and will not, and will not cause
or allow its agents or representatives to, prepare, make, use, authorize, approve or distribute any written communication (as defined by Rule 405 of the Securities Act) that constitutes an offer to sell or a solicitation of an offer to buy the
Securities, or otherwise is prepared to market the Securities, other than (i) the Time of Sale Document, (ii) the Final Offering Memorandum and (iii) any electronic roadshow or other written communication (as defined by Rule 405 of
the Securities Act) used in accordance with Section 5(c) hereof 

  
 Page 3

	 	
(each such communication by the Company or its agents or representatives described in this clause (iii) and listed on Schedule III hereto, a “Company Additional Written
Communication”). 

  

	(c)	No Material Misstatement or Omission. (i) The Time of Sale Document, as of the Applicable Time (as defined below), did not and, at the Closing Date
(as amended or supplemented in accordance with this Agreement), will not include any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they
were made, not misleading, (ii) the Final Offering Memorandum, as of the date thereof, and at the Closing Date (as amended or supplemented in accordance with this Agreement), will not include any untrue statement of a material fact or omit to
state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading and (iii) each such Company Additional Written Communication, when taken together with the Time of Sale
Document, as of the Applicable Time, did not, and, at the Closing Date, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading, except in each case that the representations and warranties set forth in this paragraph do not apply to statements or omissions made in reliance upon and in conformity with information relating to the Initial
Purchasers and furnished to the Company or any Guarantor in writing by or on behalf of the Initial Purchasers expressly for use in the Time of Sale Document or the Final Offering Memorandum as set forth in Section 13. No injunction or order has
been issued that either (i) asserts that any of the Transactions is subject to the registration requirements of the Securities Act or (ii) would prevent or suspend the issuance or sale of any of the Securities or the use of the Time of
Sale Document or the Final Offering Memorandum in any jurisdiction. No statement of material fact included in the Final Offering Memorandum has been omitted from the Time of Sale Document, and no statement of material fact included in the Time of
Sale Document has been omitted from the Final Offering Memorandum. “Applicable Time” means 11:54 a.m., New York City time, on the date of this Agreement. 

 

	(d)	Preparation of the Financial Statements. 

 (i) The audited consolidated financial statements and related notes of the Company and its consolidated subsidiaries contained in the Time of Sale Document and the Final Offering Memorandum (the
“Company Financial Statements”) present fairly in all material respects the financial position, results of operations and cash flows of the Company and its consolidated subsidiaries, as of the respective dates and for the respective
periods to which they apply and have been prepared in accordance with generally accepted accounting principles of the United States (“GAAP”) applied on a consistent basis throughout the periods involved and the requirements of
Regulation S-X. 
 (ii) The audited and unaudited reviewed consolidated financial statements and related notes of
Behavioral Centers of America, LLC, a Delaware limited liability company (“BCA”), and its consolidated subsidiaries contained in 

  
 Page 4

 
the Time of Sale Document and the Final Offering Memorandum (the “BCA Financial Statements”) present fairly in all material respects the financial position, results of operations
and cash flows of BCA and its consolidated subsidiaries, as of the respective dates and for the respective periods to which they apply and have been prepared in accordance with GAAP applied on a consistent basis throughout the periods involved and
the requirements of Regulation S-X. 
 (iii) The audited and unaudited reviewed consolidated financial statements
and related notes of AmiCare Behavioral Centers, LLC, a Delaware limited liability company (“AmiCare”), and its consolidated subsidiaries contained in the Time of Sale Document and the Final Offering Memorandum (the “AmiCare
Financial Statements”) present fairly in all material respects the financial position, results of operations and cash flows of AmiCare and its consolidated subsidiaries, as of the respective dates and for the respective periods to which
they apply and have been prepared in accordance with GAAP applied on a consistent basis throughout the periods involved and the requirements of Regulation S-X. 
 (iv) The financial data set forth under the caption “Selected Consolidated Financial and Operating Data” in the Time of Sale Document and the Final Offering Memorandum has been prepared on a
basis consistent with that of the Company Financial Statements and fairly and accurately present in all material respects the financial position and results of operations of the Company. 

(v) The unaudited pro forma financial information and related notes contained in the Time of Sale Document and the Final
Offering Memorandum under the captions “Summary—Summary Historical Condensed Consolidated Financial Data and Unaudited Pro Forma Condensed Consolidated Financial Data” and “Unaudited Pro Forma Condensed Combined Financial
Information” have been prepared in accordance with the requirements of Regulation S-X, have been properly presented on the bases described therein and give effect to assumptions used in the preparation thereof on a reasonable basis and in good
faith, and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein. 
 (vi) The financial, statistical and market and industry data and forward-looking statements (within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”)) contained in the Time of Sale Document and the Final Offering Memorandum are fairly and accurately presented in all material respects and are based on or derived from sources that the
Company believes to be reliable and accurate. 
 (vii) The interactive data in eXtensible Business Reporting
Language (“XBRL”) incorporated by reference in the Time of Sale Document and the Final Offering Memorandum fairly presents the information called for in all material respects and have been prepared in accordance with the SEC’s
rules and guidelines applicable thereto. 

  
 Page 5

	(e)	Independent Accountants. 

 (i) Ernst & Young LLP (“E&Y”), which has expressed its opinion with respect to the financial statements of the Company and its consolidated subsidiaries including the related
notes thereto contained in the Time of Sale Document and the Final Offering Memorandum, are (i) independent public or certified public accountants as required by the Securities Act and the Exchange Act with respect to the Company, (ii) in
compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X and (iii) a registered public accounting firm as defined by the Public Company Accounting Oversight Board (the
“PCAOB”) whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn. 
 (ii) Lattimore Black Morgan & Cain PC (“LBMC”), which has expressed its opinion with respect to the financial statements of BCA and its consolidated subsidiaries including the
related notes thereto contained in the Time of Sale Document and the Final Offering Memorandum, are (i) independent public or certified public accountants as required by the Securities Act and the Exchange Act with respect to BCA, (ii) in
compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X and (iii) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or
revoked and who has not requested such registration to be withdrawn. 
 (iii) LBMC, which has expressed its
opinion with respect to the financial statements of AmiCare and its consolidated subsidiaries including the related notes thereto contained in the Time of Sale Document and the Final Offering Memorandum, are (i) independent public or certified
public accountants as required by the Securities Act and the Exchange Act with respect to AmiCare, (ii) in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X and
(iii) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn. 

 

	(f)	 No Material Adverse Change. Subsequent to the respective dates as of which information is contained in the Time of Sale Document
(exclusive of any amendment thereto subsequent to the date hereof) and the Final Offering Memorandum (exclusive of any amendment thereto subsequent to the date hereof), except as disclosed in the Time of Sale Document (exclusive of any amendment
thereto subsequent to the date hereof) and the Final Offering Memorandum (exclusive of any amendment thereto subsequent to the date hereof), (i) neither the Company nor any of the Subsidiaries has incurred any liabilities, direct or contingent,
including without limitation any losses or interference 

  
 Page 6

	 	
with its business from fire, explosion, flood, earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action,
order or decree, that are material, individually or in the aggregate, to the Company and the Subsidiaries, taken as a whole, or has entered into any material transactions not in the ordinary course of business, (ii) there has not been any
material decrease in the capital stock or any material increase in any short-term or long-term indebtedness of the Company or the Subsidiaries, or any payment of or declaration to pay any dividends or any other distribution with respect to the
Company, and (iii) there has not been any material adverse change in the properties, business, prospects, operations, earnings, assets, liabilities or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole
(each of clauses (i), (ii) and (iii), a “Material Adverse Change”). To the Company’s knowledge, there is no event that is reasonably likely to occur, which if it were to occur, would, individually or in the aggregate, have
a Material Adverse Effect (as defined below) except as disclosed in the Time of Sale Document and the Final Offering Memorandum. 

  

	(g)	Rating Agencies. No “nationally recognized statistical rating organization” (as defined in Section 3(a)(62) of the Exchange Act) (i) has
imposed (or has informed the Company that it is considering imposing) any condition (financial or otherwise) to retain any rating assigned to the Company or any of the Subsidiaries or to any securities of the Company or any of the Subsidiaries or
(ii) has indicated to the Company that it is considering (A) the downgrading, suspension, or withdrawal of, or any review (or of any potential or intended review) for a possible negative change in, any rating so assigned (including,
without limitation, the placing of any of the foregoing ratings on credit watch with negative implications or under review with an uncertain direction) or (B) any negative change in the outlook for any rating of the Company or any of the
Subsidiaries or any securities of the Company or any of the Subsidiaries. 

  

	(h)	Subsidiaries. Each of the Company’s “subsidiaries” (for purposes of this Agreement, as defined in Rule 405 under the Securities Act) is listed in
Exhibit 21 to the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 (the “Subsidiaries”), and the Company does not own or control, directly or indirectly, any corporation, association or other
entity other than the Subsidiaries listed therein. 

  

	(i)	 Incorporation and Good Standing of the Company and its Subsidiaries; Material Adverse Effect. The Company and each of the Subsidiaries
(i) has been duly organized or formed, as the case may be, is validly existing and is in good standing under the laws of its jurisdiction of organization, (ii) has all requisite power and authority to carry on its business and to own,
lease and operate its properties and assets as described in the Time of Sale Document and in the Final Offering Memorandum and (iii) is duly qualified or licensed to do business and is in good standing as a foreign corporation, partnership or
other entity as the case may be, authorized to do business in each jurisdiction in which the nature of such businesses or the ownership or leasing of such properties requires such qualification, except where the failure to be so qualified would not,
individually or in the aggregate, have a material adverse effect on (A) the properties, business, prospects, operations, earnings, assets, liabilities or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole,
(B) the ability of the Company or any 

  
 Page 7

	 	
Subsidiary to perform its obligations in all material respects under any Transaction Document, (C) the validity or enforceability of any of the Transaction Documents, or (D) the
consummation of any of the Transactions (each, a “Material Adverse Effect”). 

  

	(j)	Capitalization and Other Capital Stock Matters. The table under the caption “Capitalization” in the Time of Sale Document and the Final Offering
Memorandum (including the footnotes thereto) sets forth, as of its date, the capitalization of the Company. All of the outstanding shares of capital stock or other equity interests of each of the Subsidiaries have been duly authorized and validly
issued, are fully paid and non-assessable and are owned, directly or indirectly, by the Company, free and clear of all liens, security interests, mortgages, pledges, charges, equities, claims or restrictions on transferability or encumbrances of any
kind (collectively, “Liens”), other than those Permitted Liens (as defined in the Indenture) and those imposed by the Securities Act and the securities or “Blue Sky” laws of certain U.S. state or non-U.S. jurisdictions.
Except as disclosed in the Time of Sale Document and the Final Offering Memorandum, there are no outstanding (A) options, warrants or other rights to purchase from the Company or any of the Guarantors, (B) agreements, contracts,
arrangements or other obligations of the Company or any of the Guarantors to issue or (C) other rights to convert any obligation into or exchange any securities for, in the case of each of clauses (A) through (C), shares of capital stock
of or other ownership or equity interests in the Company or any of the Guarantors. 

  

	(k)	Legal Power and Authority. Each of the Company and the Guarantors has all necessary power and authority to execute, deliver and perform their respective
obligations under the Transaction Documents to which they are or will become a party and to consummate the Transactions. 

  

	(l)	This Agreement, the Indenture and the Registration Rights Agreement. This Agreement has been duly and validly authorized, executed and delivered by the Company
and the Guarantors. Each of the Indenture and the Registration Rights Agreement has been duly and validly authorized and, on the Closing Date, will be duly and validly executed and delivered, by the Company and the Guarantors. Each of the Indenture
and the Registration Rights Agreement, when executed and delivered by the Company, the Guarantors and each of the other parties thereto, will constitute a legal, valid and binding obligation of each of the Company and Guarantors, enforceable against
each of the Company and the Guarantors in accordance with its terms, except that the enforcement thereof may be subject to (i) bankruptcy, insolvency, reorganization, receivership, moratorium, fraudulent conveyance, fraudulent transfer or other
similar laws now or hereafter in effect relating to creditors’ rights generally, (ii) general principles of equity (whether applied by a court of law or equity) and the discretion of the court before which any proceeding therefor may be
brought and (iii) with respect to the Registration Rights Agreement’s rights to indemnity or contribution thereunder, federal and state securities laws and public policy considerations. This Agreement and, when executed and delivered, the
Indenture and the Registration Rights Agreement, will conform in all material respects to the descriptions thereof in the Time of Sale Document and the Final Offering Memorandum. When executed and delivered by the Company and the Guarantors, the
Indenture will meet the requirements for qualification under the Trust Indenture Act of 1939, as amended, and the rules and regulations of the SEC thereunder (collectively, the “TIA”). 

  
 Page 8

	(m)	Notes. The Notes and the Exchange Notes have each been duly and validly authorized by the Company and, when duly authenticated by the Trustee, issued and
delivered by the Company in accordance with the terms of the Indenture (and, in the case of the Notes, delivered to and paid for by the Initial Purchasers in accordance with the terms of this Agreement), will have been duly executed, authenticated,
issued and delivered and will constitute legal, valid and binding obligations of the Company, entitled to the benefit of the Indenture and the Registration Rights Agreement, and enforceable against the Company in accordance with their terms, except
that the enforcement thereof may be subject to (i) bankruptcy, insolvency, reorganization, receivership, moratorium, fraudulent conveyance, fraudulent transfer or other similar laws now or hereafter in effect relating to creditors’ rights
generally and (ii) general principles of equity (whether applied by a court of law or equity) and the discretion of the court before which any proceeding therefor may be brought. When executed and delivered, the Notes will conform in all
material respects to the descriptions thereof in the Time of Sale Document and the Final Offering Memorandum and will be in the form contemplated by the Indenture. 

 

	(n)	Guarantees. The Guarantees have been duly and validly authorized by the Guarantors and, when issued and executed by the Guarantors, will have been duly executed,
authenticated, issued and delivered and will constitute legal, valid and binding obligations of the Guarantors, entitled to the benefit of the Indenture and the Registration Rights Agreement, and enforceable against the Guarantors in accordance with
their terms, except that the enforcement thereof may be subject to (i) bankruptcy, insolvency, reorganization, receivership, moratorium, fraudulent conveyance, fraudulent transfer or other similar laws now or hereafter in effect relating to
creditors’ rights generally, and (ii) general principles of equity (whether applied by a court of law or equity) and the discretion of the court before which any proceeding therefor may be brought. When executed and delivered, the
Guarantees will conform in all material respects to the descriptions thereof in the Time of Sale Document and the Final Offering Memorandum. 

  

	(o)	 Compliance with Existing Instruments and Applicable Law. Neither the Company nor any of the Subsidiaries is (i) in violation of its
certificate of incorporation, by-laws or other organizational documents (the “Charter Documents”); (ii) in violation of any U.S. or non-U.S. federal, state or local statute, law (including, without limitation, common law) or
ordinance, or any judgment, decree, rule, regulation, order or injunction (collectively, “Applicable Law”) of any U.S. or non-U.S. federal, state, local or other governmental or regulatory authority, governmental or regulatory
agency or body, court, arbitrator or self-regulatory organization (each, a “Governmental Authority”), applicable to any of them or any of their respective properties; or (iii) in breach of or default under, and there is no
condition that would constitute, a Debt Repayment Triggering Event (as hereafter defined) any bond, debenture, note, loan or other evidence of indebtedness, indenture, mortgage, deed of trust, lease or any other agreement or instrument to which any
of them is a party or by which any of them or their respective property is bound (collectively, the “Applicable Agreements”), except, in the case of clauses (ii) and
(iii)

  
 Page 9

	 	
for such violations, breaches or defaults that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. As used herein, a “Debt Repayment
Triggering Event” means any event or condition that gives, or with the giving of notice or lapse of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the
right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of the Subsidiaries or any of their respective properties. 

 

	(p)	No Conflicts. Neither the execution, delivery or performance of the Transaction Documents nor the consummation of any of the Transactions will conflict with,
violate, constitute a breach of or a default (with the passage of time or otherwise) or a Debt Repayment Triggering Event under, or result in the imposition of a Lien on any assets of the Company or any of the Guarantors, the imposition of any
penalty or a Debt Repayment Triggering Event under or pursuant to (i) the Charter Documents, (ii) any Applicable Agreement (including the consent to the issuance and sale of the Securities by the “Majority WCP Investors” (as
defined in the Stockholders Agreement, dated as of November 1, 2011, by and among the Company, the WCP Investors named therein and the other parties thereto), which shall have been obtained prior to the execution of this Agreement),
(iii) any Applicable Law or (iv) any order, writ, judgment, injunction, decree, determination or award binding upon or affecting the Company and the Guarantors, except, in the case of clauses (ii), (iii) and (iv) as would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. After consummation of the Offering and the Transactions, no Default or Event of Default will exist. 

 

	(q)	No Consents. No consent, approval, authorization, order, filing or registration of or with any Governmental Authority or third party is required for execution,
delivery or performance of the Transaction Documents or the consummation of the Transactions by the Company and the Guarantors, except (i) those that have been obtained or made and are in full force and effect or will be made as of the Closing
Date, (ii) as may be required under the securities or “Blue Sky” laws of U.S. state or non-U.S. jurisdictions or other non-U.S. laws applicable to the purchase of the Securities outside the U.S. in connection with the Transactions,
(iii) those contemplated by the Registration Rights Agreement, (iv) the filing of a Current Report on Form 8-K with the SEC as may be required under the Securities Act and the Exchange Act, as the case may be, regarding the Transaction
Documents and the Transactions and (v) those the failure of which to obtain or make would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

 

	(r)	 No Material Applicable Laws or Proceedings. There is no (i) Applicable Law that is enacted, adopted or issued, (ii) stop order
suspending the qualification or exemption from qualification of any of the Securities in any jurisdiction that has been issued and no proceeding for that purpose has been commenced or, to the Company’s knowledge, is pending or contemplated as
of the Closing Date and (iii) except as disclosed in the Time of Sale Document and the Final Offering Memorandum, action, claim, suit, demand, hearing, notice of violation or deficiency, or proceeding pending or, to the knowledge of the
Company, threatened or contemplated by Governmental Authorities or threatened by 

  
 Page 10

	 	
others (collectively, “Proceedings”), that, with respect to clauses (i), (ii) and (iii) of this paragraph (A) would, as of the date hereof and at the Closing Date,
restrain, enjoin, prevent or interfere with the consummation of the Offering or any of the Transactions or (B) would, individually or in the aggregate, have a Material Adverse Effect. 

 

	(s)	All Necessary Permits. Each of the Company and the Subsidiaries possess all licenses, permits, certificates, consents, orders, approvals and other authorizations
from, and has made all declarations and filings with, all Governmental Authorities, presently required or necessary to own or lease, as the case may be, and to operate its properties and to carry on its businesses as now or proposed to be conducted
as described in the Time of Sale Document and the Final Offering Memorandum (“Permits”), except where the failure to possess such Permits would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. Each of the Company and the Subsidiaries has fulfilled and performed all of its obligations with respect to such Permits, except where the failure to perform such obligations would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. No event has occurred which allows, or after notice or lapse of time would allow, revocation or termination of any such Permit or has resulted, or after notice or lapse of time would result, in any other
material impairment of the rights of the holder of any such Permit, except where such revocation or termination would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. None of the Company or the
Subsidiaries has received or has any reason to believe it will receive any notice of any proceeding relating to revocation or modification of any such Permit, except as described in the Time of Sale Document and the Final Offering Memorandum or
except where such revocation or modification would not, individually or in the aggregate, have a Material Adverse Effect. 

  

	(t)	Title to Properties. Each of the Company and the Subsidiaries has good and marketable title to all real property owned by it and good title to all material
personal property owned by it and good and valid title to all leasehold estates in real and material personal property being leased by it and, as of the Closing Date, will be free and clear of all Liens other than Permitted Liens. The real property,
improvements, equipment and personal property held under lease by the Company or any of the Subsidiaries are held under valid and enforceable leases, with such exceptions as are not material and do not materially interfere with the use made or
proposed to be made of such real property, improvements, equipment or personal property by the Company or such Subsidiary. 

  

	(u)	 Tax Law Compliance. All material tax returns required by applicable federal, state or local law to be filed with any taxing authority by or on
behalf of the Company or any of its Subsidiaries have been duly filed when due (including any applicable extensions) and all such tax returns are, or shall be at the time of filing, true, complete and correct in all material respects. All material
taxes that are due from the Company and the Subsidiaries have been paid other than those (i) currently payable without penalty or interest or (ii) being contested in good faith and by appropriate proceedings and for which adequate accruals
have been established in accordance with GAAP, applied on a consistent basis throughout the periods involved. To the knowledge of the Company, there are no actual or proposed tax assessments against the Company or any of the Subsidiaries that would,
individually or in the aggregate, have a Material Adverse Effect. The accruals on the 

  
 Page 11

	 	
books and records of the Company and the Subsidiaries in respect of any material tax liability for any period not finally determined are adequate to meet any assessments of tax for any such
period. 

  

	(v)	Intellectual Property Rights. To the knowledge of the Company, each of the Company and the Subsidiaries owns, or is licensed under, and has the right to use, all
patents, patent rights, licenses, inventions, copyrights, know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, domain names and trade
names (collectively, “Intellectual Property”) necessary for the conduct of its businesses and, as of the Closing Date, the Intellectual Property will be free and clear of all Liens, other than Permitted Liens. The Company is not a
party to, or bound by, any options, licenses or agreements with respect to the intellectual property rights of any other person or entity that are necessary to be described in the Time of Sale Document or the Final Offering Memorandum to avoid a
material misstatement or omission and are not described therein. No claims or notices of any potential claim have been asserted by any person against the Company or any of its Subsidiaries challenging the use of any such Intellectual Property by the
Company or any of the Subsidiaries or questioning the validity or effectiveness of any Intellectual Property or any license or agreement related thereto, other than any claims that, if successful, would not, individually or in the aggregate, have a
Material Adverse Effect. Except as described in the Time of Sale Document and the Final Offering Memorandum, none of the Intellectual Property used by the Company or any of the Subsidiaries has been obtained or is being used by the Company or any of
the Subsidiaries in violation of any contractual obligation binding on the Company or any of the Subsidiaries or, to the Company or any of the Subsidiaries’ knowledge, its officers, directors or employees or otherwise in violation of the rights
of any person, other than any violations that would not, individually or in the aggregate, have a Material Adverse Effect. 

  

	(w)	ERISA Matters. Except as would not result in a Lien on any assets of the Company or any of its Subsidiaries: (i) each of the Company, the Subsidiaries and
each ERISA Affiliate (as hereinafter defined) has fulfilled its obligations, if any, under the minimum funding standards of Section 302 of the United States Employee Retirement Income Security Act of 1974, as amended (“ERISA”)
with respect to each “pension plan” (as defined in Section 3(2) of ERISA), subject to Section 302 of ERISA, which the Company, the Subsidiaries or any ERISA Affiliate sponsors or maintains, or with respect to which it has
(or within the last three years had) any obligation to make contributions, and (ii) each such plan is in compliance in all material respects with the presently applicable provisions of ERISA and the Internal Revenue Code of 1986, as amended
(the “Code”). None of the Company, the Subsidiaries or any ERISA Affiliate has incurred any unpaid material liability to the Pension Benefit Guaranty Corporation (other than for the payment of premiums in the ordinary course) or to
any such plan under Title IV of ERISA. “ERISA Affiliate” means a corporation, trade or business that is, along with the Company or any Subsidiary, a member of a controlled group of corporations or a controlled group of trades or
businesses, as described in Section 414 of the Code or Section 4001 of ERISA. 

  
 Page 12

	(x)	Labor Matters. Other than as described in the Time of Sale Document and the Final Offering Memorandum, and except as could not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect, (i) neither the Company nor any of the Guarantors is party to or bound by any collective bargaining agreement with any labor organization; (ii) there is no union representation
question existing with respect to the employees of the Company or the Guarantors, and, to the knowledge of the Company, after due inquiry, no union organizing activities are taking place that, could, individually or in the aggregate, have a Material
Adverse Effect; (iii) to the knowledge of the Company, after due inquiry, no union organizing or decertification efforts are underway or threatened against the Company or the Guarantors; (iv) no labor strike, work stoppage, slowdown or
other material labor dispute is pending against the Company or the Guarantors, or, to the Company’s knowledge, after due inquiry, threatened against the Company or the Guarantors; (v) there is no worker’s compensation liability,
experience or matter that could be reasonably expected to have a Material Adverse Effect; (vi) to the knowledge of the Company, after due inquiry, there is no threatened or pending liability against the Company or the Guarantors pursuant to the
Worker Adjustment Retraining and Notification Act of 1988, as amended (“WARN”), or any similar state or local law; (vii) there is no employment-related charge, complaint, grievance, investigation, unfair labor practice claim or
inquiry of any kind, pending against the Company or the Guarantors that could, individually or in the aggregate, have a Material Adverse Effect; and (viii) to the knowledge of the Company and the Guarantors, no employee or agent of the Company
or the Guarantors has committed any act or omission giving rise to liability for any violation identified in subsection (vi) and (vii) above, other than such acts or omissions that would not, individually or in the aggregate, have a
Material Adverse Effect. 

  

	(y)	Compliance with Environmental Laws. Each of the Company and the Subsidiaries (i) is in compliance with all applicable U.S. and non-U.S. federal, state and
local laws and regulations relating to occupational health and safety (with respect to hazardous or toxic substances or wastes), the pollution or protection of the environment, hazardous or toxic substances or wastes, pollutants or contaminants
(“Environmental Laws”), (ii) has received and is in compliance with all permits, licenses or other approvals required of it under applicable Environmental Laws and (iii) has not received notice of, and is not aware of, any
actual or potential liability under Environmental Laws, including for damages to natural resources or the investigation or remediation of any disposal, release or existence of hazardous or toxic substances or wastes, pollutants or contaminants, in
each case except where such non-compliance with Environmental Laws, failure to receive and comply with required permits, licenses or other approvals, or liability would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. Neither the Company nor any of the Subsidiaries has been named as a potentially responsible party under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended, or any similar U.S. or non-U.S.
state or local Environmental Laws or is otherwise required by any Environmental Law to investigate or remediate any pollutants or contaminants, except where such requirements would not, individually or in the aggregate, reasonably be expected to
have a Material Adverse Effect, whether or not arising from transactions in the ordinary course of business. 

  
 Page 13

	(z)	Insurance. Each of the Company and the Subsidiaries have insurance covering their respective properties, operations, personnel and businesses, including business
interruption insurance, which insurance is in amounts and insures against such losses and risks as are prudent and customary in the businesses in which they are engaged. All material policies of insurance insuring the Company or any of the
Subsidiaries or their respective businesses, assets, employees, officers and directors are in full force and effect. Except with respect to the shareholder litigation described in the Time of Sale Document and the Final Offering Memorandum, there
are no material claims by the Company or any of the Subsidiaries under any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of rights clause. Neither the Company nor any such
Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business as now
conducted and at a cost that would not, individually or in the aggregate, result in a Material Adverse Effect. 

  

	(aa)	Accounting System. The Company and each of the Subsidiaries make and keep accurate books and records and maintain a system of internal accounting controls and
procedures sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorization, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP, and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any material differences. The interactive data in XBRL incorporated by reference in the Time of Sale Document and the Final Offering Memorandum
fairly present the information called for in all material respects and are prepared in accordance with the SEC’s rules and guidelines applicable thereto. Neither the Company nor the Guarantors has any “material weaknesses” or
“significant deficiencies” (each, as defined in Rule 12b-2 of the Exchange Act), or is aware of any fraud, whether or not material, that involves management or other employees who have a role in the internal controls of the Company or the
Guarantors (whether or not remediated) except as disclosed in the Time of Sale Document and the Final Offering Memorandum in all material respects. Since the date of the most recent evaluation of such disclosure controls and procedures and internal
controls, there have been no material changes in internal controls or in other factors that could significantly affect internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses.

  

	(bb)	 Use of Proceeds; Solvency; Going Concern. On the Closing Date, after giving pro forma effect to the Offering and the use of proceeds therefrom
described under the caption “Use of Proceeds” in the Time of Sale Document and Final Offering Memorandum, the Company, on a consolidated basis, (i) will be Solvent (as hereinafter defined), (ii) will have sufficient capital for
carrying on its business and (iii) will be able to pay its debts as they mature. As used in this paragraph, the term “Solvent” means, with respect to a particular date, that on such date (i) the present fair market value (or
present fair saleable value) of the assets of the Company on a consolidated basis, is not less than the total 

  
 Page 14

	 	
amount required to pay the liabilities of the Company, on a consolidated basis, on its total existing debts and liabilities (including contingent liabilities) as they become absolute and matured;
(ii) the Company, on a consolidated basis, is able to pay its debts and other liabilities, contingent obligations and commitments as they mature and become due in the normal course of business; (iii) assuming consummation of the issuance
of the Securities as contemplated by this Agreement and the Time of Sale Document and Final Offering Memorandum, the Company, on a consolidated basis, is not incurring debts or liabilities beyond its ability to pay as such debts and liabilities
mature; (iv) the Company, on a consolidated basis, is not engaged in any business or transaction, and does not propose to engage in any business or transaction, for which its property would constitute unreasonably small capital after giving due
consideration to the prevailing practice in the industry in which the Company, on a consolidated basis, is engaged; and (v) the Company, on a consolidated basis, is not otherwise insolvent under the standards set forth in Applicable Laws.

  

	(cc)	No Price Stabilization or Manipulation. Neither the Company nor any of its affiliates (as defined in Rule 405 of the Securities Act)
(“Affiliates”) has and, to the Company’s knowledge, no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in, or that has constituted or which might reasonably be
expected to constitute, the stabilization or manipulation of the price of the Securities, whether to facilitate the sale or resale of any of the Securities or otherwise, (ii) sold, bid for, purchased, or paid anyone any compensation for
soliciting purchases of, any of the Securities, or (iii) except as disclosed in the Time of Sale Document and the Final Offering Memorandum, paid or agreed to pay to any person any compensation for soliciting another to purchase any of the
Securities. 

  

	(dd)	No Registration Required Under the Securities Act or Qualification Under the TIA. Without limiting any provision herein, no registration under the Securities Act
and no qualification of the Indenture under the TIA is required for the offer or sale of the Securities to the Initial Purchasers as contemplated hereby or for the Exempt Resales, assuming (i) that the purchasers in the Exempt Resales are QIBs
or are not “U.S. persons” (as defined under Regulation S of the Securities Act), (ii) the accuracy of the Initial Purchasers’ representations contained herein regarding the absence of general solicitation in connection with the
sale of the Securities to the Initial Purchasers and in the Exempt Resales and (iii) the Initial Purchasers’ compliance with the procedures set forth in Section 6. 

 

	(ee)	 No Integration. The Securities will be, upon issuance, eligible for resale pursuant to Rule 144A under the Securities Act and no other
securities of the Company are of the same class (within the meaning of Rule 144A under the Securities Act) as the Securities and listed on a national securities exchange registered under Section 6 of the Exchange Act, or quoted in a U.S.
automated inter-dealer quotation system. No securities of the Company of the same class as the Securities have been offered, issued or sold by the Company or any of its Affiliates within the six-month period immediately prior to the date hereof; and
the Company does not have any intention of making, and will not make, an offer or sale of such securities of the Company of the same class as the Securities, for a period of ninety days after the date of this Agreement, except for the offering of
the 

  
 Page 15

	 	
Securities as contemplated by this Agreement or the Registration Rights Agreement. As used in this paragraph, the terms “offer” and “sale” have the meanings specified in
Section 2(a)(3) of the Securities Act. 

  

	(ff)	No Directed Selling Efforts. None of the Company, any of its Affiliates or other person acting on behalf of the Company has, with respect to Securities sold
outside the United States, offered the Securities to buyers qualifying as “U.S. persons” (as defined in Rule 902 under the Securities Act) or engaged in any directed selling efforts within the meaning of Rule 902 under the Securities Act;
the Company, any Affiliate of the Company and any person acting on behalf of the Company have complied with and will implement the “offering restrictions” within the meaning of such Rule 902; and neither the Company nor any of its
Affiliates has entered or will enter into any arrangement or agreement with respect to the distribution of the Securities, except for this Agreement; provided that no representation is made in this paragraph with respect to the actions of the
Initial Purchasers. 

  

	(gg)	No Applicable Registration or Other Similar Rights. Except as disclosed in the Time of Sale Document and the Final Offering Memorandum, there are no persons with
registration or other similar rights to have any equity or debt securities of the Company or any Affiliate registered for sale under a registration statement, except for rights (i) contained in the Registration Rights Agreement or (ii) as
have been duly waived. 

  

	(hh)	Margin Requirements. None of the Transactions or the application of the proceeds of the Securities will violate or result in a violation of Section 7 of the
Exchange Act (including, without limitation, Regulation T (12 C.F.R. Part 220), Regulation U (12 C.F.R. Part 221) or Regulation X (12 C.F.R. Part 224) of the Board of Governors of the Federal Reserve System). 

 

	(ii)	Investment Company Act. The Company has been advised of the Investment Company Act of 1940, as amended, and the rules and regulations of the SEC thereunder
(collectively, the “Investment Company Act”); as of the date hereof and, after giving effect to the Offering and the use of proceeds of the Offering, each of the Company and the Guarantors is not and will not be, individually or on
a consolidated basis, an “investment company” that is required to be registered under the Investment Company Act; and following the Closing, the Company and the Guarantors will conduct their businesses in a manner so as not to be required
to register under the Investment Company Act. 

  

	(jj)	No Brokers. Neither the Company nor any of its Affiliates has engaged any broker, finder, commission agent or other person (other than the Initial Purchasers) in
connection with the Offering or any of the Transactions, and neither the Company nor any of its Affiliates is under any obligation to pay any broker’s fee or commission in connection with such Transactions (other than commissions or fees to the
Initial Purchasers). 

  

	(kk)	 No Restrictions on Payments of Dividends. As of the Closing Date, except as otherwise disclosed in the Time of Sale Document and the Final
Offering Memorandum, and except as prohibited or restricted under Applicable Law, there will be no encumbrances or 

  
 Page 16

	 	
restrictions on the ability of any Subsidiary of the Company (x) to pay dividends or make other distributions on such Subsidiary’s capital stock or to pay any indebtedness to the
Company or any other Subsidiary of the Company, (y) to make loans or advances or pay any indebtedness to, or investments in, the Company or any other Subsidiary or (z) to transfer any of its property or assets to the Company or any other
Subsidiary of the Company. 

  

	(ll)	Sarbanes-Oxley. There is and has been no failure on the part of the Company and the Subsidiaries or any of the officers and directors of the Company or any of
the Subsidiaries, in their capacities as such, to comply with any applicable provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith. 

 

	(mm)	Foreign Corrupt Practices Act. None of the Company or any Subsidiary, or to the Company’s knowledge, any director, officer, employee, Affiliate or any agent
or other person acting on behalf of the Company or any Subsidiary has, in the course of its actions for, or on behalf of, the Company or any Subsidiary, taken any action, directly or indirectly, that would result in a violation by such persons of
the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the “FCPA”), including, without limitation, (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any domestic government official, “foreign official” (as defined in the FCPA) or employee from corporate
funds; (iii) violated or is in violation of any provision of the FCPA or any applicable non-U.S. anti-bribery statute or regulation; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to
any domestic government official, such foreign official or employee. The Company, its Subsidiaries and, to the knowledge of the Company, its Affiliates, have conducted their business in compliance with the FCPA. 

 

	(nn)	Money Laundering. The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or
body or any arbitrator involving the Company or any of the Subsidiaries with respect to the Money Laundering Laws is pending or, to the Company’s knowledge, threatened. 

 

	(oo)	 OFAC. Neither the Company nor the Subsidiaries nor, to the Company’s knowledge, any director, officer, agent, employee or Affiliate of the
Company or any of the Subsidiaries or other person acting on their behalf is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) nor is the Company or
any of its Subsidiaries located in a country or territory that is subject to U.S. sanctions administered by OFAC; and the Company will not directly or indirectly use the proceeds of the Offering, or lend, contribute or otherwise

  
 Page 17

	 	
make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) for the purpose of financing the activities of any person currently subject to any U.S.
sanctions administered by OFAC or that is in Burma/Myanmar, Cuba, Iran, Libya, North Korea or in any other country that is at the time subject to U.S. sanctions administered by OFAC or (ii) in any other manner that will result in a violation by
any person (including any person participating in the Offering, whether as initial purchaser, advisor, investor or otherwise) of any U.S. sanctions administered by OFAC. 

 

	(pp)	Financial Services and Market Act. The Company has not taken or omitted to take any action and will not take any action or omit to take any action (such as
issuing any press release or making any other public announcement referring to the Offering without an appropriate stabilization legend) which may result in the loss by the Initial Purchasers of the ability to rely on any stabilization safe harbour
provided by the Financial Services Authority of the United Kingdom under the Financial Services and Markets Act 2000 (the “FSMA”); provided, however, that an appropriate stabilization legend was not in the Preliminary
Offering Memorandum or the Pricing Supplement. The Company has been informed of the guidance relating to stabilization provided by the Financial Services Authority of the United Kingdom, in particular the guidance contained in Section MAR 2 of the
Financial Services Handbook. 

  

	(qq)	Disclosure Controls and Procedures; Deficiencies in or Changes to Internal Control Over Financial Reporting. The Company has established and maintains disclosure
controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act), which (i) are designed to ensure that material information relating to the Company, including its consolidated Subsidiaries, is made known to the
Company’s principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange Act are being prepared; (ii) have been
evaluated by management of the Company for effectiveness as of the end of the Company’s most recent fiscal year; and (iii) are effective in all material respects to perform the functions for which they were established. Since the end of
the Company’s most recent audited fiscal year, there have been no significant deficiencies or material weakness in the Company’s internal control over financial reporting (whether or not remediated) and no change in the Company’s
internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. The Company is not aware of any change in its internal control over
financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 

 

	(rr)	 Medicare and Medicaid Programs. To the extent required in connection with their respective businesses, each of the Company and its Subsidiaries
has the requisite provider number or other authorization to bill the Medicare program and the respective Medicaid program in the state or states in which such entity operates unless failure to maintain such provider number or other authorization
would not, individually or in the aggregate, have a Material Adverse Effect; neither the Company nor any of its Subsidiaries is subject to any pending or, to the Company’s knowledge, threatened or contemplated action which could reasonably be
expected to result either in a revocation of any provider number or 

  
 Page 18

	 	
authorization or in the Company’s or any Subsidiary’s exclusion from the Medicare or any state Medicaid programs; the Company’s and each of its Subsidiaries’ business
practices have been structured in a manner reasonably designed to comply with the federal or state laws governing Medicare and state Medicaid programs, including, without limitation, Sections 1320a-7a and 1320a-7b of Title 42 of the United States
Code, and the Company reasonably believes that it is in compliance with such laws; the Company and its Subsidiaries have taken reasonable actions designed to ensure that they do not: (i) violate the False Claims Act, 31 U.S.C. §§
3729-3733 or (ii) allow any individual with an ownership or control interest (as defined in 42 U.S.C. § 1320a-3(a)(3)) in the Company or any of its Subsidiary or have any officer, director or managing employee (as defined in 42 U.S.C.
§ 1320a-5(b)) of the Company or any of its Subsidiaries who would be a person excluded from participation in any federal health care program (as defined in 42 U.S.C. § 1320a-7b(f)) as described in 42 U.S.C. § 1320a-7(b)(8); and the
Company and its Subsidiaries have structured their respective businesses practices in a manner designed to comply with the federal and state laws regarding physician ownership of (or financial relationship with), and referral to, entities providing
healthcare-related goods or services, and with laws requiring disclosure of financial interests held by physicians in entities to which they may refer patients for the provisions of healthcare-related goods or services, and the Company and its
Subsidiaries are in compliance with such laws. 

  

	(ss)	Certificates. Each certificate signed by any officer of the Company or any of the Subsidiaries, delivered to the Initial Purchasers shall be deemed a
representation and warranty by the Company or any such Subsidiary (and not individually by such officer) to the Initial Purchasers with respect to the matters covered thereby. 

5. Covenants of the Company and the Guarantors. Each of the Company and the Guarantors, jointly and severally, covenants
and agrees with the Initial Purchasers as follows: 
  

	(a)	Securities Law Compliance. To (i) advise the Initial Purchasers promptly after obtaining knowledge (and, if requested by the Representative, confirm such
advice in writing) of (A) the issuance by any U.S. or non-U.S. federal or state securities commission of any stop order suspending the qualification or exemption from qualification of any of the Securities for offer or sale in any jurisdiction,
or the initiation of any proceeding for such purpose by any U.S. or non-U.S. federal or state securities commission or other regulatory authority, or (B) the happening of any event that makes any statement of a material fact made in the Time of
Sale Document, any Company Additional Written Communication or the Final Offering Memorandum, untrue or that requires the making of any additions to or changes in the Time of Sale Document, any Company Additional Written Communication, or the Final
Offering Memorandum, to make the statements therein, in the light of the circumstances under which they were made, not misleading, (ii) use its reasonable best efforts to prevent the issuance of any stop order or order suspending the
qualification or exemption from qualification of any of the Securities under any securities or “Blue Sky” laws of U.S. state or non-U.S. jurisdictions and (iii) if, at any time, any U.S. or non-U.S. federal or state securities
commission or other regulatory authority shall issue an order suspending the qualification or exemption from qualification of any of the Securities under any such laws, use its reasonable best efforts to obtain the withdrawal or lifting of such
order at the earliest possible time. 

  
 Page 19

	(b)	Offering Documents. To (i) furnish the Initial Purchasers, without charge, as many copies of the Time of Sale Document and the Final Offering Memorandum,
and any amendments or supplements thereto, as the Initial Purchasers may reasonably request, and (ii) promptly prepare, upon the Initial Purchasers’ reasonable request, any amendment or supplement to the Time of Sale Document or Final
Offering Memorandum that the Initial Purchasers, upon advice of legal counsel, determine may be necessary in connection with Exempt Resales (and the Company and the Guarantors hereby consent to the use of the Time of Sale Document and the Final
Offering Memorandum, and any amendments and supplements thereto prepared by, or approved in writing, by the Company, by the Initial Purchasers in connection with Exempt Resales). 

 

	(c)	Consent to Amendments and Supplements. Not to amend or supplement the Time of Sale Document or the Final Offering Memorandum prior to the Closing Date, or at any
time prior to the completion of the resale by the Initial Purchasers of all the Securities purchased by the Initial Purchasers, unless the Representative shall previously have been advised thereof and shall have provided its written consent thereto.
Before making, preparing, using, authorizing, approving or referring to any Company Additional Written Communications, the Company will furnish to the Representative and counsel for the Representative a copy of such written communication for review
and will not make, prepare, use, authorize, approve or refer to any such written communication to which the Representative reasonably objects within a reasonable amount of time. The Company and the Guarantors consent to the use by the Initial
Purchasers of a Company Additional Written Communication that contains (A) information describing the preliminary terms of the Securities or their offering or (B) information that describes the final terms of the Securities or their
offering and that is included in or is subsequently included in the Final Offering Memorandum, including by means of the Pricing Supplement. 

  

	(d)	 Preparation of Amendments and Supplements to Offering Documents. So long as the Initial Purchasers shall hold any of the Securities, (i) if
any event shall occur as a result of which, in the reasonable judgment of the Company or the Initial Purchasers, it becomes necessary or advisable to amend or supplement the Time of Sale Document or the Final Offering Memorandum to correct any
untrue statement of a material fact or omission to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it is necessary to amend or supplement the Time
of Sale Document or the Final Offering Memorandum to comply with any Applicable Law, to prepare, at the expense of the Company, an appropriate amendment or supplement to the Time of Sale Document and the Final Offering Memorandum (in form and
substance reasonably satisfactory to the Initial Purchasers) so that (A) as so amended or supplemented, the Time of Sale Document and the Final Offering Memorandum will not include an untrue statement of material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, and (B) the Time of Sale Document and the Final Offering Memorandum will comply with Applicable Law and
(ii) if in the reasonable judgment of the Company it becomes necessary or advisable to 

  
 Page 20

	 	
amend or supplement the Time of Sale Document or the Final Offering Memorandum so that the Time of Sale Document and the Final Offering Memorandum will contain all of the information specified
in, and meet the requirements of, Rule 144A(d)(4) of the Securities Act, to prepare an appropriate amendment or supplement to the Time of Sale Document or the Final Offering Memorandum (in form and substance reasonably satisfactory to the Initial
Purchasers) so that the Time of Sale Document or the Final Offering Memorandum, as so amended or supplemented, will contain the information specified in, and meet the requirements of, such Rule. 

 

	(e)	“Blue Sky” Law Compliance. To cooperate with the Initial Purchasers and the Initial Purchasers’ counsel in connection with the qualification of
the Securities under the securities or “Blue Sky” laws of U.S. state or non-U.S. jurisdictions as the Initial Purchasers may request and continue such qualification in effect so long as reasonably required for Exempt Resales. The Company
will advise the Initial Purchasers promptly of the suspension of any such exemption relating to the Securities for offering, sale or trading in any jurisdiction that the Company has been informed by the Initial Purchasers is a jurisdiction into
which Securities were sold by the Initial Purchasers or any initiation or threat of any proceeding for any such purpose, in each case, of which it becomes aware, and in the event of the issuance of any order suspending such exemption, the Company
shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment. 

  

	(f)	 Payment of Expenses. Whether or not any of the Offering or the Transactions are consummated or this Agreement is terminated, to pay (i) all
costs, expenses, fees and taxes incident to and in connection with: (A) the preparation, printing and distribution of the Time of Sale Document and the Final Offering Memorandum and all amendments and supplements thereto (including, without
limitation, financial statements and exhibits), and all other agreements, memoranda, correspondence and other documents prepared and delivered in connection herewith, (B) the negotiation, printing, processing and distribution (including,
without limitation, word processing and duplication costs) and delivery of, each of the Transaction Documents, (C) the preparation, issuance and delivery of the Securities, (D) the qualification of the Securities for offer and sale under
the securities or “Blue Sky” laws of U.S. state or non-U.S. jurisdictions (including reasonable fees and disbursements of the Initial Purchasers’ counsel relating thereto), (E) furnishing such copies of the Time of Sale Document
and the Final Offering Memorandum, and all amendments and supplements thereto, as may reasonably be requested for use by the Initial Purchasers and (F) the performance of the obligations of the Company and the Guarantors obligations under the
Registration Rights Agreement, including but not limited to the Exchange Offer, the Exchange Offer Registration Statement and any Shelf Registration Statement, (ii) all fees and expenses of the counsel, accountants and any other experts or
advisors retained by the Company or the Guarantors, (iii) all fees and expenses (including fees and expenses of counsel) of the Company or the Guarantors in connection with approval of the Securities by DTC for “book-entry” transfer,
(iv) all fees charged by rating agencies in connection with the rating of the Securities, (v) all fees and expenses (including reasonable fees and expenses of counsel) of the Trustee, (vi) any filing fees incident to, and any
reasonable fees and disbursements of Initial Purchasers’ counsel in connection with the review, if any, by the 

  
 Page 21

	 	
Financial Industry Regulatory Authority, Inc. of the terms of the sale of the Securities or the Exchange Notes and (vii) the Initial Purchasers’ reasonable out-of-pocket expenses
incurred in connection with the Offering, including 50% of the cost of any chartered aircraft; provided that the Initial Purchasers shall pay their own legal expenses, except as otherwise provided in clauses (i)(D) and (vi) above and
Sections 8 and 9 of this Agreement. 

  

	(g)	Use of Proceeds. To use the proceeds of the Offering in the manner described in the Time of Sale Document and the Final Offering Memorandum under the caption
“Use of Proceeds.” 

  

	(h)	Transaction Documents. To do and perform all things required to be done and performed under the Transaction Documents prior to and after the Closing Date.

  

	(i)	Integration. Not to, and to ensure that no Affiliate of the Company will, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
“security” (as defined in the Securities Act) that would be integrated with the sale of the Securities in a manner that would require the registration under the Securities Act of the sale to the Initial Purchasers or to the Subsequent
Purchasers of the Securities. 

  

	(j)	Stabilization or Manipulation. Not to take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in
stabilization or manipulation of the price of the Securities or any other reference security, whether to facilitate the sale or resale of the Securities or otherwise. 

 

	(k)	DTC. To comply with the representation letter of the Company to DTC relating to the approval of the Securities by DTC for “book-entry” transfer.

  

	(l)	Additional Filings; Rule 144A Information. Prior to the completion of the placement of the Securities by the Initial Purchasers with the Subsequent Purchasers,
the Company shall file, on a timely basis, with the SEC and the NASDAQ National Market all reports and documents required to be filed under Section 13 or 15 of the Exchange Act. Additionally, for so long as any of the Securities remain
outstanding, during any period in which the Company is not subject to Section 13 or 15(d) of the Exchange Act, to make available, upon request, to any owner of the Securities in connection with any sale thereof and any prospective Subsequent
Purchasers of such Securities from such owner, the information required by Rule 144A(d)(4) under the Securities Act. 

  

	(m)	Furnish Trustee and Noteholder Reports. For so long as any of the Securities remain outstanding, to furnish to the Initial Purchasers, upon request, copies of
all reports and other communications (financial or otherwise) furnished by the Company to the Trustee or to the holders of the Securities and, as soon as available, copies of any reports or financial statements furnished to or filed by the Company
with the SEC or any national securities exchange on which the Securities may be listed. 

  

	(n)	 Additional Offering Materials. Except in connection with the Exchange Offer or the filing of the Shelf Registration Statement, not to, and not
to authorize or permit any person acting on its behalf to, (i) distribute any offering material in connection with the 

  
 Page 22

	 	
offer and sale of the Securities other than the Time of Sale Document and the Final Offering Memorandum and any Company Additional Written Communications (used in accordance with this Agreement)
and any amendments and supplements to the Preliminary Offering Memorandum or the Final Offering Memorandum or any Company Additional Written Communication prepared in compliance with this Agreement, (ii) solicit any offer to buy or offer to
sell the Securities by means of any form of general solicitation or general advertising (including, without limitation, as such terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning
of Section 4(2) of the Securities Act, or (iii) engage in any directed selling efforts with respect to the Securities within the meaning of Regulation S, and all such persons will comply with the offering restrictions requirement of
Regulation S. 

  

	(o)	Sale of Restricted Securities. During the one year period after the Closing Date (or such shorter period as may be provided for in Rule 144 under the Securities
Act, as the same may be in effect from time to time), to not, and to not permit any current or future Subsidiaries of either the Company or any other Affiliates controlled by the Company to, resell any of the Securities which constitute
“restricted securities” under Rule 144 that have been reacquired by the Company, any current or future Subsidiaries or any other Affiliates controlled by the Company, except pursuant to an effective registration statement under the
Securities Act. 

  

	(p)	Stamp Taxes. To pay all stamp or other issuance or transfer taxes or duties other similar fees or charges which may be imposed by any governmental or regulatory
authority in connection with the execution and delivery of this Agreement or the issuance or sale of the Securities to the Initial Purchasers pursuant to this Agreement. 

 

	(q)	Good Standings. To deliver to the Initial Purchasers on the Closing Date satisfactory evidence of the good standing of the Company and the Guarantors in their
respective jurisdictions of organization and the good standing of the Company and the Subsidiaries in such other jurisdictions as the Initial Purchasers may reasonably request, in each case in writing or any standard form of telecommunication, from
the appropriate governmental authorities of such jurisdictions. 

  

	(r)	Investment Company. For a period of two years following the Closing Date, the Company and its Subsidiaries will conduct their businesses in a manner so as to not
be required to register under the Investment Company Act. 

  

	(s)	Lock–up. During the period beginning from the date hereof and continuing until the date that is 90 days after the Closing Date, not to, directly or
indirectly, offer, sell, contract or grant any option to sell, pledge, transfer or establish an open “put equivalent position” within the meaning of Rule 16a-1 under the Exchange Act, or otherwise dispose of, or announce the offering of,
or file any registration statement under the Securities Act in respect of, any securities of the Company that are substantially similar to the Securities (except as provided hereunder) without the prior written consent of the Representative (which
consent may be withheld at the sole discretion of the Representative). 

  
 Page 23

	(t)	Legended Securities. Each certificate for a Note will bear the legend contained in “Notice to Investors” in the Preliminary Offering Memorandum for the
time period and upon the other terms stated in the Preliminary Offering Memorandum. 

 6. Representations
and Warranties of the Initial Purchasers. Each Initial Purchaser, severally and not jointly, represents and warrants to, and agrees with the Company and the Guarantors, that: 

 

	(a)	Initial Purchasers’ Status, Resale Terms. It is a “QIB” (as defined in Rule 144A under the Securities Act) and it will offer the Securities
for resale only upon the terms and conditions set forth in this Agreement and in the Time of Sale Document and the Final Offering Memorandum. It is purchasing the Securities pursuant to a private sale exemption from registration under the Securities
Act. 

  

	(b)	Resale of Securities. It will solicit offers to buy the Securities only from, and will offer and sell the Securities only to, persons reasonably believed by the
Initial Purchasers (A) to be QIBs or (B) to not be “U.S. persons” (as defined under Regulation S under the Securities Act) and in compliance with laws applicable to such persons in jurisdictions outside of the United States;
provided, however, that in purchasing such Securities, such persons are deemed to have represented and agreed as provided under the caption “Notice to Investors” contained in the Time of Sale Document and the Final Offering
Memorandum. 

  

	(c)	General Solicitation. No form of general solicitation or general advertising in violation of the Securities Act has been or will be used nor will any offers in
any manner involving a public offering within the meaning of Section 4(2) of the Securities Act or, with respect to Securities to be sold in reliance on Regulation S, by means of any directed selling efforts be made by such Initial Purchasers
or any of its representatives in connection with the offer and sale of any of the Securities. 

  

	(d)	Subsequent Purchaser Notifications. 

 (i) Resales Under Rule 144A. It will take reasonable steps to inform persons acquiring Securities from the Initial Purchasers in the United States that the Securities (A) have not been and
will not be registered under the Securities Act, (B) are being sold to them without registration under the Securities Act in reliance on Rule 144A and (C) may not be offered, sold or otherwise transferred except (D) to the Company,
(2) outside the United States in accordance with Regulation S or (3) inside the United States in accordance with (x) Rule 144A to a person whom the seller reasonably believes is a QIB that is purchasing such Securities for its own
account or for the account of a QIB to whom notice is given that the offer, sale or transfer is being made in reliance on Rule 144A or (y) pursuant to another available exemption from registration under the Securities Act. 

(ii) Resales under Regulation S. It agrees that, at or prior to confirmation of sale of the Securities, other than
a sale pursuant to Rule 144A, it 

  
 Page 24

 
will have sent to each distributor, dealer or person receiving a selling concession, fee or other remuneration that purchases the Securities from it during the 40-day distribution compliance
period referred to in Rule 903 under the Securities Act a confirmation or notice in accordance with Regulation S. 
 7.
Conditions. The obligations of the Initial Purchasers to purchase the Securities under this Agreement are subject to the performance by each of the Company and the Guarantors of their respective covenants and obligations hereunder and the
satisfaction of each of the following conditions: 
  

	(a)	Representations, Warranties and Agreements. As of the date hereof and as of the Closing Date, all the representations and warranties of the Company and the
Guarantors contained in this Agreement shall be true and correct. On or prior to the Closing Date, the Company and each Guarantor shall have performed or complied with all of the agreements and satisfied all conditions on their respective parts to
be performed, complied with or satisfied pursuant to the Transaction Documents. 

  

	(b)	Closing Deliverables. The Initial Purchasers shall have received on the Closing Date: 

(i) Officers’ Certificate. A certificate dated the Closing Date, signed by (1) the Chief Executive
Officer and (2) the principal financial or accounting officer of the Company and the Guarantors, on behalf of the Company and the Guarantors, to the effect that (a) the representations and warranties set forth in Section 4 hereof are
true and correct in all material respects with the same force and effect as though expressly made at and as of the Closing Date, (b) the Company and the Guarantors have performed and complied with all agreements and satisfied all conditions in
all material respects on its part to be performed or satisfied at or prior to the Closing Date, (c) at the Closing Date, since the date hereof, no event or events have occurred, no information has become known nor does any condition exist that,
individually or in the aggregate, would have a Material Adverse Effect, (d) since the date of the most recent financial statements in the Time of Sale Document and the Final Offering Memorandum (exclusive of any amendment or supplement thereto
after the date hereof), other than as described in the Time of Sale Document and the Final Offering Memorandum (exclusive of any amendment or supplement thereto after the date hereof) or contemplated hereby, neither the Company, the Guarantors nor
any other Subsidiary has incurred any liabilities or obligations, direct or contingent, not in the ordinary course of business, that are material to the Company and the Subsidiaries, taken as a whole, or entered into any transactions not in the
ordinary course of business that are material to the business, condition (financial or otherwise) or results of operations or prospects of the Company and the Subsidiaries, taken as a whole, and there has not been any change in the capital stock or
long-term indebtedness of the Company, the Guarantors or any other Subsidiary of the Company that is material to the business, condition (financial or otherwise) or results of operations or prospects of the Company and the Subsidiaries, taken as a
whole, (e) to his knowledge, the sale of the Securities has not been enjoined (temporarily or permanently) and (f) to the effect of Section 7(f) below. 

  
 Page 25

 (ii) Secretary’s Certificate. A certificate, dated the Closing
Date, executed by the Secretary of the Company and each Guarantor, certifying such customary matters as the Initial Purchasers may reasonably request. 
 (iii) Good Standing Certificates. A certificate evidencing good standing of the Company and the Guarantors in their respective jurisdictions of organization as of a recent date. A certificate
evidencing qualification by such entity as a foreign corporation in good standing issued by the Secretaries of State (or comparable office) as of a recent date in such other jurisdictions as the Initial Purchasers may reasonably request. 

(iv) CFO’s Certificate. A certificate of the Chief Financial Officer of the Company, dated the Closing Date,
relating to certain financial information included or incorporated by reference in the Time of Sale Document and the Final Offering Memorandum, substantially in the form of Exhibit B attached hereto. 

(v) Company Counsel Opinion. The opinion and negative assurance letter of Waller Lansden Dortch & Davis,
LLP, counsel to the Company and the Guarantors, dated the Closing Date and addressed to the Initial Purchasers, substantially in the form of Exhibit A attached hereto. 

(vi) Local Counsel Opinions. The opinion of (a) Lewis and Roca LLP, counsel to the Guarantors organized in
Arizona and New Mexico, (b) Dover Dixon Horne PLLC, counsel to the Guarantors organized in Arkansas, (c) Carlton Fields, P.A., counsel to the Guarantors organized in Florida, (d) Sanders & Ranck, P.C., counsel to the
Guarantors organized in Georgia, (e) Frost Brown Todd LLC, counsel to the Guarantors organized in Indiana, (f) Goulston & Storrs, counsel to the Guarantors organized in Massachusetts, (g) Butler, Snow, O’Mara,
Stevens & Cannada, PLLC, counsel to the Guarantors organized in Mississippi, (h) Karell, Dyre, Haney PLLP, counsel to the Guarantors organized in Montana, (i) Ice Miller LLP, counsel to the Guarantors organized in Ohio,
(j) McAfee & Tate, counsel to the Guarantors organized in Oklahoma, (k) Pepper Hamilton LLP, counsel to the Guarantors organized in Pennsylvania, (l) Nelson Mullins, counsel to the Guarantors organized in South Carolina,
(m) McGuire, Craddock & Strother, P.C., counsel to the Guarantors organized in Texas, in each case, dated the Closing Date, addressed to the Initial Purchasers and in form and substance reasonably acceptable to the Initial Purchasers.

 (vii) Initial Purchasers Counsel Opinion. An opinion and negative assurance letter, dated the Closing
Date, of Davis Polk & Wardwell LLP, counsel to the Initial Purchasers, in form satisfactory to the Initial Purchasers covering such matters as are customarily covered in such opinions. 

  
 Page 26

 (viii) Comfort Letters. The Initial Purchasers shall have received
from each of (1) E&Y, with respect to (x) the Company and (y) Haven Hospital Holdings, LLC and Haven Hospital Holdings of Texas, LLC, and (2) LBMC, with respect to (x) BCA and (y) AmiCare: (A) a customary
initial comfort letter delivered according to Statement of Auditing Standards No. 72 (or any successor bulletin), dated the date hereof, in form and substance reasonably satisfactory to the Initial Purchasers and its counsel, with respect to
the financial statements and certain financial information contained in the Time of Sale Document and the Final Offering Memorandum, and (B) a customary “bring-down” comfort letter, dated the Closing Date, in form and substance
reasonably satisfactory to the Initial Purchasers and its counsel, which includes, among other things, a reaffirmation of the statements made in its initial letter furnished pursuant to clause (A) with respect to such financial statements and
financial information contained in the Time of Sale Document and the Final Offering Memorandum. 
 (ix)
Additional Documents. The Initial Purchasers and counsel for the Initial Purchasers shall have received such information, documents and opinions as they may reasonably request for the purposes of enabling them to pass upon the issuance and
sale of the Securities as contemplated herein, or in order to evidence the accuracy of any of the representations and warranties, or the satisfaction of any of the conditions or agreements, herein contained. 

 

	(c)	Executed Documents. The Initial Purchasers shall have received fully executed copies of each Transaction Document (each of which shall be in full force and
effect) and each opinion, certificate, letter and other document to be delivered in connection with the Offering or any other Transaction. 

  

	(d)	Credit Agreement Amendment. An amendment to the Amended and Restated Credit Agreement, dated as of December 31, 2012, among the Company, its subsidiaries
identified therein, the lenders identified therein and Bank of America, N.A., as administrative agent, swing line lender and L/C issuer, and Fifth Third Bank, as syndication agent, to permit the issuance and sale of the Securities shall have become
effective; and the Initial Purchasers shall have received satisfactory evidence of such amendment substantially concurrently with the consummation of the Offering. 

 

	(e)	No Material Adverse Change. Subsequent to the date of this Agreement, there shall not have been any Material Adverse Change that could, in the sole judgment of
the Initial Purchasers, be expected to (i) make it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Document and the
Final Offering Memorandum, or (ii) materially impair the investment quality of any of the Securities. 

  

	(f)	No Ratings Agency Change. Subsequent to the date of this Agreement, there shall not have occurred any downgrading, nor shall any notice have been given of any
intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any securities of the Company or any of its subsidiaries by any “nationally recognized
statistical rating organization” as such term is defined for purposes of Section 3(a)(62) of the Exchange Act. 

  
 Page 27

	(g)	No Hostilities. Any outbreak or escalation of hostilities or other national or international calamity or crisis, including acts of terrorism, or material adverse
change or material disruption in economic conditions in, or in the financial markets of, the United States (it being understood that any such change or disruption shall be relative to such conditions and markets as in effect on the date hereof), if
the effect of such outbreak, escalation, calamity, crisis, act or material adverse change in the economic conditions in, or in the financial markets of, the United States could be reasonably expected to make it, in the Representative’s sole
judgment, impracticable or inadvisable to market or proceed with the offering or delivery of the Securities on the terms and in the manner contemplated in the Time of Sale Document and the Final Offering Memorandum or to enforce contracts for the
sale of any of the Securities. 

  

	(h)	No Suspension in Trading; Banking Moratorium. (i) Trading in the Company’s common stock shall have been suspended by the SEC or the NASDAQ National
Market or a suspension or limitation of trading generally in securities on the New York Stock Exchange, the American Stock Exchange or the NASDAQ National Market or any setting of limitations on prices for securities generally occurs on any such
exchange or market or (ii) the declaration of a banking moratorium by any Governmental Authority has occurred or the taking of any action by any Governmental Authority after the date hereof in respect of its monetary or fiscal affairs that, in
the case of clause (i) or (ii) of this paragraph, in the Initial Purchasers’ sole judgment could reasonably be expected to have a material adverse effect on the financial markets in the United States or elsewhere.

  

	(i)	Corporate Proceedings. All corporate proceedings and other legal matters incident to the authorization, form and validity of the Transaction Documents and the
Transactions and all other legal matters relating of the offering, issuance and sale of the Securities and the Transactions shall be reasonably satisfactory in all material respects to counsel to the Initial Purchasers; and the Company shall have
furnished to such counsel all documents and information that they may reasonably request to enable them to pass upon such matters. 

  

	(j)	Partial Redemption of Existing Notes. The Company shall have satisfied all conditions set forth in the Company’s notice of redemption, dated
February 11, 2013, to holders of the Company’s 12.875% Senior Notes due 2018 (the “Existing Notes”) for the redemption of $52.5 million of the aggregate principal amount of the Existing Notes to be completed on or about
the Closing Date. 

 8. Indemnification and Contribution. 

 

	(a)	 Indemnification by the Company and the Guarantors. The Company and each of the Guarantors, jointly and severally, agree to indemnify and hold
harmless each Initial Purchaser, its affiliates, directors, officers and employees, and each person, if any, who controls such Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act,
against any losses, claims, damages, liabilities or 

  
 Page 28

	 	
expenses of any kind to which such Initial Purchaser, affiliate, director, officer, employee or such controlling person may become subject under the Securities Act, the Exchange Act or other
federal or state statutory law or regulation, or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of the Company), insofar as any such losses, claims, damages, liabilities
or expenses (or actions in respect thereof) arise out of or are based upon: 

 (i) any untrue
statement or alleged untrue statement of a material fact contained in the Preliminary Offering Memorandum, the Time of Sale Document, any Company Additional Written Communication or the Final Offering Memorandum, or any amendment or supplement
thereto; 
 (ii) the omission or alleged omission to state, in the Preliminary Offering Memorandum, the Time of
Sale Document, any Company Additional Written Communication or the Final Offering Memorandum, or any amendment or supplement thereto, a material fact necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading; or 
 (iii) the violation of any laws or regulations of foreign jurisdictions where Securities
have been offered or sold; 
 and, subject to the provisions hereof, will reimburse, as incurred, such Initial Purchaser and its
affiliates, directors, officers, employees and each such controlling persons for any reasonable legal or other expenses (including the reasonable fees and disbursements of counsel chosen by the Representative and incurred in accordance with the
provisions of Section 8(c)) incurred by such person in connection with investigating, defending against, settling, compromising, paying or appearing as a third-party witness in connection with any such loss, claim, damage, liability, expense or
action in respect thereof; provided, however, the Company and the Guarantors will not be liable in any such case to the extent (but only to the extent) that a court of competent jurisdiction shall have determined by a final,
unappealable judgment that such loss, claim, damage, liability or expense resulted solely from any untrue statement or alleged untrue statement or omission or alleged omission made in the Preliminary Offering Memorandum, the Time of Sale Document,
any Company Additional Written Communication or the Final Offering Memorandum, or any amendment or supplement thereto, in reliance upon and in conformity with written information concerning the Initial Purchasers furnished to the Company by the
Representative specifically for use therein, it being understood and agreed that the only such information furnished by the Representative to the Company consists of the information set forth in Section 13 hereof. The indemnity agreement set
forth in this Section 8 shall be in addition to any liability that the Company and the Guarantors may otherwise have. 
  

	(b)	 Indemnification by the Initial Purchasers. Each Initial Purchaser agrees, severally and not jointly, to indemnify and hold harmless each of the
Company, each of the Guarantors and their respective affiliates, directors, officers, employees and each person, if any, who controls the Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act
against any losses, claims, damages, liabilities or expenses to 

  
 Page 29

	 	
which the Company, such Guarantors or any such affiliate, director, officer, employee or controlling person may become subject under the Securities Act, the Exchange Act or otherwise, insofar as
a court of competent jurisdiction shall have determined by a final, unappealable judgment that such losses, claims, damages, liabilities or expenses (or actions in respect thereof) have resulted solely from (i) any untrue statement or alleged
untrue statement of any material fact contained in the Preliminary Offering Memorandum, the Time of Sale Document or the Final Offering Memorandum or any amendment or supplement thereto or (ii) the omission or the alleged omission to state
therein a material fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, in each case to the extent (but only to the extent) that such untrue statement or alleged untrue statement or
omission or alleged omission was made in reliance upon and in conformity with written information concerning the Initial Purchasers furnished to the Company by the Representative specifically for use therein as set forth in Section 13; and,
subject to the limitation set forth immediately preceding this clause, will reimburse, as incurred, any reasonable legal or other expenses (including the fees and disbursements of counsel incurred in accordance with the provisions of
Section 8(c)) incurred by the Company, each of the Guarantors or any such affiliate, director, officer, employee or controlling person in connection with any such loss, claim, damage, liability, expense or action in respect thereof. The
indemnity agreement set forth in this Section shall be in addition to any liability that the Initial Purchasers may otherwise have. 

  

	(c)	 Notifications and Other Indemnification Procedures. As promptly as reasonably practicable after receipt by an indemnified party under this
Section 8 of notice of the commencement of any action for which such indemnified party is entitled to indemnification under this Section 8, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying
party under this Section 8, notify the indemnifying party of the commencement thereof in writing; but the omission to so notify the indemnifying party (i) will not relieve such indemnifying party from any liability under Section 8(a)
or (b) above unless and only to the extent it is materially prejudiced by such failure (through the forfeiture of substantive rights and defenses) and (ii) will not, in any event, relieve the indemnifying party from any obligations to any
indemnified party other than the indemnification obligation provided in Section 8(a) and (b) above. In case any such action is brought against any indemnified party, and it notifies the indemnifying party of the commencement thereof, the
indemnifying party will be entitled to participate therein and, to the extent that it may elect, jointly with any other indemnifying party similarly notified by written notice delivered to the indemnified party promptly after receiving the aforesaid
notice from such indemnified party, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party; provided, however, that if (i) the use of counsel chosen by the indemnifying party to represent the
indemnified party would present such counsel with a conflict of interest, (ii) the defendants in any such action include both the indemnified party and the indemnifying party, and the indemnified party shall have been advised by counsel that a
conflict may arise between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be one or more legal defenses available to it and/or other indemnified parties that are
different from or additional to those available to the indemnifying party, or (iii) the indemnifying party 

  
 Page 30

	 	
shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after receipt by the indemnifying party of notice of
the institution of such action, then, in each such case, the indemnifying party shall not have the right to direct the defense of such action on behalf of such indemnified party or parties and such indemnified party or parties shall have the right
to select separate counsel to defend such action on behalf of such indemnified party or parties at the expense of the indemnifying party. After notice from the indemnifying party to such indemnified party of its election so to assume the defense
thereof and approval by such indemnified party of counsel appointed to defend such action, the indemnifying party will not be liable to such indemnified party under this Section 8 for any legal or other expenses, other than reasonable costs of
investigation, subsequently incurred by such indemnified party in connection with the defense thereof, unless (i) the indemnified party shall have employed separate counsel in accordance with the proviso to the immediately preceding sentence
(it being understood, however, that in connection with such action the indemnifying party shall not be liable for the fees and expenses of more than one separate counsel (in addition to local counsel) in any one action or separate but substantially
similar actions in the same jurisdiction arising out of the same general allegations or circumstances, designated by the Representative in the case of Section 8(a) or the Company in the case of Section 8(b), representing the indemnified
parties under such Section 8(a) or (b), as the case may be, who are parties to such action or actions), (ii) the indemnifying party has authorized in writing the employment of counsel for the indemnified party at the expense of the
indemnifying party or (iii) the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of commencement of the action, in each
of which cases the fees and expenses of counsel shall be at the expense of the indemnifying party and shall be paid as they are incurred. After such notice from the indemnifying party to such indemnified party, the indemnifying party will not be
liable for the costs and expenses of any settlement of such action effected by such indemnified party without the prior written consent of the indemnifying party (which consent shall not be unreasonably withheld), unless such indemnified party
waived in writing its rights under this Section 8, in which case the indemnified party may effect such a settlement without such consent. 

  

	(d)	 Settlements. No indemnifying party shall be liable under this Section 8 for any settlement of any claim or action (or threatened claim or
action) effected without its written consent, which shall not be unreasonably withheld, but if a claim or action settled with its written consent, or if there be a final judgment for the plaintiff with respect to any such claim or action, each
indemnifying party jointly and severally agrees, subject to the exceptions and limitations set forth above, to indemnify and hold harmless each indemnified party from and against any and all losses, claims, damages or liabilities (and legal and
other expenses as set forth above) incurred by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees
and expenses of counsel as contemplated by this Section 8, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30
days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed 

  
 Page 31

	 	
the indemnified party in accordance with such request or disputed in good faith the indemnified party’s entitlement to such reimbursement prior to the date of such settlement. No
indemnifying party shall, without the prior written consent of the indemnified party (which consent shall not be unreasonably withheld), effect any settlement or compromise of any pending or threatened proceeding in respect of which the indemnified
party is or could have been a party, or indemnity could have been sought hereunder by the indemnified party, unless such settlement (A) includes an unconditional written release of the indemnified party, in form and substance satisfactory to
the indemnified party, from all liability on claims that are the subject matter of such proceeding and (B) does not include any statement as to an admission of fault, culpability or failure to act by or on behalf of the indemnified party.

  

	(e)	Contribution. In circumstances in which the indemnity agreements provided for in this Section are unavailable to, or insufficient to hold harmless, an
indemnified party in respect of any losses, claims, damages, liabilities or expenses (or actions in respect thereof), each indemnifying party, in order to provide for just and equitable contributions, shall contribute to the amount paid or payable
by such indemnified party as a result of such losses, claims, damages, liabilities or expenses (or actions in respect thereof) in such proportion as is appropriate to reflect (i) the relative benefits received by the indemnifying party or
parties, on the one hand, and the indemnified party, on the other hand, from the Offering or (ii) if the allocation provided by the foregoing clause (i) is not permitted by applicable law, not only such relative benefits but also the
relative fault of the indemnifying party or parties, on the one hand, and the indemnified party, on the other hand, in connection with the statements or omissions or alleged statements or omissions that resulted in such losses, claims, damages,
liabilities or expenses (or actions in respect thereof), as well as any other relevant equitable considerations. The relative benefits received by the Company and the Guarantors, on the one hand, and the Initial Purchasers, on the other hand, shall
be deemed to be in the same proportion as the total proceeds from the Offering (before deducting expenses) received by the Company bear to the total discounts and commissions received by the Initial Purchasers. The relative fault of the parties
shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand,
or the Initial Purchasers pursuant to Section 8(b) above, on the other hand, the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission or alleged statement or omissions,
and any other equitable considerations appropriate in the circumstances. 

  

	(f)	 Equitable Consideration. The Company, the Guarantors and the Initial Purchasers agree that it would not be equitable if the amount of such
contribution determined pursuant to Section 8(e) were determined by pro rata or per capita allocation (even if the Initial Purchasers were treated as one entity for such purpose) or by any other method of allocation that does not take into
account the equitable considerations referred to in Section 8(e). Notwithstanding any other provision of this Section 8, no Initial Purchaser shall be obligated to make contributions hereunder that in the aggregate exceed the total
discounts, commissions and other compensation received by such Initial Purchaser under this Agreement, less the aggregate amount of any damages that such Initial Purchaser has

  
 Page 32

	 	
otherwise been required to pay by reason of the untrue or alleged untrue statements or the omissions or alleged omissions to state a material fact. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Initial Purchasers’ obligations to contribute
pursuant to this Section 8 are several, and not joint, in proportion to their respective commitments as set forth opposite their names in Schedule I. For purposes of Section 8(e), each director, officer and employee of an Initial
Purchaser, and each person, if any, who controls such Initial Purchaser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, shall have the same rights to contribution as such Initial Purchaser, and
each director, officer and employee of the Company and the Guarantors, and each person, if any, who controls the Company or any of the Guarantors within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act,
shall have the same rights to contribution as the Company and the Guarantors. 

 9. Termination. The
Representative may terminate this Agreement at any time prior to the Closing Date by written notice to the Company if any of the events described in Sections 7(e) (No Material Adverse Change), 7(g) (No Hostilities) or 7(h) (No Suspension in Trading;
Banking Moratorium) shall have occurred or if the conditions set forth in Section 7 hereof are not satisfied or waived at or prior to the Closing Date. Any termination pursuant to this Section 9 shall be without liability on the part of
(a) the Company or the Guarantors to the Initial Purchasers, except that the Company and the Guarantors shall be obligated to reimburse the expenses of the Initial Purchasers pursuant to Section 5(f) hereof, together with any other
reasonable legal fees and expenses incurred by the Initial Purchasers in connection with the Offering, or (b) the Initial Purchasers to the Company or the Guarantors, except, in the case of each of clauses (a) and (b), that the provisions
of Sections 8 and 10 hereof shall at all times be effective and shall survive such termination. 
 10. Survival.
The representations and warranties, covenants, indemnities and contribution and expense reimbursement provisions and other agreements of the parties hereto set forth in or made pursuant to this Agreement shall remain operative and in full force and
effect, and will survive, regardless of (i) any investigation, or statement as to the results thereof, made by or on behalf of such party, (ii) the acceptance of the Securities, and payment for them hereunder, and (iii) any
termination of this Agreement. 
 11. Default of One or More of the Several Initial Purchasers. If any one or more
of the several Initial Purchasers shall fail or refuse to purchase Securities that it or they have agreed to purchase hereunder on the Closing Date, and the aggregate amount of Securities which such defaulting Initial Purchaser or Initial Purchasers
agreed but failed or refused to purchase does not exceed 10% of the aggregate amount of the Securities to be purchased on such date, the other Initial Purchasers shall be obligated, severally, in the proportions that the amount of Securities set
forth opposite their respective names on Schedule I bears to the aggregate amount of Securities set forth opposite the names of all such non-defaulting Initial Purchasers, or in such other proportions as may be specified by the Initial Purchasers
with the consent of the non-defaulting Initial Purchasers, to purchase the Securities which such defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase on the Closing Date. If any one or more of the Initial
Purchasers shall fail or refuse to purchase Securities and the aggregate amount 

  
 Page 33

 
of Securities with respect to which such default occurs exceeds 10% of the aggregate amount of Securities to be purchased on the Closing Date, and arrangements satisfactory to the Initial
Purchasers and the Company for the purchase of such Securities are not made within 48 hours after such default, this Agreement shall terminate without liability of any party to any other party except that the provisions of Sections 5(f), 8 and 9
hereof shall at all times be effective and shall survive such termination. In any such case either the Initial Purchasers or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days in order that the
required changes, if any, to the Final Offering Memorandum or any other documents or arrangements may be effected. 
 As used in
this Agreement, the term “Initial Purchaser” shall be deemed to include any person substituted for a defaulting Initial Purchaser under this Section 11. Any action taken under this Section 11 shall not relieve any
defaulting Initial Purchaser from liability in respect of any default of such Initial Purchaser under this Agreement. 
 12.
No Advisory or Fiduciary Relationship. The Company and the Guarantors acknowledge and agree that: (i) the purchase and sale of the Securities pursuant to this Agreement, including the determination of the offering price of the
Securities and any related discounts and commissions, is an arm’s-length commercial transaction between the Company and the Guarantors, on the one hand, and the Initial Purchasers, on the other hand, and the Company is capable of evaluating and
understanding and understands and accepts the terms, risks and conditions of the transactions contemplated by this Agreement; (ii) in connection with each transaction contemplated hereby and the process leading to such transaction each Initial
Purchaser is and has been acting solely as a principal and is not the agent or fiduciary of the Company and the Guarantors, or their respective affiliates, stockholders, creditors or employees or any other party; (iii) no Initial Purchaser has
assumed nor will assume an advisory or fiduciary responsibility in favor of the Company or any Guarantor with respect to any of the transactions contemplated hereby or the process leading thereto (irrespective of whether such Initial Purchaser has
advised or is currently advising the Company or any Guarantor on other matters) or any other obligation to the Company or any Guarantor except the obligations expressly set forth in this Agreement; (iv) the several Initial Purchasers and their
respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Company and the Guarantors, and the several Initial Purchasers have no obligation to disclose any of such interests by virtue
of any fiduciary or advisory relationship; and (v) no Initial Purchaser has provided any legal, accounting, regulatory or tax advice with respect to the Offering, and the Company and the Guarantors have consulted their own legal, accounting,
regulatory and tax advisors to the extent they deemed appropriate. 
 13. Information Supplied by Initial
Purchasers. Each of the Company and the Guarantors acknowledge that, for purposes of Section 4(d) and Section 8, the only information that the Initial Purchasers have furnished to the Company specifically for use in the Preliminary
Offering Memorandum or the Final Offering Memorandum are the statements set forth in the first sentence of the fifth paragraph, the second and third sentences of the sixth paragraph, the ninth paragraph and the nineteenth paragraph under the caption
“Plan of Distribution” in the Preliminary Offering Memorandum and the Final Offering Memorandum. 

  
 Page 34

 14. Miscellaneous. 

 

	(a)	Notices. Notices given pursuant to any provision of this Agreement shall be addressed as follows: (i) if to the Company, to: Acadia Healthcare Company,
Inc., 830 Crescent Centre Drive, Suite 610, Franklin, TN 37067, Attention: Christopher L. Howard, Executive Vice President, General Counsel and Secretary, with a copy to: Waller Lansden Dortch & Davis, LLP, James H. Nixon, III, 511 Union
Street, Suite 2700, Nashville, TN 37219, and (ii) if to the Initial Purchasers, to: Merrill Lynch, Pierce, Fenner & Smith Incorporated, One Bryant Park, New York, New York 10036 (Facsimile: 212-901-7897), Attention: HY Legal
Department, with a copy to Davis Polk & Wardwell LLP, 450 Lexington Avenue, New York, New York 10017 (Facsimile: 212-701-5111), Attention: Michael Kaplan (or in any case to such other address as the person to be notified may have requested
in writing). 

  

	(b)	Beneficiaries. This Agreement has been and is made solely for the benefit of and shall be binding upon the Company, the Guarantors, the Initial Purchasers and to
the extent provided in Section 8 hereof, the controlling persons, affiliates, officers, directors, partners, employees, representatives and agents referred to in Section 8 hereof and their respective heirs, executors, administrators,
successors and assigns, all as and to the extent provided in this Agreement, and no other person shall acquire or have any right under or by virtue of this Agreement. The term “successors and assigns” shall not include a purchaser of any
of the Securities from the Initial Purchasers merely because of such purchase. Notwithstanding the foregoing, it is expressly understood and agreed that each purchaser who purchases Securities from the Initial Purchasers is intended to be a
beneficiary of the covenants of the Company and the Guarantors contained in the Registration Rights Agreement to the same extent as if the Securities were sold and those covenants were made directly to such purchaser by the Company and the
Guarantors, and each such purchaser shall have the right to take action against the Company and the Guarantors to enforce, and obtain damages for any breach of, those covenants. 

 

	(c)	Authority of the Representative. Any action by the Initial Purchasers hereunder may be taken by the Representative on behalf of the Initial Purchasers, and any
such action taken by the Representative shall be binding upon the Initial Purchasers. 

  

	(d)	Governing Law; Jurisdiction; Waiver of Jury Trial; Venue. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New
York. Each of the Company, the Guarantors and the Initial Purchasers hereby expressly and irrevocably (i) submits to the non-exclusive jurisdiction of the federal and state courts sitting in the Borough of Manhattan in the City of New York in
any suit or proceeding arising out of or relating to this Agreement or the Transactions, and (ii) waives (a) its right to a trial by jury in any legal action or proceeding relating to this Agreement, the Transactions or any course of
conduct, course of dealing, statements (whether verbal or written) or actions of the Initial Purchasers or the Company and the Guarantors, as applicable, and for any counterclaim related to any of the foregoing and (b) any obligation which it
may have or hereafter may have to the laying of venue of any such litigation brought in any such court referred to above and any claim that any such litigation has been brought in an inconvenient forum. 

  
 Page 35

	(e)	Entire Agreement; Counterparts. This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all
contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument. 

  

	(f)	Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

  

	(g)	Separability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or
unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable best
efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. 

 

	(h)	Amendment. This Agreement may be amended, modified or supplemented, and waivers or consents to departures from the provisions hereof may be given,
provided that the same are in writing and signed by all of the signatories hereto. 

  
 Page 36

 Please confirm that the foregoing correctly sets forth the agreement between the Company,
the Guarantors and the Initial Purchasers. 
  

					
	Very truly yours,
	
	ACADIA HEALTHCARE COMPANY, INC.
		
	By:	 	 /s/ Brent Turner

		 	Name:	 	Brent Turner
		 	Title:	 	President

  
 Acadia –
Purchase Agreement 
 Page 37 

 GUARANTORS: 

 

	
	 ABILENE BEHAVIORAL HEALTH, LLC

 
 ACADIA - YFCS HOLDINGS, INC.

 
 ACADIA MANAGEMENT COMPANY, LLC

 
 ACADIA MERGER SUB, LLC

 
 ACADIANA ADDICTION CENTER, LLC

 
 AMICARE BEHAVIORAL CENTERS, LLC

 
 AMICARE CONTRACT SERVICES, LLC

 
 ASCENT ACQUISITION CORPORATION

 
 ASCENT ACQUISITION CORPORATION -
CYPDC
  
 ASCENT ACQUISITION
CORPORATION - PSC
  
 BCA OF DETROIT,
LLC
  
 BCA REAL ESTATE HOLDINGS,
LLC
  
 BEHAVIORAL CENTERS OF
AMERICA, LLC
  
 BEHAVIORAL HEALTH
ONLINE, INC.
  
 CEDAR CREST
CLINIC
  
 CHILD & YOUTH
PEDIATRIC DAY CLINICS, INC
  

CHILDREN’S BEHAVIORAL SOLUTIONS, LLC

 
 CHILDRENS MEDICAL TRANSPORTATION SERVICES,
LLC
  
 COMMODORE ACQUISITION SUB,
LLC
  
 DETROIT BEHAVIORAL INSTITUTE,
INC.
  
 FORT SMITH HEALTHCARE REAL
ESTATE, L.C.
  
 FSRE, LLC

 
 FVRE, LLC

 
 GENERATIONS BEHAVIORAL HEALTH - GENEVA,
LLC
  
 GREENLEAF CENTER,
LLC
  
 HABILITATION CENTER,
INC.
  
 HEALTHCARE MANAGEMENT AND
INVESTMENT OF OHIO, LLC
  
 HEP BCA
HOLDINGS CORP.
  
 HERMITAGE
BEHAVIORAL, LLC

 

	
	 HMIH CEDAR CREST, LLC

 
 KIDS BEHAVIORAL HEALTH OF MONTANA,
INC.
  
 LAKELAND HOSPITAL
ACQUISITION CORPORATION
  
 LAKEVIEW
BEHAVIORAL HEALTH SYSTEM LLC
  

LINDEN BCA BLOCKER CORP.
  

MED PROPERTIES, INC.
  

MEDUCARE TRANSPORT, L.L.C.
  

MEMORIAL HOSPITAL ACQUISITION CORPORATION

 
 MILLCREEK MANAGEMENT CORPORATION

 
 MILLCREEK SCHOOL OF ARKANSAS,
INC.
  
 MILLCREEK SCHOOLS
INC.
  
 NORTHEAST BEHAVIORAL HEALTH,
LLC
  
 OHIO HOSPITAL FOR PSYCHIATRY,
LLC
  
 OPTIONS COMMUNITY BASED
SERVICES, INC.
  
 OPTIONS TREATMENT
CENTER ACQUISITION CORPORATION
  

PEDIATRIC SPECIALTY CARE PROPERTIES, LLC

 
 PEDIATRIC SPECIALTY CARE, INC.

 
 PHC MEADOWWOOD, INC.

 
 PHC OF MICHIGAN, INC.

 
 PHC OF NEVADA, INC.

 
 PHC OF UTAH, INC.

 
 PHC OF VIRGINIA, INC.

 
 PINEWOOD ENTERPRISES, L.C.

 
 PINEWOOD HEALTHCARE REALTY, L.P.

 
 PINEWOOD SERVICES, INC.

 
 PINEY RIDGE TREATMENT CENTER, LLC

 
 PRC I, INC.

 
 

  
 Acadia –
Purchase Agreement 
 Page 38 

	
	 PSYCHIATRIC RESOURCE PARTNERS, INC.

 
 REBOUND BEHAVIORAL HEALTH, LLC

 
 RED RIVER HOSPITAL, LLC

 
 REHABILITATION CENTERS, INC.

 
 RENAISSANCE RECOVERY, INC.

 
 RESOLUTE ACQUISITION CORPORATION

 
 RESOURCE COMMUNITY BASED SERVICES,
INC.
  
 RIVERWOODS BEHAVIORAL
HEALTH, LLC
  
 ROLLING HILLS
HOSPITAL, INC.
  
 ROLLING HILLS
PROPERTIES, INC.
  
 RTC RESOURCE
ACQUISITION CORPORATION
  
 SBOF-BCA
HOLDINGS CORPORATION
  
 SEVEN HILLS
HOSPITAL, INC.
  
 SHAKER CLINIC,
LLC
  
 SONORA BEHAVIORAL HEALTH
HOSPITAL, LLC
  
 SOUTHWESTERN
CHILDREN’S HEALTH SERVICES, INC.
  
 SOUTHWOOD PSYCHIATRIC HOSPITAL, INC.

 

	
	 STONE CREST CLINIC

 
 SUCCESS ACQUISITION CORPORATION

 
 SUNCOAST BEHAVIORAL, LLC

 
 SW BEHAVIORAL, LLC

 
 TBA TEXARKANA, L.L.C.

 
 TEN LAKES CENTER, LLC

 
 TK BEHAVIORAL, LLC

 
 VALLEY BEHAVIORAL HEALTH SYSTEM,
LLC
  
 VANTAGE POINT BEHAVIORAL
HEALTH, LLC
  
 VERMILION HOSPITAL,
LLC
  
 VILLAGE BEHAVIORAL HEALTH,
LLC
  
 VISTA BEHAVIORAL HEALTH,
LLC
  
 WELLPLACE, INC.

 
 YFCS HOLDINGS - GEORGIA, INC.

 
 YFCS MANAGEMENT, INC.

 
 YOUTH AND FAMILY CENTERED SERVICES OF
FLORIDA, INC.
  
 YOUTH AND FAMILY
CENTERED SERVICES OF NEW MEXICO, INC.
  
 YOUTH AND FAMILY CENTERED SERVICES, INC.

 
 

  

					
	By:	 	 /s/ Brent Turner

		 	Name:	 	Brent Turner
		 	Title:	 	Vice President and Assistant Secretary

  
 Acadia –
Purchase Agreement 
 Page 39 

 MERRILL LYNCH, PIERCE, FENNER &
SMITH 
 INCORPORATED 
 Acting on behalf of itself 
 and as the Representative of 

the several Initial Purchasers 
  

			
	By:	 	 /s/ James C. Brett

		 	Name: James C. Brett
		 	Managing Director

  
 Acadia –
Purchase Agreement 
 Page 40 

 SCHEDULE I 

 

					
	 Initial Purchasers
	  	Aggregate Principal
Amount of Securities to
be Purchased	 
	 Merrill Lynch, Pierce, Fenner & Smith Incorporated
	  	$	90,000,000	  
	 Citigroup Global Markets Inc.
	  	 	22,500,000	  
	 Jefferies LLC.
	  	 	22,500,000	  
	 Fifth Third Securities, Inc.
	  	 	15,000,000	  
		
	 Total
	  	$	150,000,000	  

 SCHEDULE II 

PRICING SUPPLEMENT 
 [See Attached] 

 SCHEDULE III 
 Recorded/electronic “roadshow” presentation (as posted on netroadshow.com) 

  
 Page 43

 EXHIBIT A 

FORM OF OPINION AND NEGATIVE ASSURANCE LETTER OF WALLER 
 LANSDEN DORTCH & DAVIS, LLP 
 March     , 2013

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 
 as representative of the Initial Purchasers 
 One Bryant Park 

New York, NY 10036 
 Re:
Acadia Healthcare Company, Inc.     % Senior Notes due 2021 
 Ladies and Gentlemen: 

We have acted as special counsel to Acadia Healthcare Company, Inc., a Delaware corporation, (the “Company”), and all of
the entities set forth on Schedule A hereto, each of which is a direct or indirect wholly-owned domestic subsidiary of the Company (the “Guarantors”), in connection with the execution and delivery of the Purchase Agreement,
dated as of March     , 2013 (the “Purchase Agreement”), among the Company, the Guarantors and Merrill Lynch, Pierce, Fenner & Smith Incorporated, acting on behalf of itself and as the representative of
the several Initial Purchasers, in connection with the sale and delivery to the Initial Purchasers under the terms of the Purchase Agreement of an aggregate principal amount of $150,000,000 of the Company’s
[        ]% Senior Notes due 2021 (the “Notes”) and certain other agreements, instruments and documents related to the Purchase Agreement. We have also acted as special Delaware counsel
to the parties listed as Covered Guarantors on Schedule A hereto (the “Covered Guarantors”). This opinion is being delivered to you at the request of the Company pursuant to Section 7(b)(v) of the Purchase
Agreement. Capitalized terms used herein and not otherwise defined herein shall have the same meanings herein as defined in the Purchase Agreement. 
 The notes contemplated by the Registration Rights Agreement (as defined below) to be offered to holders of Notes in exchange for the Notes are referred to herein as the “Exchange Notes”
and the guarantee to be offered to holders in respect of the Exchange Notes is referred to herein as the “Exchange Guarantee.” The offer to exchange the Notes and the Guarantee for the Exchange Notes and the Exchange Guarantee as
contemplated by the Registration Rights Agreement is referred to herein as the “Exchange Offer.” 
 In
rendering the opinions set forth herein, we have examined and relied on originals or copies, certified or otherwise identified to our satisfaction, of the following: 
 (a) the Preliminary Offering Memorandum, dated as of March 4, 2013, covering the offer and sale of the Notes, as supplemented or amended by the Pricing Supplement, dated
[        ], containing the terms of the Notes (collectively, the “Time of Sale Document”); 

  
 1 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

(b) the Final Offering Memorandum, dated as of [            ], covering the
offer and sale of the Notes (the “Final Offering Memorandum”); 
 (c) executed counterparts of the Purchase
Agreement; 
 (d) executed counterparts of the Indenture, dated as of
[            ], among the Company, the Guarantors and U.S. Bank, National Association, as trustee, with respect to the Notes (the “Indenture”); 

(e) an executed copy of the Registration Rights Agreement, dated as of
[            ], by and among the Company, the Guarantors and the Initial Purchasers (the “Registration Rights Agreement”); 

(f) an executed copy of the 144A Global Note; 
 (g) an executed copy of the Regulation S Temporary Global Note; 
 (i) an executed
copy of the Guarantee of the Guarantors delivered pursuant to the Indenture; 
 (j) a certified copy of the Certificate of
Incorporation of the Company as filed with the Delaware Secretary of State on October 24, 2005, and a certified copy of the current bylaws of the Company (collectively the “Company Governing Documents”); 

(k) a certified copy of the Articles of Incorporation, Certificate of Incorporation, or Articles of Organization, as applicable, of each
Covered Guarantor, as filed with the applicable Secretary of State, and a certified copy of the current bylaws, operating agreement or limited liability company agreement, as applicable, of each Covered Guarantor (collectively the “Guarantor
Governing Documents”); 
 (l) a certified copy of the resolutions adopted by the Board of Directors of the Company
effective as of February 28, 2013; 
 (m) a certified copy of the resolutions adopted by the Pricing Committee of the Board
of Directors of the Company, effective as of March [    ], 2013; 

  
 2 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

(n) certified copies of the consent actions of the respective Board of Directors, the sole member or the managing member, as applicable,
of each of the Covered Guarantors, effective as of February 28, 2013; and 
 (o) certificates of existence or good
standing, as applicable, for the Company and each Covered Guarantor issued by the Secretary of State of the State of Delaware. 

In addition, we have examined such other documents, agreements, and certificates as we have deemed necessary or appropriate as a basis
for the opinion set forth below. 
 The documents described in clauses (c) through (i) above are collectively referred
to as the “Transaction Documents.” References to “DGCL” shall mean the General Corporation Law of the State of Delaware as in effect on the date hereof. In addition, references to (i) “Applicable
Laws” shall mean the DGCL, the Delaware Limited Liability Company Act, and the statutes, rules, regulations and judicial decisions of the State of New York or of the United States of America that, in our experience, are normally applicable
to transactions of the type contemplated by the Purchase Agreement without considering the participation by the Company in any regulated industry; (ii) the term “Applicable Orders” means any order, ruling, decree, judgment or
similar action of any executive, legislative, judicial, administrative or regulatory body having jurisdiction over the Company or the Covered Guarantors, or mediator or arbitrator known to us or identified by the Company or any Covered Guarantor as
being applicable to them and identified on Schedule B hereto; and (iii) the term “Applicable Contracts” means any agreement or instrument to which the Company or any Covered Guarantor is subject and which has been
specifically identified to us by the Company or such Covered Guarantor in Schedule C hereto, which are the contracts listed as “material agreements.” 
 For purposes of this opinion, the term “Health Care Laws” shall mean those statutes, rules and regulations, judgments, decrees or orders which are generally applicable to hospitals,
behavioral healthcare facilities and health care providers as a group described in those sections of the Time of Sale Document and the Final Offering Memorandum (collectively, the “OM”) described in our opinion below, including,
without limitation, (i) healthcare licensure, permit, certificate of need and medical waste requirements, (ii) Titles XVIII, XIX and XXI of the Social Security Act, (iii) the “anti-kickback statute” (§1128B(b) of the
Social Security Act) as amended by the Health Insurance Portability and Accountability Act of 1996 and the regulations promulgated thereunder, (iv) the Stark laws (§1877 of the Social Security Act) and the regulations promulgated
thereunder, (v) the False Claims Act, (vi) the Health Insurance Portability and Accountability Act of 1996, (vii) the Patient Protection and Affordable Care Act, (viii) the Health Care and Education Reconciliation Act of 2010,
and (ix) certain published state statutes, rules and regulations available to us concerning matters similar to those covered by clauses (ii) through (viii) above. 

  
 3 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

Assumptions 
 In rendering the opinions set forth herein, we have assumed, with your consent: 

(i) The genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as
originals, the conformity to original documents of all documents submitted to us as certified or photostatic copies and the authenticity of the originals of such copies. As to any facts material to this opinion which we did not independently
establish or verify, we have relied upon statements and representations of the Company or the Guarantors and their officers and other representatives and of public officials and have assumed that such matters remain true and correct through the date
hereof; 
 (ii) The execution, delivery and performance by the Company and each Guarantor of the Transaction Documents does not
and will not conflict with, contravene, violate or constitute a default under (i) any lease, indenture, instrument or other agreement to which the Company, and Guarantor or their property is subject (other than the Applicable Contracts as to
which we express our opinion in Opinion No. 11 herein), (ii) any rule, law or regulation to which the Company or any Guarantor is subject (other than Applicable Laws as to which we express our opinion in Opinion No. 11 herein) or
(iii) any judicial or administrative order or decree of any governmental authority (other than Applicable Orders as to which we express our opinion in Opinion No. 11 herein); 

(iii) Except as covered by our opinion in Opinion No. 12 herein, no authorization, consent or other approval of, notice to or filing
with any court, governmental authority or regulatory body is required to authorize or is required in connection with the execution, delivery or performance by the Company or any Guarantor of any Transaction Document to which they are a party or the
transactions contemplated thereby; 
 (iv) There is no action, suit or proceeding pending or threatened against or affecting the
Company or any Guarantor before any court, governmental department or other authority (other than Applicable Orders as to which we express our opinion in Opinion No. 11 herein and other than as we express our opinion in Opinion No. 17
herein) which purports to affect the legality, validity or enforceability of any Transaction Document or the transactions contemplated thereby; 
 (v) Each Transaction Document is the legal, valid, and binding obligation of each party thereto (other than the Company or the Covered Guarantors), enforceable against such other parties in accordance
with its terms; 
 (vi) All factual matters, including, without limitation, representations and warranties contained in the
Transaction Documents, the Applicable Contracts or in certificates provided to us by or on behalf of the Company or others, are true and correct as set forth therein; 

  
 4 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

(vii) There are no other written or oral agreements among any or all of the parties that would alter or amend the agreements set forth in
the Transaction Documents and the Applicable Contracts; 
 (viii) With respect to any guarantee of indebtedness by a Guarantor
on a joint and several basis, the benefit of which is in the Company or another Guarantor, we have assumed that such Guarantor will benefit from the extension of credit to the extent necessary to make such guarantee a valid corporate act of the
Guarantor; and 
 (ix) The Initial Purchasers have given value pursuant to the Purchase Agreement. 

We are admitted to practice in the State of Tennessee and certain members of our firm are admitted to the bar in the State of New York.
The opinions herein relating to the laws of the State of New York are given by such members on behalf of the firm. We express no opinion as to the laws of any jurisdiction other than: (i) the laws of the State of New York, (ii) the DGCL
and the Delaware Limited Liability Company Act, (iii) the federal laws of the United States of America to the extent specifically referred to herein, without considering the participation by the Company or any Guarantors in any regulated
industry. We call your attention to the fact that there may be laws, regulations or judicial decisions not included in the sources reviewed by us but nonetheless relevant to the opinions rendered with respect to the DGCL and the Delaware Limited
Liability Company Act; our opinions do not address the effect of such other materials. 
 For purposes of any opinion
referencing the “good standing” of any entity, we have relied solely on certificates of existence, active status and/or good standing, as applicable, from the jurisdictions as set forth on Schedule A. We have assumed that there has
been no relevant change or development between the dates of the certificates of existence, active status and/or good standing referenced above and the date of this letter. We have assumed that all transactions contemplated by the Purchase Agreement
have occurred simultaneously. 
 Opinions Rendered 

Based upon the foregoing, and in reliance thereon, and subject to the limitations, qualifications, exceptions and assumptions set forth
herein, we are of the opinion that as of the date hereof: 
 (1) The Company is existing as a corporation in good standing under
the laws of the State of Delaware. 
 (2) The Company has corporate power and authority to own and lease its properties and to
conduct its business as described in the OM and to enter into and perform its obligations under the Transaction Documents to which it is a party. 

  
 5 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

(3) Each Covered Guarantor is existing as a corporation or limited liability company, as applicable, in good standing under the laws of
Delaware, has corporate or limited liability company, as applicable, power and authority to own and lease its properties and to conduct its business as described in the OM and to enter into and perform its obligations under the Transaction Documents
to which it is a party. 
 (4) The Purchase Agreement has been duly authorized, executed and delivered by the Company and each
of the Covered Guarantors. 
 (5) The Indenture has been duly authorized, executed and delivered by the Company and each of the
Covered Guarantors. Assuming the due authorization, execution and delivery of the Indenture by the Trustee and each of the Non-Covered Guarantors, the Indenture constitutes a valid and binding agreement of the Company and each Guarantor in
accordance with the terms thereof, enforceable against the Company and each Guarantor in accordance with its terms. 
 (6) The
Registration Rights Agreement has been duly authorized, executed and delivered by the Company and each of the Covered Guarantors. Assuming due authorization, execution and delivery of the Registration Rights Agreement by the Initial Purchasers and
each of the Non-Covered Guarantors, the Registration Rights Agreement is a valid and binding obligation of the Company and each of the Guarantors and is enforceable against the Company and each of the Guarantors in accordance with its terms.

 (7) The Notes have been duly authorized, executed and delivered by the Company for issuance and sale pursuant to the Purchase
Agreement and the Indenture and, when authenticated by the Trustee in the manner provided in the Indenture (assuming the due authorization, execution and delivery of the Indenture by the Trustee and each of the Non-Covered Guarantors) and delivered
against payment of the purchase price therefor, will constitute “Notes” under the terms of the Indenture, will be the valid and binding obligations of the Company, and will be enforceable against the Company in accordance
with their terms. 
 (8) The Guarantee has been duly authorized, executed and delivered by each of the Covered Guarantors and,
when the Notes have been paid for by the Initial Purchasers in accordance with the terms of the Purchase Agreement (assuming the due authorization, execution and delivery of the Indenture by the Trustee and each of the Non-Covered Guarantors, the
due authorization, execution and delivery of the Guarantee by each of the Non-Covered Guarantors and the due authentication and delivery of the Notes by the Trustee in accordance with the Indenture), will constitute a
“Guarantee” under the terms of the Indenture, will be the valid and binding obligation of each of the Guarantors, and will be enforceable against each of the Guarantors in accordance with its terms. 

(9) The Exchange Notes (having identical terms in all material respects to the Notes and evidencing the same continuing indebtedness of
the Company (except with respect to transfer restrictions described in the Final Offering Memorandum)) have been duly authorized by 

  
 6 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

the Company and, when duly executed and delivered by the Company and issued in accordance with the terms of the Indenture, the Registration Rights Agreement and the Exchange Offer (assuming the
due authorization, execution and delivery of the Indenture by the Trustee and each of the Non-Covered Guarantors, the due authentication and delivery of the Exchange Notes by the Trustee and the due authorization, execution and delivery of the
Registration Rights Agreement by the Initial Purchasers and each of the Non-Covered Guarantors), the Exchange Notes will be the valid and binding obligation of the Company, and will be enforceable against the Company in accordance with their terms.

 (10) The Exchange Guarantee (which shall be consistent with the Guarantee) has been duly authorized by each of the Covered
Guarantors and, when the Exchange Notes have been duly executed, authenticated, issued and delivered and the Exchange Guarantee has been executed and delivered, each in the manner provided for in the Registration Rights Agreement and the Indenture
(assuming the due authorization, execution and delivery of the Indenture by the Trustee and each of the Non-Covered Guarantors, the due authorization, execution and delivery of the Exchange Guarantee by each of the Non-Covered Guarantors, the due
authentication and delivery of the Exchange Notes by the Trustee and the due authorization, execution and delivery of the Registration Rights Agreement by the Initial Purchasers and each of the Non-Covered Guarantors), the Exchange Guarantee will be
the valid and binding obligation of each of the Guarantors, and will be enforceable against each of the Guarantors in accordance with its terms. 
 (11) The execution and delivery of the Transaction Documents by the Company and the Guarantors and the performance by the Company and the Guarantors to the extent a party thereto of their respective
obligations thereunder (other than performance under the indemnification section of the Purchase Agreement, as to which we render no opinion): (i) will not constitute a breach of, or Default or a Debt Repayment Triggering Event under, or result
in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its subsidiaries pursuant to any Applicable Contract, except for such breaches, defaults, liens, charges or encumbrances as would
not, individually or in the aggregate, result in a Material Adverse Effect, (ii) will not result in any violation of the provisions of the certificate of incorporation or bylaws of the Company or the applicable Guarantor Governing Documents of
any Covered Guarantor, (iii) will not result in any violation of any Applicable Law or Applicable Order, except for such breaches, defaults, liens, charges or encumbrances as would not, individually or in the aggregate, result in a Material
Adverse Effect. If an Applicable Contract is governed by the laws of a jurisdiction other than New York, we have assumed such Applicable Contract is governed by the laws of the State of New York. 

(12) No consent, approval, authorization or other order of, any court or other governmental authority, is required for the issuance and
sale by the Company of the Notes to the Initial Purchasers, or the consummation by each of the Company and the Covered Guarantors of the transactions contemplated thereby and by the OM, except such as may be required under the Securities Act, the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Trust 

  
 7 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

Indenture Act and the security or “blue sky” laws of the various states (and the rules and regulations thereunder), as to which we express no opinion in this paragraph, or which have
been obtained or made by the Company or the Covered Guarantors, as applicable, and are in full force and effect under the Securities Act. 
 (13) Assuming (i) the accuracy and completeness of the representations, warranties and covenants of the Company, the Guarantors, and the Initial Purchasers contained in the Purchase Agreement,
(ii) the compliance with the procedures set forth in the Trust Indenture Act in the manner contemplated by the Purchase Agreement and the OM, and (iii) that the Initial Purchasers have a reasonable belief that the purchasers who buy such
Notes in the initial resale thereof are “qualified institutional buyers” as defined in Rule 144A promulgated under the Securities Act, or persons other than “U.S. persons” in connection with offers and sales made in reliance upon
Regulation S under the Securities Act, no registration under the Securities Act of the Notes is required in connection with the purchase of the Notes by the Initial Purchasers or in connection with the initial resale of the Notes by the Initial
Purchasers in the manner contemplated by the Purchase Agreement and the OM. We express no opinion, however, as to when or under what circumstances any Notes initially sold by the Initial Purchasers may be reoffered or resold. 

(14)(a) The statements in the OM under the headings “Description of the Notes”, “Exchange Offer”, and
“Description of Other Indebtedness”, insofar as such statements constitute matters of law, summaries of legal matters, the Company’s certificate of incorporation or bylaw provisions, documents, or legal proceedings have been reviewed
by us and fairly present and summarize, in all material respects, the matters referred to therein. 
 (b) The statements in the
OM under the heading “Certain U.S. Federal Income Tax Considerations”, insofar as such statements constitute matters of law, summaries of legal matters, or legal conclusions, have been reviewed by us and fairly present and summarize, in
all material respects, the matters referred to therein. 
 (15) The legal statements in the materials relating to Health Care
Laws encompassed under the captions set forth in Schedule D hereto, insofar as such statements constitute overviews or summaries of the laws and regulations referred to therein, including the qualifications set forth therein, fairly present
and summarize, in all material respects, such laws and regulations referred to therein. 
 (16) Neither the Company nor any
Guarantor is, or, after giving effect to the offering and sale of the Notes to the Initial Purchasers and the application of the proceeds thereof as described in the OM under the caption “Use of Proceeds”, will be required to register as
an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 

  
 8 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

(17) To our knowledge, there is no legal or governmental proceeding pending to which the Company or any Guarantor is a party that has
caused us to conclude that such proceeding would be required to be described by Item 103 of Regulation S-K under the Securities Act if the issuance of the Notes and the Guarantee was being registered under the Securities Act, but is not so
described in the OM. 
 (18) The documents incorporated by reference in the OM (other than the financial statements, any notes
thereto, schedules, and other financial or statistical information derived therefrom and included therein or omitted therefrom, including without limitation such financial or statistical information provided in an interactive data format using XBRL
or any statements made in the exhibits thereto, as to which we express no opinion), when they were filed with the SEC, complied as to form in all material respects with the requirements of the Exchange Act. 

We have not verified, are not passing upon and do not assume any responsibility for, the accuracy, completeness or fairness of the
statements contained in the Time of Sale Document or the Final Offering Memorandum, except as stated in paragraphs 14, 15 and 17 above. We have participated, however, in the preparation of the OM during the course of which preparation we
examined various documents and other papers and participated in conferences with officers and representatives of the Company, representatives of the Company’s independent registered public accounting firm and the accountants for Behavioral
Centers of America, LLC and AmiCare Behavioral Centers, LLC, and your representatives and counsel, at which conferences the contents of the OM, including all documents filed under the Exchange Act and deemed incorporated by reference therein, were
discussed, reviewed and revised. On the basis of the information that was developed in the course of our participation, considered in light of our understanding of applicable law and the experience we have gained through our practice, no facts have
come to our attention that lead us to believe that the Time of Sale Document (including any document filed under the Exchange Act and deemed incorporated by reference therein) at the Applicable Time or that the Final Offering Memorandum (including
any document filed under the Exchange Act and deemed incorporated by reference therein) as of its date and the date hereof contained or contains any untrue statement of a material fact or omitted or omits to state any material fact required to be
stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading (except that in each case we do not make any statement as to the financial statements, any notes thereto, schedules
and other financial or statistical information derived therefrom and included in or incorporated by reference into or omitted from the Time of Sale Document and the Final Offering Memorandum, including, without limitation, such financial or
statistical information provided in an interactive data format using XBRL or any statements made in the exhibits thereto). 

  
 9 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

Qualifications 
 The opinions expressed above are subject to the following qualifications: 
 (i)
Enforcement may be limited by applicable bankruptcy, fraudulent conveyance, insolvency, reorganization, moratorium or similar laws affecting creditors’ rights generally; 
 (ii) Enforcement may be limited by general principles of equity (regardless of whether enforcement is sought in equity or at law); 
 (iii) We express no opinion as to: (A) the enforceability of any rights to contribution or indemnification for losses that result from the bad faith, negligence, gross negligence or willful
misconduct of the party seeking indemnification or contribution, (B) the enforceability of any rights to liquidated damages, penalties, punitive damages, indemnification or contribution insofar as such rights purport to limit or affect a claim
based on tort or duty imposed by law, (C) the enforceability of indemnification obligations relating to environmental matters, or (D) the enforceability of those portions of indemnity provisions that purport by their terms to survive for
indeterminate time periods; 
 (iv) Where we render an opinion on facts “known to us” or “to our knowledge,”
we have based such opinion not upon our own independent verification but solely upon the conscious awareness of any attorney actively involved in the representation of Company in connection with the Transaction Documents after consultation with
attorneys at our firm who regularly advise the Company and receipt of certificates executed by the officers of the Company and other persons covering such matters. Where we render an opinion “to our knowledge,” we have therefore conducted
no independent investigation of such matters; 
 (v) We express no opinion as to provisions of the Transaction Documents that
specify the law of a particular jurisdiction as governing law to the extent that (A) such provisions purport to make the law of a particular jurisdiction controlling as to the perfection of security interests, (B) procedural rather than
substantive laws are involved, (C) such provisions purport to affect interests in real estate not located in Tennessee, or (D) such provisions purport to confer jurisdiction upon any court in which lay venue in a specific court or courts;

 (vi) We express no opinion with respect to the enforceability of (A) a requirement that provisions of the Transaction
Documents may only be waived in writing, (B) provisions stating that the failure to exercise or delay in exercising rights or remedies will not operate as a waiver of such right or remedy, (C) rights to attorneys’ fees to the extent
limited by applicable laws that provide that any recovery of attorneys’ fees is limited to reasonable attorneys’ fees, (D) provisions by which the Company waives the right to become a debtor under the U.S. Bankruptcy Code or other
bankruptcy law, (E) provisions regarding confession of judgment which violate public policy, (F) purported waivers of the benefits of statutory provisions or common law rights that may be unenforceable where held to be contrary to public
policy, (G) the enforceability of self-help provisions and provisions which purport to establish evidentiary standards, (H) any federal, state or local tax law, rule or regulation, (I) statements

  
 10 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

that the Trustee is entitled to the appointment of a receiver as a matter of right, (J) that purport to establish rules of construction for contracts or evidentiary standards for suits or
proceedings, (K) that purport to allow any action to be taken in the sole or absolute discretion of a party or only upon the payment of money or posting of additional collateral, (L) that purport to preserve and maintain any security
interest or guaranty despite the unenforceability of the obligations secured or guaranteed thereby, (M) that purport to grant rights of setoff or similar rights, (N) that grant powers of attorney which violate public policy,
(O) providing for collection of interest on interest, (P) provisions that increases the rate of interest or imposes any fee upon any default (other than the provisions regarding Additional Interest under the Registration Rights
Agreement), or (Q) providing for recourse or exercise of any remedial rights in the absence of notice and a hearing; 
 (vii) We express no opinion as to the effect of compliance or non-compliance of any party (other than the Company and the Covered Guarantors) to any of the transactions contemplated by any of the
Transaction Documents with any laws or regulations applicable because of the legal or regulatory status or the nature of the business of any party (other than the Company and the Covered Guarantors) to such transactions. 

(viii) We express no opinion regarding any claims which may now or hereafter be secured in favor of any taxing authority; 

(ix) With respect to the opinion contained in Opinion No. 11, we express no opinion regarding (i) compliance with or the effect
of financial ratios or similar financial covenants contained in the Transaction Documents or any other agreement, (ii) any laws, rules or regulations to which the Company or the Guarantors may be subject as a result of the Initial
Purchasers’ legal or regulatory status or the involvement of the Initial Purchasers in such transactions, (ii) any laws, rules or regulations relating to misrepresentations or fraud or (iii) the Securities Act of 1933, as amended (the
“Securities Act”), the Exchange Act, or the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”); 
 (x) The opinion contained in Opinion No. 14(b) above with respect to “Certain U.S. Federal Income Tax Considerations” is based on relevant provisions of the Internal Revenue Code of 1986,
as amended, Treasury regulations promulgated thereunder, current positions of the Internal Revenue Service (the “IRS”) contained in published Revenue Rulings and Revenue Procedures, current administrative positions of the IRS and
existing judicial decisions, as currently in effect, all of which are subject to change, prospectively or retroactively, at any time, and which might result in material modifications of our opinion. Our opinion does not foreclose the possibility of
a contrary determination by the IRS or a court of competent jurisdiction, or of a contrary position taken by the IRS or the Treasury Department in regulations or rulings issued in the future. No ruling has been or is expected to be sought from the
IRS with respect to the statements made and the conclusions reached in the opinion. There can be no assurance that the conclusions of U.S. federal tax law presented therein will not be successfully challenged by the IRS or significantly altered by
new legislation, changes in IRS positions or 

  
 11 

 Merrill Lynch, Pierce, Fenner & Smith Incorporated, 

as representative of the Initial Purchasers 

March     , 2013 
  

judicial decisions, any of which challenges or alterations may be applied retroactively with respect to completed transactions. In this regard, an opinion of counsel with respect to an issue
represents counsel’s best professional judgment with respect to the outcome on the merits with respect to such issue, if such issue were to be litigated, but an opinion is not binding on the IRS or the courts, and is not a guarantee that the
IRS will not assert a contrary position with respect to such issue or that a court will not sustain such a position asserted by the IRS. 
 This opinion is given as of the date hereof, and we disclaim any obligation to update this opinion letter after the date hereof. This opinion is rendered only to the addressee and is solely for its
benefit in connection with the above-referenced transactions. This opinion may not be relied upon by the addressee for any other purpose, or quoted to or relied upon by any other person, firm, corporation or other entity for any purpose without our
prior written consent. 
 TO ENSURE COMPLIANCE WITH REQUIREMENTS IMPOSED BY THE INTERNAL REVENUE SERVICE, WE INFORM YOU THAT THIS LETTER AND THE
OPINIONS CONTAINED HEREIN WERE NOT INTENDED OR WRITTEN TO BE USED, AND CANNOT BE USED, NOR RELIED UPON, BY ANY TAXPAYER FOR THE PURPOSE OF AVOIDING TAX-RELATED PENALTIES UNDER THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. THIS LETTER AND THE
OPINION CONTAINED HEREIN WERE WRITTEN IN CONNECTION WITH THE PROMOTION OR MARKETING OF THE NOTES. EACH TAXPAYER SHOULD SEEK ADVICE BASED ON THE TAXPAYER’S PARTICULAR CIRCUMSTANCES FROM AN INDEPENDENT TAX ADVISOR. 

Very truly yours, 

  
 12 

 Schedule A 

Covered Guarantors 
  

			
	 Name of Entity
	 	 State of Incorporation/Formation

	 Abilene Behavioral Health, LLC
	 	DE
	 Acadia - YFCS Holdings, Inc.
	 	DE
	 Acadia Management Company, LLC
	 	DE
	 Acadia Merger Sub, LLC
	 	DE
	 Acadiana Addiction Center, LLC
	 	DE
	 AmiCare Behavioral Centers, LLC
	 	DE
	 AmiCare Contract Services, LLC
	 	DE
	 BCA of Detroit, LLC
	 	DE
	 BCA Real Estate Holdings, LLC
	 	DE
	 Behavioral Centers of America, LLC
	 	DE
	 Children’s Behavioral Solutions, LLC
	 	DE
	 Commodore Acquisition Sub, LLC
	 	DE
	 Greenleaf Center, LLC
	 	DE
	 HEP BCA Holdings Corp.
	 	DE
	 Hermitage Behavioral, LLC
	 	DE
	 HMIH Cedar Crest, LLC
	 	DE
	 Lakeview Behavioral Health System LLC
	 	DE
	 Linden BCA Blocker Corp.
	 	DE
	 PHC Meadowwood, Inc.
	 	DE
	 Northeast Behavioral Health, LLC
	 	DE
	 Piney Ridge Treatment Center, LLC
	 	DE
	 PRC I, Inc.
	 	DE
	 Psychiatric Resource Partners, Inc.
	 	DE
	 Red River Hospital, LLC
	 	DE
	 RiverWoods Behavioral Health, LLC
	 	DE
	 SBOF-BCA Holdings Corporation
	 	DE
	 Seven Hills Hospital, Inc.
	 	DE
	 Suncoast Behavioral, LLC
	 	DE
	 SW Behavioral, LLC
	 	DE
	 Sonora Behavioral Health Hospital, LLC
	 	DE
	 TK Behavioral, LLC
	 	DE
	 Valley Behavioral Health System, LLC
	 	DE
	 Vermilion Hospital, LLC
	 	DE
	 Village Behavioral Health, LLC
	 	DE
	 Vista Behavioral Health, LLC
	 	DE

  
 13 

 Non-Covered Guarantors 

 

			
	 Company
	 	 State of Incorporation/Formation

	 Ascent Acquisition Corporation
	 	AR
	 Ascent Acquisition Corporation - CYPDC
	 	AR
	 Ascent Acquisition Corporation - PSC
	 	AR
	 Child & Youth Pediatric Day Clinics, Inc
	 	AR
	 Childrens Medical Transportation Services, LLC
	 	AR
	 FSRE, LLC
	 	AR
	 FVRE, LLC
	 	AR
	 Habilitation Center, Inc.
	 	AR
	 Med Properties, Inc.
	 	AR
	 Meducare Transport, L.L.C.
	 	AR
	 Millcreek School of Arkansas, Inc.
	 	AR
	 Pediatric Specialty Care Properties, LLC
	 	AR
	 Pediatric Specialty Care, Inc.
	 	AR
	 Southwestern Children’s Health Services, Inc.
	 	AZ
	 Youth And Family Centered Services Of Florida, Inc.
	 	FL
	 Lakeland Hospital Acquisition Corporation
	 	GA
	 Millcreek Management Corporation
	 	GA
	 YFCS Holdings - Georgia, Inc.
	 	GA
	 YFCS Management, Inc.
	 	GA
	 Youth and Family Centered Services, Inc.
	 	GA
	 Options Community Based Services, Inc.
	 	IN
	 Options Treatment Center Acquisition Corporation
	 	IN
	 Resolute Acquisition Corporation
	 	IN
	 Resource Community Based Services, Inc.
	 	IN
	 RTC Resource Acquisition Corporation
	 	IN
	 Success Acquisition Corporation
	 	IN
	 Behavioral Health Online, Inc.
	 	MA
	 Detroit Behavioral Institute, Inc.
	 	MA
	 PHC of Michigan, Inc.
	 	MA
	 PHC of Nevada, Inc.
	 	MA
	 PHC of Utah, Inc.
	 	MA
	 PHC of Virginia, Inc.
	 	MA
	 Renaissance Recovery, Inc.
	 	MA
	 Wellplace, Inc.
	 	MA
	 Stone Crest Clinic
	 	MI
	 Millcreek Schools Inc.
	 	MS
	 Rehabilitation Centers, Inc.
	 	MS
	 Kids Behavioral Health of Montana, Inc.
	 	MT
	 Memorial Hospital Acquisition Corporation
	 	NM
	 Youth And Family Centered Services of New Mexico, Inc.
	 	NM
	 Generations Behavioral Health - Geneva, LLC
	 	OH
	 Healthcare Management and Investment of Ohio, LLC
	 	OH
	 Ohio Hospital for Psychiatry, LLC
	 	OH
	 Shaker Clinic, LLC
	 	OH
	 Ten Lakes Center, LLC
	 	OH
	 Rolling Hills Hospital, Inc.
	 	OK
	 Rolling Hills Properties, Inc.
	 	OK

  
 14 

 Non-Covered Guarantors, Continued 

 

			
	 Company
	 	 State of Incorporation/Formation

	 Southwood Psychiatric Hospital, Inc.
	 	PA
	 Rebound Behavioral Health, LLC
	 	SC
	 Cedar Crest Clinic
	 	TX
	 Fort Smith Healthcare Real Estate, L.C.
	 	TX
	 Pinewood Enterprises, L.C.
	 	TX
	 Pinewood Healthcare Realty, L.P.
	 	TX
	 Pinewood Services, Inc.
	 	TX
	 TBA Texarkana, L.L.C.
	 	TX
	 Vantage Point Behavioral Health, LLC
	 	TX

  
 15 

 Schedule B 

Applicable Orders 

None. 

  
 16 

 Schedule C 

Applicable Contracts 
  

	1.	Indenture, dated November 1, 2011, by and among the Company, the guarantors party thereto and U.S. Bank National Association, as amended. 

 

	2.	Form of 12.875% Senior Note due 2018. (Included in No. 1) 

  

	3.	Registration Rights Agreement, dated November 1, 2011, by and among the Company, the guarantors party thereto and Jefferies & Company, Inc.

  

	4.	Stockholders Agreement, dated November 1, 2011, as amended April 25, 2012, by and among the Company and certain stockholders party thereto.

  

	5.	Amended and Restated Registration Rights Agreement, dated April 1, 2011, by and among the Company and the other persons party thereto. 

 

	6.	Form of Subscription Agreement and Warrant. 

  

	7.	Amended and Restated Credit Agreement, dated December 31, 2012, by and among Bank of America, NA (Administrative Agent, Swing Line Lender and L/C Issuer) and the
Company (f/k/a Acadia Healthcare Company, LLC), the guarantors listed on the signature pages thereto, and the lenders listed on the signature pages thereto, as amended by that certain Consent and First Amendment, dated as of March
[    ], 2013, among the Company, the guarantors listed on the signature pages thereto, and the Required Lenders 

  

	8.	Engagement Agreement, dated January 7, 2011, between True Partners Consulting LLC and the Company. 

 

	9.	Termination Agreement, dated as of November 1, 2011, by and between Waud Capital Partners, L.L.C. and the Company. 

 

	10.	Underwriting Agreement, dated December 6, 2012, by and among the Company, the selling stockholders named in Schedule B thereof and Merrill Lynch, Pierce,
Fenner & Smith Incorporated, Citigroup Global Markets Inc. and Jefferies & Company, Inc., as representatives of the several underwriters named therein. 

 

	11.	Consent under Stockholders Agreement, dated February 28, 2013, of Waud Capital Partners II, L.P., Waud Capital Partners QP II, L.P., Waud Capital Partners III,
L.P., and Waud Capital Partners QP III, L.P. 

  
 17 

 Schedule D 

Captions In the OM 

The following captions under “Risk Factors” in the OM: 
  

	1.	Our revenues and results of operations are significantly affected by payments received from the government and third-party payors. 

 

	2.	We may be required to spend substantial amounts to comply with legislative and regulatory initiatives relating to privacy and security of patient health
information. 

  

	3.	We have been and could become the subject of governmental investigations, regulatory actions and whistleblower lawsuits. 

 

	4.	We are subject to uncertainties regarding recent health reform and budget legislation. 

 

	5.	State efforts to regulate the construction or expansion of healthcare facilities could impair our ability to operate and expand our operations.

  

	6.	Controls designed to reduce inpatient services may reduce our revenues. 

 

	7.	We are required to treat patients with emergency medical conditions regardless of ability to pay. 

 

	8.	A cyber security incident could cause a violation of HIPAA, breach of member privacy, or other negative impacts. 

The following captions under “Business” in the OM: 
  

	1.	Sources of Revenue 

  

	2.	Regulation 

  
 18 

 EXHIBIT B 

CERTIFICATE 

OF THE 

CHIEF FINANCIAL OFFICER 
 OF 
 ACADIA HEALTHCARE COMPANY, INC. 

March 12, 2013 
 I, David Duckworth, Chief Financial Officer of Acadia Healthcare Company, Inc., a Delaware corporation (the “Company”), do hereby certify, pursuant to Section 7(b)(iv) of the
Purchase Agreement (the “Purchase Agreement”), dated March 7, 2013, among the Company, the Guarantors party thereto and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representative of the initial purchasers
(the “Initial Purchasers”), relating to the issue and sale of $150,000,000 aggregate principal amount of 6.125% Senior Notes due 2021 (the “Notes”), as described in the Time of Sale Document and the Final Offering
Memorandum (as such terms are defined in the Purchase Agreement), as follows: 
  

	 	1.	I am knowledgeable with respect to the internal accounting practices, policies, procedures and controls of the Company. 

 

	 	2.	I have supervised the compilation of and reviewed the financial information included or incorporated by reference in the Time of Sale Document and the Final Offering
Memorandum as identified on Exhibit A attached hereto (the “Financial Information”). 

  

	 	3.	In my opinion, (a) the Financial Information has been properly derived from the books and records of the Company and its subsidiaries for the periods presented,
(b) the Financial Information has been presented on the basis described in the Time of Sale Document and the Final Offering Memorandum and (c) the assumptions used in the preparation of the Financial Information are made on a reasonable
basis and in good faith and the adjustments used therein are appropriate to give effect to the transactions and circumstances referred to therein. 

 This certificate is being furnished to the Initial Purchasers to assist them in conducting and documenting their investigation of the Company and its subsidiaries in connection with the offering of the
Notes. 
 (Signature Page Follows) 

  
 1 

 NOW THEREFORE, the undersigned has executed and delivered this certificate on behalf of the
Company as of the date first written above. 
  

					
		
	By:	 	  

		 	Name:	 	David M. Duckworth
		 	Title:	 	Chief Financial Officer

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00214-of-00352.parquet"}]]